Methods and associated kits for spatial analysis - Patents.com

The method uses spatial probes and molecular probes with recording tags to analyze macromolecules, addressing limitations in existing technologies by enabling high-throughput, multiplexed, and spatially-resolved analysis of proteins and peptides.

JP7578294B2Active Publication Date: 2024-11-06ENCODIA INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021569054
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-05-20
Filing Date
2020-05-19
Publication Date
2024-11-06
Estimated Expiration
2040-05-19

AI Technical Summary

Technical Problem

Existing methods for analyzing macromolecules, such as proteins, are limited in their ability to provide high-throughput, multiplexed, and spatially-resolved information about the identity, concentration, and distribution of multiple macromolecules in a sample, often requiring additional samples and lacking sensitivity and accuracy.

Method used

A method involving the use of spatial probes and molecular probes with recording tags to transfer information for sequence determination, allowing for the analysis of macromolecules by correlating their spatial location with their sequence information through barcode encoding and detectable labels.

Benefits of technology

Enables high-throughput, multiplexed, and spatially-resolved analysis of macromolecules, providing accurate sequence information and spatial distribution data, enhancing the characterization of proteins and peptides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578294000002
    Figure 0007578294000002
  • Figure 0007578294000003
    Figure 0007578294000003
  • Figure 0007578294000001
    Figure 0007578294000001
Patent Text Reader

Abstract

Provided herein are methods and compositions for spatial analysis of macromolecules (e.g., proteins, polypeptides, or peptides). In some embodiments, the methods are for analyzing a macromolecule or multiple macromolecules (e.g., peptides, polypeptides, and proteins) including determining spatial information and sequencing the macromolecule. In some embodiments, the analysis uses barcoding and / or nucleic acid encoding of molecular recognition events and / or detectable labels. Also provided are compositions, e.g., kits, containing components for carrying out the provided methods for analyzing macromolecules.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] Related Applications This application claims priority to U.S. Provisional Patent Application No. 62 / 850,410, filed May 20, 2019, and U.S. Provisional Patent Application No. 62 / 850,426, filed May 20, 2019, the disclosures and contents of each of which are incorporated by reference in their entirety for all purposes.

[0002] Sequence listing in ASCII text This patent or application file contains a sequence listing submitted in computer-readable ASCII text format (Filename: 4614-2001840_20200518_SeqList_ST25.txt, Recorded: May 18, 2020, Size: 693 bytes). The contents of the sequence listing file are incorporated herein by reference in their entirety.

[0003] The present disclosure relates to methods and compositions for the analysis or spatial analysis of macromolecules (e.g., proteins, polypeptides, or peptides). In some embodiments, the methods are for analyzing a macromolecule or multiple macromolecules (e.g., peptides, polypeptides, and proteins) and include assessing or determining the spatial information, properties, sequence, and / or identity of the macromolecule. In some embodiments, the analysis uses barcoding and nucleic acid encoding of molecular recognition events and / or detectable labels. Also provided are compositions, e.g., kits, containing components for carrying out the provided methods for analyzing macromolecules. [Background technology]

[0004] Existing methods for identifying and analyzing molecules from a sample while providing information about the sample's characteristics, such as the identity, concentration, and / or spatial distribution of multiple macromolecules within the sample, are limited. For example, known approaches for identifying proteins while preserving other sample or spatial information are not suitable for analyzing a large number of unknown proteins within a sample. Some current techniques may require the use of additional biological samples from sources that detect only a few targets at a time, limiting the ability to determine the relative characteristics of targets between samples. Furthermore, in certain instances, limited amounts of sample may be available for analysis, or individual samples may require further analysis, including analysis of protein identity and / or sequence. In some cases, imaging-based approaches for large numbers of cells may lack the ability to provide information about the cellular characteristics of a sample, such as cell type or phenotype. Thus, there remains a need in the art for improved techniques related to macromolecule (e.g., polypeptide or polynucleotide) analysis that enable characterization that is multiplexed and / or can provide spatial information, identity, and / or highly parallelized, accurate, sensitive, and / or high-throughput protein sequencing. Summary of the Invention [Means for solving the problem]

[0005] This Summary of the Invention is not intended to be used to limit the scope of the claimed subject matter. Other features, details, utilities, and advantages of the claimed subject matter will become apparent from the detailed description, including the embodiments disclosed in the accompanying drawings and the appended claims.

[0006] Provided herein is a method for analyzing a macromolecule, comprising: providing a spatial sample containing a macromolecule associated with a recording tag at a spatial location; assessing (e.g., observing) in situ the spatial location of the macromolecule within the spatial sample; binding a molecular probe containing a probe tag to the macromolecule within the spatial sample or a portion thereof proximate to the macromolecule; extending the recording tag by transferring information from the probe tag within the molecular probe to the recording tag, wherein transferring the information from the probe tag to the recording tag generates an extended recording tag; determining the sequence of at least the probe tag within the extended recording tag; and correlating the sequence of the probe tag within the extended recording tag with the assessed molecular probe and / or spatial location, thereby associating information from the sequence of the extended recording tag, or a portion thereof, with the spatial location of the observed macromolecule.

[0007] Provided herein is a method for analyzing a macromolecule (e.g., a protein, polypeptide, or peptide), comprising: (a) providing a spatial sample containing the macromolecule associated with a recording tag; (b1) providing a spatial probe containing the spatial tag to the spatial sample; (b2) evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; (b3) extending the recording tag by transferring information from the spatial tag in the spatial probe to the recording tag; (c1) binding a molecular probe containing the probe tag to the macromolecule or a portion proximate to the macromolecule within the spatial sample; and (c2) binding the probe in the molecular probe. (d) determining the sequence of at least the probe tag and the probe tag in the extended recording tag; and (e) correlating the sequence of the spatial tag determined in step (d) with the spatial tag evaluated in step (b2), thereby associating information from the sequence of the extended recording tag or a portion thereof, e.g., information from the spatial tag and / or probe tag determined in step (d), with the spatial location of the spatial probe evaluated in step (b2).

[0008] In some embodiments, the method is for analyzing a plurality of macromolecules. In some embodiments, the macromolecules are polypeptides. Optionally, the method further comprises performing a macromolecular analysis assay or a polypeptide analysis assay. In some embodiments, the method comprises binding a plurality of molecular probes and a plurality of spatial probes to the spatial sample. In some embodiments, information from a plurality of probe tags is transferred to a recording tag. In some embodiments, information from a plurality of spatial tags is transferred to a recording tag. In some embodiments, a cycle of binding with a molecular probe, transferring information from the probe tag associated with the molecular probe to the recording tag (thereby extending the recording tag and generating an extended recording tag), binding with a spatial probe, and transferring information from the spatial tag associated with the spatial probe to the recording tag (thereby extending the recording tag and generating an extended recording tag) is performed. The probe tag and / or spatial tag may include a barcode in addition to other optional nucleic acid components. In some embodiments, one or more of the provided steps are repeated one or more times. In some embodiments, the order of performing at least some of the steps of the method may be changed.

[0009] In some embodiments, the method further includes performing a macromolecule analysis assay, such as a polypeptide analysis assay. The macromolecule analysis assay includes contacting the macromolecule with one or more binding agents and transferring identification information from a coding tag associated with the binding agent to a recording tag. In some embodiments, the contacting of the macromolecule with the binding agent and the transfer of information from the coding tag to the recording tag are repeated two or more times. In some embodiments, the macromolecule and associated recording tag, including information transferred from the probe tag and spatial tag, are released from the spatial sample before performing the macromolecule analysis assay. In some of these embodiments, the macromolecule analysis assay includes one or more cycles of contacting the macromolecule with a binding agent capable of binding to the macromolecule, where the binding agent includes a coding tag having identification information related to the binding agent, and transferring the information from the coding tag to the recording tag to further extend the extended recording tag. In some embodiments, the extended recording tag includes information from one or more spatial tags, one or more probe tags, and optionally one or more coding tags.

[0010] Provided herein are methods for analyzing macromolecules (e.g., proteins, polypeptides, or peptides), comprising: (a) providing a recording tag to a spatial sample containing the macromolecule; (b) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion proximal to the macromolecule within the spatial sample; (c) transferring information from the probe tag within the molecular probe to the recording tag to generate an extended recording tag; (d) evaluating, e.g., observing, the detectable label to obtain spatial information about the molecular probe; (e) determining the sequence of at least the probe tag within the extended recording tag; and (f) correlating the sequence of the probe tag determined in step (e) with the molecular probe, thereby associating information from the sequence determined in step (e) with its spatial information determined in step (d). In some embodiments, the method is for analyzing a plurality of macromolecules. In some aspects, the macromolecule is a polypeptide. In some embodiments, the method comprises binding a plurality of molecular probes, each comprising a detectable label and a probe tag, to the spatial sample. The molecular probes may bind to the macromolecule within the spatial sample or to a portion proximal to the macromolecule within the spatial sample. In some embodiments, the molecular probe binds to a moiety that binds to, associates with, or forms a complex with a macromolecule within the spatial sample. In some embodiments, information from multiple probe tags is transferred to a recording tag. In some embodiments, cycles of binding with molecular probes, transferring information from the molecular probes to the recording tag, and / or evaluating, e.g., observing, the detectable label are performed. In some aspects, the order of performing at least some of the steps of any of the provided methods can be changed. In some embodiments, the recording tag is not associated with or attached to the macromolecule. In some embodiments, the recording tag is associated with or attached to the macromolecule.

[0011] In some embodiments, the method further includes performing a macromolecule analysis assay. In some cases, the macromolecule analysis assay is a polypeptide analysis assay that includes contacting the macromolecule with a binding agent associated with a coding tag and transferring information from the coding tag to a recording tag, thereby extending the recording tag. In some embodiments, the macromolecule and associated recording tag containing the information transferred from the probe tag are released from the spatial sample before performing the macromolecule analysis assay. In some of these embodiments, the macromolecule analysis assay includes one or more cycles of contacting the macromolecule with a binding agent capable of binding to the macromolecule, where the binding agent includes a coding tag having identifying information related to the binding agent, and transferring the information from the coding tag to the recording tag to further extend the extended recording tag.

[0012] Also provided herein are kits and reagents for carrying out any of the methods for analyzing macromolecules, e.g., polypeptides, provided herein. In some embodiments, the kits include one or more of the following components: spatial probes, spatial tags, molecular probes, probe tags, reagents for sequencing, reagents for carrying out nucleic acid extension recording tags, reagents for attaching or transferring recording tags, binding agents, reagents for transferring identifying information from probe tags or spatial tags to recording tags, reagents for transferring identifying information from coding tags to recording tags, and / or solid supports.

[0013] Non-limiting embodiments of the present invention will now be described by way of example with reference to the accompanying drawings, which are schematic and not intended to be drawn to scale. For illustrative purposes, not every component will be labeled in every drawing, nor will every component of every embodiment of the invention be shown unless illustration is necessary to enable those skilled in the art to understand the invention. In certain embodiments, for example, the following items are provided: (Item 1) 1. A method for analyzing a macromolecule, comprising: (a) providing a spatial sample containing macromolecules associated with recording tags at spatial locations; (b) assessing in situ the spatial location of the macromolecule within the spatial sample; and (c1) binding a molecular probe comprising a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (c2) extending the recording tag by transferring information from the probe tag in the molecular probe to the recording tag, wherein transferring information from the probe tag to the recording tag generates an extended recording tag; and (d) determining the sequence of the probe tag within at least the extended recording tag; (e) correlating the sequence of the probe tag determined in step (d) with the molecular probe and / or the spatial location evaluated in step (b); Thereby associating information from the sequence of the extended recording tag or portion thereof determined in step (d) with the spatial location evaluated in step (b). (Item 2) 1. A method for analyzing a macromolecule, comprising: (a) providing a spatial sample containing a macromolecule associated with a recording tag; (b1) providing a spatial probe comprising a spatial tag to the spatial sample; (b2) evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; (b3) decompressing the recording tag by transferring information from the spatial tag in the spatial probe to the recording tag; (c1) binding a molecular probe comprising a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (c2) extending the recording tag by transferring information from the probe tag in the molecular probe to the recording tag, wherein transferring information from the spatial tag and / or probe tag to the recording tag generates an extended recording tag; and (d) determining the sequence of the probe tag and spatial tag within at least the extended recording tag; (e) correlating the sequence of the spatial tags determined in step (d) with the spatial tags evaluated in step (b2); This method associates information from the sequence of the extended recording tag or part thereof, e.g., the information from the spatial tag and / or probe tag determined in step (d), with the spatial position of the spatial probe evaluated in step (b2). (Item 3) 3. The method according to claim 1, wherein the method is for analyzing a plurality of macromolecules within the spatial sample. (Item 4) 4. The method according to any one of items 1 to 3, wherein the macromolecule is a protein, a polypeptide, or a peptide. (Item 5) 5. The method according to any one of items 1 to 4, wherein the method comprises binding a plurality of molecular probes to the spatial sample. (Item 6) 6. The method according to any one of items 2 to 5, wherein the method comprises providing a plurality of spatial probes to the spatial sample. (Item 7) 7. The method according to any one of items 1 to 6, further comprising repeating step (c1) and step (c2) sequentially two or more times. (Item 8) 7. The method of claim 6, further comprising removing the molecular probe from the spatial sample before repeating step (c1). (Item 9) 9. The method according to any one of items 2 to 8, wherein the spatial probe comprises a support and a spatial tag comprising a nucleic acid. (Item 10) 10. The method of claim 9, wherein the support comprises beads or nanoparticles. (Item 11) Item 11. The method according to item 10, wherein the beads or nanoparticles have a diameter in the range of about 50 nm to about 100 μm, about 50 nm to about 50 μm, about 50 nm to about 10 μm, about 0.1 μm to about 100 μm, about 0.1 μm to about 50 μm, about 10 μm to about 50 μm, about 5 μm to about 10 μm, about 0.5 μm to about 100 μm, about 0.5 μm to about 50 μm, about 0.5 μm to about 10 μm, about 0.5 μm to about 5 μm, or about 0.5 μm to about 1 μm. (Item 12) 12. The method of any one of items 2 to 11, wherein the spatial probe comprises a barcoded bead. (Item 13) 13. The method according to any one of items 6 to 12, wherein the spatial probes are randomly distributed on the spatial sample. (Item 14) 14. The method according to any one of items 9 to 13, wherein the spatial tag is attached to the support with a cleavable linker. (Item 15) 15. The method of any one of items 1 to 14, wherein the spatial tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. (Item 16) 16. The method of any one of items 2 to 15, wherein the spatial tag comprises a universal priming site. (Item 17) 17. The method of any one of items 2 to 16, wherein the spatial tag comprises a barcode. (Item 18) 18. The method of claim 17, wherein the spatial probe comprises a plurality of barcodes. (Item 19) 19. The method of claim 18, wherein the spatial probe comprises two or more copies of the same barcode. (Item 20) 20. The method of any one of items 2 to 19, wherein the spatial tag comprises a spacer. (Item 21) 21. The method according to any one of items 2 to 20, wherein the spatial tag comprises a sequence complementary to the recording tag or a part thereof. (Item 22) 22. The method according to any one of items 2 to 21, wherein the spatial probe non-specifically associates with the spatial sample. (Item 23) 23. The method of claim 22, wherein the spatial probe associates with the spatial sample via charge interactions, DNA hybridization, and / or reversible chemical coupling. (Item 24) 24. The method according to any one of items 2 to 23, wherein performing step (b2) comprises obtaining an image of said spatial sample or part thereof. (Item 25) 25. The method of claim 24, wherein two or more images of the spatial sample or portion thereof are acquired. (Item 26) 26. The method of claim 25, further comprising comparing, aligning, and / or overlaying two or more images. (Item 27) 27. The method of any one of items 2 to 26, wherein performing step (b2) comprises using a microscope. (Item 28) 28. The method according to item 27, wherein the microscope is a fluorescence microscope. (Item 29) 29. The method of any one of items 2 to 28, wherein the spatial tag is evaluated in step (b2) using a decoder, the decoder comprising a detectable label and a sequence complementary to the spatial tag or a part thereof. (Item 30) 30. The method of claim 29, wherein two or more decoders are used to detect one or more of the spatial tags. (Item 31) 31. The method of claim 29 or 30, wherein the detectable label comprises a radioisotope, a fluorescent label, a colorimetric label, or an enzyme substrate label. (Item 32) 24. The method according to items 2 to 23, wherein step (b2) comprises sequencing by ligation, single molecule sequencing, single molecule fluorescence sequencing, or sequencing by probe detection. (Item 33) 33. The method according to any one of items 2 to 32, wherein the spatial tag is transferred to the recording tag by primer extension or ligation. (Item 34) 34. The method of any one of items 2 to 33, wherein extending the recording tag by transferring information from the spatial tag to the recording tag comprises contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the recording tag. (Item 35) 35. The method of any one of items 1 to 34, wherein the molecular probe comprises a nucleic acid, a polypeptide, a small molecule, or any combination thereof. (Item 36) 36. The method of claim 35, wherein the molecular probe comprises an antibody, an antigen-binding antibody fragment, a single domain antibody (sdAb), a recombinant heavy chain-only antibody (VHH), a single chain antibody (scFv), a shark-derived variable domain (vNAR), an Fv, Fab, Fab', F(ab')2, a linear antibody, a diabody, an aptamer, a peptidomimetic molecule, a fusion protein, a reactive or non-reactive small molecule, or a synthetic molecule. (Item 37) 37. The method according to any one of items 1 to 36, wherein the molecular probe comprises a targeting moiety capable of specific binding. (Item 38) 38. The method of claim 37, wherein the targeting moiety is configured to bind to a nucleic acid, a carbohydrate, a lipid, a polypeptide, a post-translational modification of a polypeptide, or any combination thereof. (Item 39) 39. The method of claim 37 or 38, wherein the targeting moiety is a protein-specific targeting moiety. (Item 40) 39. The method of claim 37 or 38, wherein the targeting moiety is an epitope-specific targeting moiety. (Item 41) 39. The method of claim 37 or 38, wherein the targeting moiety is a nucleic acid-specific targeting moiety. (Item 42) 42. The method of any one of items 37 to 41, wherein the targeting moiety is configured to bind to a cell surface marker. (Item 43) 43. The method according to any one of items 1 to 42, wherein the bonding in step (c1) comprises a chemical bond, a covalent bond, and / or a reversible bond. (Item 44) 44. The method of any one of items 1 to 43, wherein the probe tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. (Item 45) 45. The method of any one of items 1 to 44, wherein the probe tag comprises a universal priming site. (Item 46) 46. ​​The method of any one of items 1 to 45, wherein the probe tag comprises a barcode. (Item 47) 47. The method of any one of items 1 to 46, wherein the probe tag comprises a spacer. (Item 48) 48. The method according to any one of items 1 to 47, wherein the probe tag comprises a sequence complementary to the recording tag or a part thereof. (Item 49) 49. The method of any one of items 1 to 48, wherein the probe tag is transferred to the recording tag by primer extension or ligation. (Item 50) 50. The method of any one of items 1 to 49, wherein information from the probe tag is transferred to a recording tag near the associated molecular probe. (Item 51) 51. The method of any one of items 1 to 50, wherein extending the recording tag by transferring information from the probe tag to the recording tag comprises contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the recording tag. (Item 52) 52. The method of any one of items 1 to 51, wherein step (c2) comprises transferring information from the probe tag to the recording tag directly or indirectly via a copy of the probe tag. (Item 53) 53. The method of any one of items 1 to 52, wherein step (c2) comprises transferring said information from one probe tag to two or more recording tags. (Item 54) 54. The method of any one of items 1 to 53, wherein the probe tag is amplified before step (c2). (Item 55) 55. The method of claim 54, wherein the amplification is linear amplification. (Item 56) 56. The method of claim 55, wherein amplification of the probe tag is carried out using an RNA polymerase. (Item 57) 57. The method of claim 56, wherein transferring the information of the probe tag to the recording tag is performed using reverse transcription. (Item 58) 58. The method of any one of items 1 to 57, further comprising performing a macromolecular analysis assay. (Item 59) 59. The method of claim 58, wherein the macromolecular analysis assay is a polypeptide analysis assay. (Item 60) 60. The method of claim 58 or 59, wherein the macromolecular analysis assay is performed in situ. (Item 61) 61. The method of any one of items 58 to 60, further comprising releasing the macromolecule associated with the recording tag from the spatial sample prior to performing the macromolecule analysis assay. (Item 62) 62. The method of any one of items 58 to 61, further comprising collecting the macromolecule associated with the recording tag before performing the macromolecule analysis assay. (Item 63) 63. The method of any one of items 58 to 62, wherein the macromolecule is directly or indirectly coupled to a solid support prior to performing the macromolecule analytical assay. (Item 64) the macromolecular analysis assay comprising: contacting the macromolecule with a binding agent capable of binding to the macromolecule, the binding agent comprising a coding tag having identifying information regarding the binding agent; Extending the recording tag associated with the macromolecule by transferring information of the coding tag to the recording tag. (Item 65) contacting the macromolecule with an additional binding agent capable of binding to the macromolecule, the additional binding agent comprising a coding tag having identifying information regarding the additional binding agent; Extending the recording tag associated with the macromolecule by transferring the identification information of the coding tag for the additional binding agent to the recording tag one or more times. (Item 66) 66. The method of any one of items 58 to 65, wherein transferring the identification information of the coding tag to the recording tag is by primer extension or ligation. (Item 67) 66. The method of any one of items 58 to 65, wherein the transfer of the identification information of the coding tag to the recording tag is mediated by a DNA polymerase. (Item 68) 66. The method of any one of items 58 to 65, wherein transferring the identification information of the coding tag to the recording tag is mediated by DNA ligase. (Item 69) 69. The method of any one of items 58 to 68, wherein the coding tag further comprises a spacer, a binding cycle-specific sequence, a unique molecular identifier, a universal priming site, or any combination thereof. (Item 70) 70. The method of claim 69, wherein the coding tag comprises a spacer at its 3' end. (Item 71) 71. The method of any one of items 58 to 70, wherein the binding agent and the coding tag are joined by a linker. (Item 72) 72. The method according to any one of items 58 to 71, wherein the macromolecule is a polypeptide or a protein. (Item 73) 73. The method of claim 72, wherein the binding agent is a modified aminopeptidase, a modified aminoacyl-tRNA synthetase, a modified anticalin, or an antibody or binding fragment thereof. (Item 74) 74. The method according to any one of items 58 to 73, wherein the binding agent binds to a single amino acid residue, a dipeptide, a tripeptide, or a post-translational modification of the peptide. (Item 75) 75. The method of claim 74, wherein the binding agent binds to an N-terminal amino acid residue, a C-terminal amino acid residue, or an internal amino acid residue. (Item 76) 75. The method of claim 74, wherein the binding agent binds to a chemically modified N-terminal amino acid residue or a chemically modified C-terminal amino acid residue. (Item 77) 77. The method of claim 75 or 76, wherein the binding agent binds to the N-terminal amino acid residue, and the N-terminal amino acid residue is cleaved after transferring the information of the coding tag to the recording tag. (Item 78) 77. The method of claim 75 or 76, wherein the binding agent binds to the C-terminal amino acid residue, and the C-terminal amino acid residue is cleaved after transferring the information of the coding tag to the recording tag. (Item 79) 79. The method according to items 1 to 78, wherein the extended recording tag comprises information from one or more probe tags, one or more spatial tags, and optionally one or more coding tags. (Item 80) 80. The method of any one of items 1 to 79, wherein the extended recording tag comprises information from two or more probe tags, two or more spatial tags, and optionally two or more coding tags. (Item 81) 81. The method of any one of items 1 to 80, wherein the extended recording tag is amplified prior to step (d). (Item 82) 81. The method of any one of items 1 to 80, wherein the elongated recording tag is released from the spatial sample prior to step (d). (Item 83) 83. The method of any one of items 58 to 82, further comprising determining at least a portion of the sequence of the macromolecule and associating it with its spatial position assessed in step (b2). (Item 84) 84. The method of claim 83, wherein step (d) comprises sequencing-by-synthesis, sequencing-by-ligation, sequencing-by-hybridization, polony sequencing, ion semiconductor sequencing, pyrosequencing, single molecule real-time sequencing, nanopore-based sequencing, or direct imaging of DNA using advanced microscopy. (Item 85) 85. The method of any one of items 1 to 84, wherein the spatial sample comprises a plurality of macromolecules, such as polypeptides. (Item 86) 86. The method of any one of items 1 to 85, wherein the spatial sample is provided on a solid support. (Item 87) 87. The method of any one of items 1 to 86, wherein the spatial sample comprises a plurality of cells deposited on a surface. (Item 88) 88. The method of any one of items 1 to 87, wherein the spatial sample comprises a tissue sample. (Item 89) 89. The method of any one of items 1 to 88, wherein the spatial sample is a formalin-fixed, paraffin-embedded (FFPE) section or a cell spread. (Item 90) 90. The method of any one of items 1 to 89, further comprising treating the spatial sample with a fixative and / or a cross-linking agent. (Item 91) 91. The method of any one of items 1 to 90, further comprising treating the spatial sample with a permeabilizing agent. (Item 92) 92. The method according to claim 90 or 91, wherein treating the spatial sample with a fixation, cross-linking, and / or permeabilization reagent is performed before step (b1) and / or step (c). (Item 93) 93. The method of any one of items 58 to 92, wherein the polypeptide is fragmented prior to performing the polypeptide analysis assay. (Item 94) 94. The method of claim 93, wherein the fragmentation is carried out by contacting the polypeptide with a protease. (Item 95) Item 95. The method of item 94, wherein the protease is trypsin, LysN, or LysC. (Item 96) 96. The method of any one of items 63 to 95, wherein the solid support is a bead, a porous bead, a porous matrix, an array, a glass surface, a silicon surface, a plastic surface, a filter, a membrane, nylon, a silicon wafer chip, a flow-through chip, a biochip comprising signal transduction electronics, a microtiter well, an ELISA plate, a rotating interferometer disk, a nitrocellulose membrane, a nitrocellulose-based polymer surface, a nanoparticle, or a microsphere. (Item 97) 97. The method of claim 96, wherein the solid support comprises polystyrene beads, polyacrylate beads, cellulose beads, dextran beads, polymer beads, agarose beads, acrylamide beads, solid core beads, porous beads, paramagnetic beads, glass beads, or controlled pore beads, or any combination thereof. (Item 98) 98. The method of any one of items 1 to 97, wherein the recording tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. (Item 99) Item 99. The method of any one of items 1 to 98, wherein step (a) comprises providing a plurality of recording tags to the spatial samples. (Item 100) Item 99. The method of any one of items 1 to 99, wherein the recording tags are included in a matrix applied to the spatial samples. (Item 101) 99. The method according to any one of items 1 to 99, wherein the recording tag is directly or indirectly associated with the macromolecule. (Item 102) 99. The method according to any one of items 1 to 99, wherein the macromolecule is directly or indirectly coupled to the recording tag. (Item 103) 103. The method of any one of items 1 to 102, wherein the recording tag comprises a unique molecular identifier (UMI). (Item 104) 104. The method of any one of items 1 to 103, wherein the recording tag comprises a compartment tag. (Item 105) 105. The method of any one of items 1 to 104, wherein the recording tag comprises a universal priming site. (Item 106) 106. The method of any one of items 1 to 105, wherein the recording tag comprises a spacer polymer. (Item 107) 107. The method of claim 106, wherein the spacer is at the 3' end of the recording tag. (Item 108) Step (a) is performed before steps (b1), (b2), (b3), (c1), (c2), (d), and (e); Step (b1) is performed before steps (b2), (d), and (e); Steps (c1) and (c2) are performed before steps (d) and (e); Steps (c1) and (c2) are performed before or after steps (b1), (b2), and / or (b3); Step (d) is performed before step (e), and / or 108. The method according to any one of items 2 to 107, wherein step (e) is carried out after steps (a)(b1), (b2), (b3), (c1), (c2), and (d). (Item 109) 109. The method of any one of items 2 to 108, wherein steps (c1) and (c2) are repeated two or more times in sequence before carrying out steps (d) and (e). (Item 110) 100. The method according to any one of items 2 to 109, wherein steps (c1) and (c2) are carried out before steps (b1), (b2), and (b3). (Item 111) 111. The method according to any one of items 2 to 110, wherein step (b2) is carried out after step (b1). (Item 112) 112. The method according to any one of items 2 to 111, wherein step (b2) is carried out before or after step (b3). (Item 113) 113. The method of any one of items 2 to 112, wherein steps (a), (c1), (c2), (b1), (b2), (b3), (d), and (e) occur in sequence. (Item 114) the molecular probes are removed prior to providing the spatial probes to the spatial sample; or 14. The method according to any one of items 2 to 113, wherein the spatial probes are removed from the sample before combining the sample with the molecular probes. (Item 115) 115. The method according to any one of items 58 to 114, wherein the macromolecular analysis assay is carried out before step (d) and step (e). (Item 116) 1. A method for analyzing a macromolecule, comprising: (a) providing a recording tag to a spatial sample containing a macromolecule; (b) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (c) transferring information from the probe tag in the molecular probe to the recording tag to generate an extended recording tag; (d) evaluating, e.g., observing, the detectable label to obtain spatial information about the molecular probe; (e) determining the sequence of the probe tag within at least the extended recording tag; (f) correlating the sequence of the probe tag determined in step (e) with the molecular probe; whereby information from said sequence determined in step (e) is associated with its spatial information determined in step (d). (Item 117) Item 117. The method of item 116, wherein the macromolecule is a protein. (Item 118) Item 117. The method of item 116, wherein the macromolecule is a polypeptide or peptide. (Item 119) 119. The method according to any one of items 116 to 118, wherein the method comprises binding a plurality of the molecular probes to the spatial sample. (Item 120) 120. The method of claim 119, wherein two or more probes are associated with the same detectable label. (Item 121) 120. The method of claim 119, wherein each molecular probe in the plurality of molecular probes is associated with a unique detectable label. (Item 122) 122. The method according to any one of items 116 to 121, further comprising repeating step (b) and step (c) sequentially two or more times. (Item 123) Item 123. The method of item 122, further comprising repeating step (d) two or more times. (Item 124) Item 124. The method of item 122 or item 123, further comprising removing the molecular probe from the spatial sample before repeating step (b). (Item 125) 124. The method of claim 112 or 123, further comprising inactivating the detectable label after evaluating, e.g., observing, the detectable label. (Item 126) 126. The method of any one of items 116 to 125, wherein the molecular probe comprises a nucleic acid, a polypeptide, a small molecule, or any combination thereof. (Item 127) 127. The method of any one of items 116 to 126, wherein the molecular probe comprises an antibody, an antigen-binding antibody fragment, a single domain antibody (sdAb), a recombinant heavy chain-only antibody (VHH), a single chain antibody (scFv), a shark-derived variable domain (vNAR), an Fv, Fab, Fab', F(ab')2, a linear antibody, a diabody, an aptamer, a peptidomimetic molecule, a fusion protein, a reactive or non-reactive small molecule, or a synthetic molecule. (Item 128) 128. The method according to any one of items 116 to 127, wherein the molecular probe comprises a targeting moiety capable of specific binding. (Item 129) 129. The method of claim 128, wherein the targeting moiety is configured to bind to a nucleic acid, a carbohydrate, a lipid, a polypeptide, a post-translational modification of a polypeptide, or any combination thereof. (Item 130) 130. The method of claim 128 or 129, wherein the targeting moiety is a protein-specific targeting moiety. (Item 131) 130. The method of claim 128 or 129, wherein the targeting moiety is an epitope-specific targeting moiety. (Item 132) 130. The method of claim 128 or 129, wherein the targeting moiety is a nucleic acid-specific targeting moiety. (Item 133) 133. The method of any one of items 128 to 132, wherein the targeting moiety is configured to bind to a cell surface marker. (Item 134) 134. The method according to any one of items 128 to 133, wherein the bonding in step (b) comprises a chemical bond, a covalent bond, and / or a reversible bond. (Item 135) 135. The method of any one of items 116 to 134, wherein the detectable label comprises a radioisotope, a fluorescent label, a colorimetric label, or an enzyme substrate label. (Item 136) 136. The method of any one of items 116 to 135, wherein evaluating, e.g. observing, the detectable label comprises obtaining a digital image of the spatial sample or a portion thereof. (Item 137) Item 137. The method of item 136, wherein two or more digital images of the spatial sample are acquired. (Item 138) Item 138. The method of item 137, wherein the two or more digital images provide combined spatial information of the plurality of molecular probes. (Item 139) Item 139. The method of item 137 or item 138, further comprising comparing, aligning, and / or overlaying at least two of the images. (Item 140) 139. The method of any one of items 116 to 139, further comprising inactivating the detectable label after evaluating, e.g., observing, the detectable label. (Item 141) 141. The method of any one of items 116 to 140, wherein evaluating, e.g., observing, the detectable label is carried out using a microscope. (Item 142) 142. The method of claim 141, wherein evaluating, e.g., observing, the detectable label is carried out using a fluorescence microscope. (Item 143) 143. The method of any one of items 116 to 142, wherein information from the probe tag is transferred to the recording tag by primer extension or ligation. (Item 144) Item 144. The method of item 143, wherein transferring information from the probe tag to the recording tag comprises contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the recording tag. (Item 145) 145. The method of any one of items 116 to 144, wherein information from the probe tag is transferred to a recording tag in the vicinity of the probe tag. (Item 146) 146. The method of any one of items 116 to 145, wherein step (c) comprises transferring information from the probe tag to the recording tag, either directly or indirectly via a copy of the probe tag. (Item 147) 147. The method of any one of items 116 to 146, wherein step (c) comprises transferring the information from one probe tag to two or more recording tags. (Item 148) 148. The method of any one of items 116 to 147, wherein the probe tag is amplified prior to step (c). (Item 149) 149. The method of claim 148, wherein amplification of the probe tag is carried out using an RNA polymerase. (Item 150) 149. The method of claim 148, wherein the amplification is linear amplification. (Item 151) 151. The method of claim 149 or 150, wherein transferring information from the probe tag to the recording tag is performed using reverse transcription. (Item 152) 152. The method of any one of items 116 to 151, wherein step (a) comprises providing the spatial samples with a plurality of recording tags. (Item 153) Item 153. The method according to any one of items 116 to 152, wherein the recording tags are included in a matrix applied to the spatial samples. (Item 154) 153. The method according to any one of items 116 to 152, wherein the recording tag is directly or indirectly associated with the macromolecule. (Item 155) 155. The method according to any one of items 116 to 151 and 154, wherein the macromolecule is directly or indirectly coupled to the recording tag. (Item 156) 156. The method of any one of items 116 to 155, further comprising performing a macromolecular analysis assay. (Item 157) 157. The method of claim 156, wherein the macromolecular analysis assay is a polypeptide analysis assay. (Item 158) 158. The method of claim 156 or 157, wherein the macromolecular analysis assay is performed in situ. (Item 159) 159. The method of any one of items 156 to 158, further comprising releasing the macromolecule associated with the recording tag from the spatial sample prior to performing the macromolecule analysis assay. (Item 160) 159. The method of any one of items 156 to 159, further comprising collecting the macromolecule associated with the recording tag before performing the macromolecule analysis assay. (Item 161) 161. The method of any one of items 156 to 160, wherein the macromolecule is directly or indirectly coupled to a solid support prior to performing the macromolecule analytical assay. (Item 162) the macromolecular analysis assay comprising: contacting the macromolecule with a binding agent capable of binding to the macromolecule, the binding agent comprising a coding tag having identifying information regarding the binding agent; and transferring the information of the coding tag to the recording tag to generate the decompressed recording tag. (Item 163) contacting the macromolecule with an additional binding agent capable of binding to the macromolecule, the additional binding agent comprising a coding tag having identifying information regarding the additional binding agent; Item 163. The method of item 162, further comprising repeating one or more times the steps of: transferring the identification information of the coding tag relating to the additional binding agent to the extended recording tag; (Item 164) Item 164. The method of item 162 or item 163, wherein the transferring of the identifying information of the coding tag to the recording tag is mediated by DNA ligase. (Item 165) Item 164. The method of item 162 or item 163, wherein the transfer of the identification information of the coding tag to the recording tag is mediated by a DNA polymerase. (Item 166) Item 164. The method of item 162 or item 163, wherein transferring the identifying information of the coding tag to the recording tag is mediated by chemical ligation. (Item 167) 167. The method of any one of items 162 to 166, wherein the coding tag further comprises a spacer, a binding cycle-specific sequence, a unique molecular identifier, a universal priming site, or any combination thereof. (Item 168) 168. The method of claim 167, wherein the coding tag comprises a spacer at its 3' end. (Item 169) 169. The method of any one of items 162 to 168, wherein the binding agent and the coding tag are joined by a linker. (Item 170) 169. The method of any one of items 162 to 169, wherein the binding agent is a polypeptide or a protein. (Item 171) 171. The method of claim 170, wherein the binding agent is a modified aminopeptidase, a modified aminoacyl-tRNA synthetase, a modified anticalin, or an antibody or binding fragment thereof. (Item 172) 172. The method according to any one of items 162 to 171, wherein the binding agent binds to a single amino acid residue, a dipeptide, a tripeptide, or a post-translational modification of the polypeptide. (Item 173) 173. The method of claim 172, wherein the binding agent binds to an N-terminal amino acid residue, a C-terminal amino acid residue, or an internal amino acid residue. (Item 174) 173. The method of claim 172, wherein the binding agent binds to a chemically modified N-terminal amino acid residue or a chemically modified C-terminal amino acid residue. (Item 175) 175. The method of claim 173 or 174, wherein the binding agent binds to the N-terminal amino acid residue, and the N-terminal amino acid residue is cleaved after transferring the information of the coding tag to the recording tag. (Item 176) 175. The method of claim 173 or 174, wherein the binding agent binds to the C-terminal amino acid residue, and the C-terminal amino acid residue is cleaved after transferring the information of the coding tag to the recording tag. (Item 177) 177. The method of any one of items 162 to 176, wherein the extended recording tag comprises information from one or more probe tags and one or more coding tags. (Item 178) 177. The method of any one of items 162 to 176, wherein the extended recording tag comprises information from two or more probe tags and two or more coding tags. (Item 179) 179. The method of any one of items 116 to 178, wherein the extended recording tag is amplified prior to step (e). (Item 180) 179. The method of any one of items 116 to 179, wherein step (e) comprises sequencing by synthesis, sequencing by ligation, sequencing by hybridization, polony sequencing, ion semiconductor sequencing, pyrosequencing, single molecule real-time sequencing, nanopore-based sequencing, or direct imaging of DNA using advanced microscopy. (Item 181) 181. The method of any one of items 116 to 180, wherein the spatial sample comprises a plurality of said macromolecules, e.g., polypeptides. (Item 182) 182. The method of any one of items 116 to 181, wherein the spatial sample is provided on a solid support. (Item 183) 183. The method of claim 182, wherein the spatial sample comprises a plurality of cells deposited on a surface. (Item 184) 183. The method of any one of items 116 to 182, wherein the spatial sample comprises a tissue sample. (Item 185) 183. The method of any one of items 116 to 182, wherein the spatial sample is a formalin-fixed, paraffin-embedded (FFPE) section or a cell spread. (Item 186) 186. The method of any one of items 156 to 185, further comprising determining at least a portion of the sequence of the macromolecule and associating it with its spatial location determined in step (d). (Item 187) 186. The method of any one of items 116 to 185, further comprising treating the spatial sample with a fixative, a cross-linking agent, and / or a permeabilizing agent. (Item 188) 188. The method of claim 187, wherein fixation, crosslinking, and / or permeabilization of the spatial sample is carried out before step (b). (Item 189) 189. The method of any one of items 157 to 188, wherein the polypeptide is fragmented prior to performing the polypeptide analysis assay. (Item 190) 190. The method of claim 189, wherein the fragmentation is carried out by contacting the polypeptide with a protease. (Item 191) 191. The method of claim 190, wherein the protease is trypsin, LysN, or LysC. (Item 192) 192. The method of any one of items 161 to 191, wherein the solid support is a bead, a porous bead, a porous matrix, an array, a glass surface, a silicon surface, a plastic surface, a filter, a membrane, nylon, a silicon wafer chip, a flow-through chip, a biochip comprising signal transduction electronics, a microtiter well, an ELISA plate, a rotating interferometer disk, a nitrocellulose membrane, a nitrocellulose-based polymer surface, a nanoparticle, or a microsphere. (Item 193) 193. The method of claim 192, wherein the solid support comprises polystyrene beads, polyacrylate beads, cellulose beads, dextran beads, polymer beads, agarose beads, acrylamide beads, solid core beads, porous beads, paramagnetic beads, glass beads, or controlled pore beads, or any combination thereof. (Item 194) 194. The method of any one of items 116 to 193, wherein the probe tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. (Item 195) 195. The method of any one of items 116 to 194, wherein the probe tag comprises a universal priming site. (Item 196) 196. The method of any one of items 116 to 195, wherein the probe tag comprises a barcode. (Item 197) 197. The method of any one of items 116 to 196, wherein the probe tag comprises a spacer. (Item 198) 198. The method of any one of items 116 to 197, wherein the recording tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. (Item 199) 199. The method of any one of items 116 to 198, wherein the recording tag comprises a unique molecular identifier (UMI). (Item 200) 200. The method of any one of items 116 to 199, wherein the recording tag comprises a compartment tag. (Item 201) 201. The method of any one of items 116 to 200, wherein the recording tag comprises a universal priming site. (Item 202) 201. The method of any one of items 116 to 200, wherein the recording tag comprises a spacer polymer. (Item 203) 203. The method of claim 202, wherein the spacer is at the 3' end of the recording tag. (Item 204) Step (a) is performed before steps (b), (c), (d), (e), and (f); Step (b) is performed before steps (c), (d), (e), and (f); Step (c) is performed before or after step (d); Step (c) is performed before steps (e) and (f); Step (d) is performed before steps (e) and (f); Step (e) is performed after steps (a), (b), (c), and (d); and / or The method according to any one of items 116 to 203, wherein step (e) is carried out before step (f). (Item 205) Steps (a), (b), (c), (d), (e), and (f) occur in sequence; or 204. The method of any one of items 116 to 203, wherein steps (a), (b), (d), (c), (e), and (f) occur in sequence. (Item 206) Item 206. The method of item 205, wherein steps (b), (c), and (d) are repeated sequentially two or more times before performing steps (e) and (f). (Item 207) Item 206. The method of item 205, wherein steps (b), (d), and (c) are repeated sequentially two or more times before performing steps (e) and (f). (Item 208) 208. The method according to any one of items 156 to 207, wherein the macromolecular analysis assay is carried out before step (e) and step (f). (Item 209) 209. The method of any one of items 156 to 208, wherein the macromolecular analysis assay is performed after steps (a), (b), (c), and (d). (Item 210) Item 10. The method of claim 1, wherein the macromolecule of step (a) is provided with a spatial tag. (Item 211) Item 211. The method of item 210, wherein the spatial tag is directly or indirectly associated with the recording tag. (Item 212) The method according to item 1 or items 210 to 211, wherein the recording tag includes a UMI. (Item 213) 3. The method of any one of items 1 and 210-212, wherein step (b) comprises analyzing the spatial tag in situ. (Item 214) 214. The method of any one of items 1 and 210-213, wherein the spatial tag sequences are analyzed using a microscope-based method. (Item 215) Item 215. The method of item 214, wherein the microscopy-based method is multiplexed. (Item 216) 216. The method of any one of items 1 and 210-215, wherein the spatial tag sequences are analyzed by sequencing. (Item 217) 217. The method of claim 216, wherein the sequencing comprises sequencing by ligation, single molecule sequencing, single molecule fluorescent sequencing, or sequencing by probe detection. (Item 218) Step (b) (b1) providing a spatial probe comprising a spatial tag to the spatial sample; (b2) evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; (b3) extending the recording tag by transferring information from the spatial tag in the spatial probe to the recording tag. (Item 219) Step (b) (b1) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (b2) evaluating, e.g., observing, the detectable label to obtain spatial information about the molecular probe. [Brief explanation of the drawings]

[0014] [Figure 1] FIG. 1 is a schematic diagram showing an exemplary workflow for providing recording tags to polypeptides in tissue sections, and steps for spatial analysis utilizing one or more molecular probes associated with detectable labels and probe tags. [Figure 2] FIG. 1 is a schematic diagram showing an exemplary workflow for providing recording tags to polypeptides in tissue sections, as well as steps for spatial analysis utilizing spatial probes (e.g., beads) associated with the spatial tags and one or more molecular probes associated with the probe tags. DETAILED DESCRIPTION OF THE INVENTION

[0015] Provided herein are methods and kits for analyzing a polymer or multiple polymers, such as peptides, polypeptides, and proteins. In some embodiments, the analysis uses barcoding and nucleic acid encoding of molecular recognition events and / or detectable labels. In some aspects, the polymer is a polypeptide. In some embodiments, the method provides information about the polymer (e.g., identity, characteristics, location within a spatial sample, spatial distribution, density, location). In some cases, the identity and / or at least a partial sequence of the polypeptide or protein within the spatial sample can be obtained from performing the method and associated with spatial information about the spatial tag within the spatial sample (such as its location within the sample).

[0016] Current methods for identifying and analyzing molecules from a sample while providing information about the sample's characteristics, such as the presence, absence, concentration, and / or spatial distribution of multiple biological targets of interest within the sample, are limited. For example, known approaches for identifying proteins while retaining other sample or spatial information are not suitable for analyzing large numbers of unknown proteins within a sample. Some current techniques detect only a few targets at a time, require the use of multiple samples, and / or may require further processing for analysis, including analysis of protein identity and / or sequence. Thus, there remains a need in the art for improved techniques related to multiplexed macromolecule (e.g., polypeptide) analysis and / or characterization that are highly parallelized, accurate, sensitive, and / or high-throughput, with the option to further perform analysis and / or protein sequencing.

[0017] In some embodiments, the present disclosure provides, in part, methods for analyzing macromolecules (e.g., peptides, polypeptides, and proteins), including obtaining spatial information (e.g., distribution and / or location) associated with the macromolecules for use in highly parallel, high-throughput digital macromolecular characterization and quantification methods, with direct application to protein and peptide characterization and sequencing. In some embodiments, the methods provide spatial information (e.g., position or location) of one or more polypeptides within a spatial sample, and the identity or partial sequence of the analyzed polypeptides.

[0018] Provided herein is a method for analyzing a macromolecule (e.g., a protein, polypeptide, or peptide), comprising: (a) providing a spatial sample containing the macromolecule associated with a recording tag; (b1) providing a spatial probe containing the spatial tag to the spatial sample; (b2) evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; (b3) extending the recording tag by transferring information from the spatial tag in the spatial probe to the recording tag; (c1) binding a molecular probe containing the probe tag to the macromolecule or a portion proximate to the macromolecule within the spatial sample; and (c2) binding the probe in the molecular probe. (b) extending the recording tag by transferring information from the tag to the recording tag, where transferring information from the spatial tag and / or probe tag to the recording tag generates an extended recording tag; (d) determining the sequence of at least the probe tag and spatial tag in the extended recording tag; and (e) correlating the sequence of the spatial tag determined in step (d) with the spatial tag evaluated in step (b2), thereby associating information from the sequence of the extended recording tag or a portion thereof, e.g., information from the spatial tag and / or probe tag determined in step (d), with the spatial location of the spatial probe evaluated in step (b2). In some embodiments, step (a) includes providing a plurality of recording tags to the spatial sample. In some of any such embodiments, the macromolecule is a polypeptide. In some embodiments, the method further includes performing a polypeptide analysis assay.

[0019] Provided herein are methods and kits for analyzing macromolecules (e.g., peptides, polypeptides, and proteins), comprising: (a) providing a recording tag to a spatial sample containing the macromolecule; (b) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion proximal to the macromolecule within the spatial sample; (c) transferring information from the probe tag within the molecular probe to the recording tag to generate an extended recording tag; (d) evaluating, e.g., observing, the detectable label to obtain spatial information about the molecular probe; (e) determining the sequence of at least the probe tag within the extended recording tag; and (f) correlating the sequence of the probe tag determined in step (e) with the molecular probe, thereby associating information from the sequence determined in step (e) with its spatial information determined in step (d). In some embodiments, the method includes performing a polypeptide analysis assay. In some embodiments, a macromolecule analysis assay is not performed before steps (e) and (f). In other embodiments, a macromolecule analysis assay is performed before steps (e) and (f).

[0020] Provided herein are methods and kits for analyzing macromolecules, comprising: (a) providing a recording tag to a spatial sample containing the macromolecule; (b) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (c) transferring information from the probe tag in the molecular probe to the recording tag to generate an extended recording tag; (d) evaluating, e.g., observing, the detectable label to obtain spatial information of the molecular probe; (e) determining the sequence of the probe tag in at least the extended recording tag; and (f) correlating the sequence of the probe tag determined in step (e) with the molecular probe, thereby associating information from the sequence determined in step (e) with its spatial information determined in step (d).

[0021] Also provided are kits for use in any of the provided methods. In some embodiments, the kits include one or more of the following components: spatial probes, spatial tags, molecular probes, probe tags, reagents for sequencing, reagents for performing nucleic acid extension recording tags, reagents for attaching or transferring recording tags, binding agents, reagents for transferring identifying information from probe tags or spatial tags to recording tags, reagents for transferring identifying information from coding tags to recording tags, and / or solid supports.

[0022] In some of any such embodiments, the macromolecule is a polypeptide. In some embodiments, multiple molecular probes are used in this method to bind to the spatial sample, and multiple spatial probes are provided for association with the spatial sample. In some embodiments, the molecular probes bind to nucleic acids, polypeptides, or other macromolecules within the spatial sample. In some embodiments, multiple cycles of binding with the molecular probes and transferring information from the molecular probes to the recording tag are performed. Transfer of information from one or more probe tags to the recording tag forms an extended recording tag using any suitable transfer method.

[0023] The method may also include providing a plurality of spatial probes to the spatial sample. In some embodiments, the spatial probes include a plurality of spatial tags, the spatial tags including barcodes. In some embodiments, the spatial probes (with associated barcodes) are randomly distributed among the spatial sample. Optionally, the method includes determining, analyzing, and / or sequencing the spatial tags in situ to obtain the spatial locations of the spatial tags within the spatial sample. In some embodiments, the method includes decoding the barcodes associated with the spatial probes in situ. In some embodiments, the method associates spatial information obtained from evaluating the spatial tags in situ to enable the spatial locations of the spatial tags within the spatial sample to be obtained along with any information recorded in the extended recording tags.

[0024] Numerous specific details are set forth in the following description to provide a thorough understanding of the present disclosure. These details are provided for illustrative purposes, and the claimed subject matter may be practiced according to the claims without some or all of these specific details. It is to be understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the claimed subject matter. It is to be understood that various features and functions described in one or more of the individual embodiments are not limited in their applicability to the particular embodiment for which they are described. Instead, they may be applied, alone or in some combination, to one or more of the other embodiments of the present disclosure, regardless of whether such an embodiment is described and whether such features are presented as part of the described embodiment. For clarity, technical material known in the art related to the claimed subject matter will not be described in such detail as to unnecessarily obscure the claimed subject matter.

[0025] All publications, including patent documents, scientific articles, and databases, referred to in this application are incorporated by reference in their entirety for all purposes to the same extent as if each individual publication was individually incorporated by reference. Citation of publications or documents is not intended as an admission that any of them is pertinent prior art, and does not constitute any admission as to the contents or date of such publications or documents.

[0026] All headings are provided for the convenience of the reader and should not be used to limit the meaning of the text that follows the heading, unless specifically stated.

[0027] definition Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. To the extent that a definition set forth in this section contradicts or otherwise conflicts with a definition set forth in any patent, application, published application, or other publication incorporated herein by reference, the definition set forth in this section shall take precedence over the definition incorporated herein by reference.

[0028] As used herein, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "a peptide" includes one or more peptides, or mixtures of peptides. Also, as used herein, unless specifically stated or apparent from the context, the term "or" is understood to be inclusive and includes both "or" and "and."

[0029] As used herein, the term "about" refers to a normal error range for each value, which is readily known to those skilled in the art. Reference herein to "about" a value or parameter encompasses (and describes) embodiments that are directed to the value or parameter itself. For example, a statement that refers to "about X" encompasses a statement about "X."

[0030] As used herein, the term "polymer" encompasses large molecules composed of smaller subunits. Examples of polymers include, but are not limited to, peptides, polypeptides, proteins, nucleic acids, carbohydrates, lipids, and macrocycles. Polymers also include chimeric polymers composed of combinations of two or more types of polymers covalently linked together (e.g., peptides linked to nucleic acids). Polymers can also include "polymer assemblies" composed of non-covalent complexes of two or more polymers. Polymer assemblies can be composed of the same type of polymer (e.g., protein-protein) or even two different types of polymers (e.g., protein-DNA).

[0031] As used herein, the term "polypeptide" encompasses peptides and proteins and refers to a molecule comprising a chain of two or more amino acids joined by peptide bonds. In some embodiments, a polypeptide contains 2 to 50 amino acids, e.g., more than 20 to 30 amino acids. In some embodiments, a peptide does not contain secondary, tertiary, or higher-order structure. In some embodiments, a polypeptide is a protein. In some embodiments, a protein contains 30 or more amino acids, e.g., more than 50 amino acids. In some embodiments, a protein contains secondary, tertiary, or higher-order structure in addition to primary structure. The amino acids of a polypeptide are most typically L-amino acids, but may also be D-amino acids, modified amino acids, amino acid analogs, amino acid mimetics, or any combination thereof. Polypeptides can be naturally occurring, synthetically produced, or recombinantly expressed. Polypeptides can be synthetically produced, isolated, recombinantly expressed, or produced by a combination of the above methodologies. Polypeptides can also contain additional groups that modify the amino acid chain, e.g., functional groups added via post-translational modifications. The polymer may be linear or branched, it may comprise modified amino acids, and it may be interrupted by non-amino acids. The term also encompasses amino acid polymers that are modified naturally or by intervention, such as disulfide bond formation, glycosylation, lipidation, acetylation, phosphorylation, or other manipulation or modification, such as conjugation with a labeling component.

[0032] As used herein, the term "amino acid" refers to an organic compound containing an amine group, a carboxylic acid group, and a side chain specific to each amino acid that functions as a monomeric subunit of a peptide. Amino acids include the 20 standard, naturally occurring, or canonical amino acids, and non-standard amino acids. Standard natural amino acids include alanine (A or Ala), cysteine ​​(C or Cys), aspartic acid (D or Asp), glutamic acid (E or Glu), phenylalanine (F or Phe), glycine (G or Gly), histidine (H or His), isoleucine (I or Ile), lysine (K or Lys), leucine (L or Leu), methionine (M or Met), asparagine (N or Asn), proline (P or Pro), glutamine (Q or Gln), arginine (R or Arg), serine (S or Ser), threonine (T or Thr), valine (V or Val), tryptophan (W or Trp), and tyrosine (Y or Tyr). Amino acids can be L-amino acids or D-amino acids. Non-standard amino acids can be naturally occurring or chemically synthesized modified amino acids, amino acid analogs, amino acid mimetics, non-standard proteinogenic amino acids, or non-proteinogenic amino acids. Examples of non-standard amino acids include, but are not limited to, selenocysteine, pyrrolysine, and N-formylmethionine, β-amino acids, homoamino acids, proline and pyruvate derivatives, 3-substituted alanine derivatives, glycine derivatives, ring-substituted phenylalanine and tyrosine derivatives, linear core amino acids, and N-methyl amino acids.

[0033] As used herein, the term "post-translational modification" refers to a modification that occurs on a peptide or protein after its translation by ribosomes is completed. Post-translational modifications can be covalent chemical modifications or enzymatic modifications. Examples of post-translational modifications include acylation, acetylation, alkylation (including methylation), biotinylation, butyrylation, carbamylation, carbonylation, deamidation, deiminiation, diphthamide formation, disulfide bridge formation, eliminylation, flavin attachment, formylation, gamma carboxylation, glutamylation, glycylation, glycosylation, glypiation, heme C attachment, hydroxylation, hypusine formation, Modifications include, but are not limited to, iodination, isoprenylation, lipidation, lipoylation, malonylation, methylation, myristolylation, oxidation, palmitoylation, PEGylation, phosphopantetheination, phosphorylation, prenylation, propionylation, retinylidene Schiff base formation, S-glutathionylation, S-nitrosylation, S-sulfenylation, selenation, succinylation, sulfination, ubiquitination, and C-terminal amidation. Post-translational modifications include modifications of the amino and / or carboxyl termini of peptides. Modifications of the terminal amino group include, but are not limited to, desamino, N-lower alkyl, N-di-lower alkyl, and N-acyl modifications. Modifications of the terminal carboxy group include, but are not limited to, amide, lower alkyl amide, dialkyl amide, and lower alkyl ester modifications (e.g., lower alkyl is C1-C4 alkyl). Post-translational modifications also include modifications of amino acids between the amino and carboxy termini, such as, but not limited to, those described above. The term post-translational modification can also include peptide modifications that include one or more detectable labels.

[0034] As used herein, the term "binding agent" refers to a nucleic acid molecule, peptide, polypeptide, protein, carbohydrate, or small molecule that binds to, associates with, integrates with, recognizes, or combines with an analyte, e.g., a macromolecule or a component or mechanism of a macromolecule. A binding agent can form a covalent or noncovalent association with an analyte, e.g., a macromolecule or a component or mechanism of a macromolecule. A binding agent can also be a chimeric binding agent composed of two or more types of molecules, such as a nucleic acid molecule-peptide chimeric binding agent or a carbohydrate-peptide chimeric binding agent. A binding agent can be a naturally occurring, synthetically produced, or recombinantly expressed molecule. A binding agent can bind to a single monomer or subunit of a macromolecule (e.g., a single amino acid of a peptide) or to multiple linked subunits of a macromolecule (e.g., dipeptides, tripeptides, or higher-order peptides of a longer peptide, polypeptide, or protein molecule). A binding agent can bind to a linear molecule or a molecule with a three-dimensional structure (also called a conformation). For example, an antibody binder may bind to a linear peptide, polypeptide, or protein, or to a conformational peptide, polypeptide, or protein. A binder may bind to the N-terminal peptide, C-terminal peptide, or intervening peptide of a peptide, polypeptide, or protein molecule. A binder may bind to the N-terminal amino acid, C-terminal amino acid, or intervening amino acid of a peptide molecule. A binder may bind, for example, to a chemically modified or labeled amino acid rather than to an unmodified or unlabeled amino acid. For example, a binder may bind to an amino acid modified with, for example, an acetyl moiety, a guanyl moiety, a dansyl moiety, a PTC moiety, a DNP moiety, an SNP moiety, or the like rather than to an amino acid lacking such a moiety. A binder may bind to a post-translational modification of a polypeptide molecule. A binder may exhibit selective binding to a component or mechanism of an analyte, such as a macromolecule (e.g., a binder may selectively bind to one of the 20 possible naturally occurring amino acid residues and bind with very low affinity or not at all to the other 19 naturally occurring amino acid residues).A binding agent may exhibit low selective binding if it can bind to multiple components or mechanisms of an analyte, such as a macromolecule (e.g., a binding agent may bind to two or more different amino acid residues with similar affinity). The binding agent comprises a coding tag, which may be joined to the binding agent by a linker.

[0035] As used herein, the term "fluorophore" refers to a molecule that absorbs electromagnetic energy at one wavelength and re-emits the energy at another wavelength. Fluorophores can be molecules or parts of molecules, including fluorescent dyes and proteins. Additionally, fluorophores can be chemically, genetically, or otherwise attached or fused to another molecule to produce a molecule "tagged" with the fluorophore.

[0036] As used herein, the term "linker" refers to one or more of a nucleotide, nucleotide analog, amino acid, peptide, polypeptide, or non-nucleotide chemical moiety used to join two molecules. Linkers are used, for example, to join a binding agent to a coding tag, a recording tag to a polypeptide, a polypeptide to a solid support, or a recording tag to a solid support. In certain embodiments, the linker joins two molecules via an enzymatic or chemical reaction (e.g., click chemistry).

[0037] As used herein, the term "ligand" refers to any molecule or moiety connected to a compound described herein. "Ligand" may refer to one or more ligands attached to a compound. In some embodiments, a ligand is a pendant group or binding site (e.g., a site to which a binding agent binds).

[0038] As used herein, the term "proteome" may include the entire set of proteins, polypeptides, or peptides (including conjugates or complexes thereof) expressed by the genome, cell, tissue, or organism of any organism at a particular time. In one embodiment, a proteome is the set of proteins expressed in a given type of cell or organism at a given time under defined conditions. Proteomics is the study of proteomes. For example, a "cellular proteome" may include the collection of proteins found in a particular cell type under a particular set of environmental conditions, such as exposure to a hormonal stimulus. The complete proteome of an organism may include the complete set of proteins from all of the various cellular proteomes. A proteome may also include the collection of proteins in a particular subcellular biological system. For example, all of the proteins in a virus may be referred to as the viral proteome. As used herein, the term "proteome" includes subsets of the proteome, including, but not limited to, the kinome; the secretome; the receptome (e.g., the GPCRome); the immunoproteome; the nutriproteomes; proteome subsets defined by post-translational modifications (e.g., phosphorylation, ubiquitination, methylation, acetylation, glycosylation, oxidation, lipidation, and / or nitrosylation), such as the phosphoproteome (e.g., the phosphotyrosine-proteome, the tyrosine-kinome, and the tyrosine-phosphatome), the glycoproteome, etc.; proteome subsets associated with a tissue or organ, a developmental stage, or a physiological or pathological state; proteome subsets associated with a cellular process such as the cell cycle, differentiation (or dedifferentiation), cell death, senescence, cell migration, transformation, or metastasis; or any combination thereof. As used herein, the term "proteomics" refers to the analysis of the proteome within cells, tissues, and body fluids, and the corresponding spatial distribution of the proteome within cells and tissues. Furthermore, proteomics studies include the dynamic state of the proteome, which changes over time as a function of biology and defined biological or chemical stimuli.

[0039] The terminal amino acid at one end of a peptide chain having a free amino group is referred to herein as the "N-terminal amino acid" (NTAA). The terminal amino acid at the other end of the chain having a free carboxyl group is referred to herein as the "C-terminal amino acid" (CTAA). The N-terminal diamino acid can include the N-terminal amino acid and the penultimate N-terminal amino acid. The C-terminal diamino acid is similarly defined for the C-terminus. When a peptide is "n" amino acids in length, the amino acids that make up the peptide can be numbered sequentially. As used herein, the NTAA is considered the nth amino acid (also referred to herein as "nNTAA"). Using this nomenclature, the next amino acid is n-1 amino acid, then n-2 amino acids, and so on down the length from the N-terminus to the C-terminus of the peptide. In certain embodiments, the NTAA, CTAA, or both can be functionalized with a chemical moiety.

[0040] As used herein, the term "nucleic acid barcode" refers to a nucleic acid molecule of about 2 to about 30 bases (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 bases) that provides a unique identifier tag or source information for a polymer, a polypeptide, a binder, a set of binders from a binding cycle, a sample of polypeptides, a set of samples, a polymer (e.g., a polypeptide) in a compartment (e.g., a droplet, bead, or separate location), a polymer (e.g., a polypeptide) in a set of compartments, a fraction of a polymer (e.g., a polypeptide), a set of polypeptide fractions, a spatial region or set of spatial regions, a library of polymers or polypeptides, a molecular probe or set of molecular probes, or a library of binders. Barcodes can be artificial or naturally occurring sequences. In certain embodiments, each barcode in a population of barcodes is different. In other embodiments, a portion of the barcodes in a population of barcodes are different, for example, at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, or 99% of the barcodes in the population of barcodes are different. The population of barcodes can be randomly or non-randomly generated. In certain embodiments, the population of barcodes is an error-correcting barcode. Barcodes can be used to computationally deconvolute multiplexed sequencing data to identify sequence reads derived from individual polypeptides, samples, libraries, etc. Barcodes can also be used to deconvolute populations of polypeptides distributed into small compartments for enhanced mapping. For example, rather than mapping peptides back to a proteome, peptides can be mapped back to their original protein molecules or protein complexes.

[0041] As used herein, "peptide barcode" or "amino acid barcode" refers to a sequence of amino acids that can have a length of at least, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 40, 50, 75, or 100 amino acids. A particular peptide barcode can be distinguished from other peptide barcodes by having a different length, sequence, or other physical property (e.g., hydrophobicity). A peptide barcode can provide a unique identifier tag or origin information for a macromolecule, a polypeptide, a binder, a set of binders from a binding cycle, a sample of polypeptides, a set of samples, a location (e.g., spatial location), a macromolecule (e.g., polypeptide) in a compartment (e.g., droplet, bead, or separate location), a macromolecule (e.g., polypeptide) in a set of compartments, a molecular fraction, a set of fractions, a spatial region or set of spatial regions, a library of macromolecules or polypeptides, a molecular probe or set of molecular probes, or a library of binders. Barcodes can be artificial or naturally occurring sequences. In certain embodiments, each barcode in a population of barcodes is different. In other embodiments, a portion of the barcodes in the population of barcodes are different, for example, at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, or 99% of the barcodes in the population of barcodes are different. The population of barcodes can be randomly or non-randomly generated.

[0042] A "sample barcode," also called a "sample tag," identifies which sample a polypeptide comes from.

[0043] As used herein, the term "coding tag" refers to a polynucleotide of any suitable length, e.g., a nucleic acid molecule of about 2 bases to about 100 bases, including any integer between 2 and 100, inclusive, that contains identifying information about its associated binding agent. A "coding tag" can also be made from a "sequenceable polymer" (see, e.g., Niu et al., 2013, Nat. Chem. 5:282-292; Roy et al., 2015, Nat. Commun. 6:7237; Lutz, 2015, Macromolecules 48:4759-4767, each of which is incorporated by reference in its entirety). A coding tag can include an encoder sequence, optionally flanked by a single spacer on one side or by spacers on both sides. A coding tag can also be composed of an optional UMI and / or an optional binding cycle-specific barcode. A coding tag can be single-stranded or double-stranded. The double-stranded coding tag may comprise blunt ends, overhanging ends, or both. The coding tag may refer to a coding tag directly attached to the binding agent, a complementary sequence hybridized to a coding tag directly attached to the binding agent (e.g., in the case of a double-stranded coding tag), or coding tag information present in an extended recording tag. In certain embodiments, the coding tag may further comprise a binding cycle-specific spacer or barcode, a unique molecular identifier, a universal priming site, or any combination thereof.

[0044] As used herein, the term "encoder sequence" or "encoder barcode" refers to a nucleic acid molecule of about 2 bases to about 30 bases (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 bases) in length that provides identifying information for its associated binder. The encoder sequence can uniquely identify its associated binder. In certain embodiments, the encoder sequence provides identifying information for its associated binder and for the binding cycle in which the binder is used. In other embodiments, the encoder sequence is combined with a separate binding cycle-specific barcode within a coding tag. Alternatively, the encoder sequence can identify the associated binder as belonging to a member of a set of two or more different binders. In some embodiments, this level of identification is sufficient for analytical purposes. For example, in some embodiments involving binders that bind amino acids, it may be sufficient to know that a peptide contains one of two possible amino acids at a particular position, rather than specifically identifying the amino acid residue at that position. In another example, a common encoder sequence used for polyclonal antibodies that recognize multiple epitopes of a protein target and contain a mixture of antibodies with varying specificities identifies a set of possible binders. In other embodiments, a sequential decoding approach can be used to provide unique identification for each binder. This is achieved by varying the encoder sequence of a given binder with repeated cycles of binding (see Gunderson et al., 2004, Genome Res. 14:870-7). The partially identifying coding tag information from each binding cycle, when combined with coding information from other cycles, produces a unique identifier for the binder; for example, it is the particular combination of coding tags, rather than the individual coding tags (or encoder sequences), that provides the unique identifying information for the binder. Preferably, the encoder sequences within a library of binders have the same or similar number of bases.

[0045] As used herein, the terms "binding cycle-specific tag," "binding cycle-specific barcode," or "binding cycle-specific sequence" refer to a unique sequence used to identify a library of binding agents used within a particular binding cycle. A binding cycle-specific tag can comprise a length of about 2 bases to about 8 bases (e.g., 2, 3, 4, 5, 6, 7, or 8 bases). A binding cycle-specific tag can be incorporated into a coding tag of a binding agent as part of a spacer sequence, part of an encoder sequence, part of a UMI, or as a separate component within the coding tag.

[0046] As used herein, the term "spacer" (Sp) refers to a nucleic acid molecule present on the end of a recording tag or coding tag, the nucleic acid molecule being about 1 base to about 20 bases in length (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 bases). In certain embodiments, the spacer sequence is adjacent to the encoder sequence of the coding tag at one or both ends. Following binding of a binder to a polypeptide, annealing between complementary spacer sequences on their associated coding and recording tags allows for transmission of binding information via a primer extension reaction or ligation to a recording tag, coding tag, or ditag construct, respectively. Sp' refers to a spacer sequence complementary to Sp. Preferably, spacer sequences within a binder library have the same number of bases. A common (shared or identical) spacer can be used in a binder library. The spacer sequence may have a "cycle-specific" sequence to track the binder used in a particular binding cycle. The spacer sequence (Sp) may be constant across all binding cycles, specific to a particular class of polypeptide, or specific to the number of binding cycles. The polypeptide class-specific spacer allows the coding tag information of a cognate binder present in the extension recording tag from a completed binding / extension cycle to anneal via the class-specific spacer to the coding tag of another binder that recognizes a polypeptide of the same class in a subsequent binding cycle. Only sequential binding of the correct cognate pair results in interacting spacer elements and effective primer extension. The spacer sequence may contain a sufficient number of bases to anneal to a complementary spacer sequence in the recording tag to initiate a primer extension (also known as polymerase extension) reaction, provide a "splint" for a ligation reaction, or mediate a "sticky-end" ligation reaction. The spacer sequence may contain fewer bases than the encoder sequence in the coding tag.

[0047] As used herein, the term "recording tag" refers to a moiety, e.g., a chemical coupling moiety, a nucleic acid molecule, or a sequencible polymer molecule, to which identifying information of a coding tag can be transferred, or to which identifying information (e.g., UMI information) about a macromolecule associated with the recording tag can be transferred to the coding tag (see, e.g., Niu et al., 2013, Nat. Chem. 5:282-292; Roy et al., 2015, Nat. Commun. 6:7237; Lutz, 2015, Macromolecules 48:4759-4767, each of which is incorporated by reference in its entirety). Identifying information can include any information that characterizes a molecule, such as information related to the sample, fraction, partition, spatial location, interacting neighbor molecules, cycle number, etc. Furthermore, the presence of UMI information can also be classified as identifying information. In certain embodiments, after a binding agent binds to a polypeptide, information from a coding tag linked to the binding agent can be transferred to a recording tag associated with the polypeptide while the binding agent is bound to the polypeptide. In other embodiments, after a binding agent binds to a polypeptide, information from a recording tag associated with the polypeptide can be transferred to a coding tag linked to the binding agent while the binding agent is still bound to the polypeptide. The recording tag can be linked directly to a macromolecule (e.g., a polypeptide), linked to a macromolecule (e.g., a polypeptide) via a multifunctional linker, or associated with a macromolecule (e.g., a polypeptide) by their proximity (or colocalization) on a solid support. The recording tag can be linked via its 5' or 3' end or at an internal site, as long as the linkage is compatible with the method used to transfer the coding tag information to the recording tag or vice versa. The recording tag can further include other functional components, such as a universal priming site, a unique molecular identifier, a barcode (e.g., a sample barcode, a fraction barcode, a spatial barcode, a compartment tag, etc.), a spacer sequence complementary to the spacer sequence of the coding tag, or any combination thereof.The spacer sequence of the recording tag is preferably at the 3' end of the recording tag in embodiments where polymerase extension is used to transfer the coding tag information to the recording tag.

[0048] As used herein, the term "primer extension," also known as "polymerase extension," refers to a reaction catalyzed by a nucleic acid polymerase (e.g., a DNA polymerase) whereby a nucleic acid molecule (e.g., an oligonucleotide primer, a spacer sequence) that is annealed to a complementary strand is extended by the polymerase using the complementary strand as a template.

[0049] As used herein, the term "unique molecular identifier" or "UMI" refers to a nucleic acid molecule of about 3 to about 40 bases (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 bases) in length that provides a unique identifier tag for each polypeptide or binder to which the UMI is linked. Polypeptide UMIs can be used to computationally deconvolute sequencing data from multiple extended record tags to identify extended record tags derived from individual polypeptides. Polypeptide UMIs can be used to accurately count original polypeptide molecules by collapsing NGS reads into unique UMIs. Binder UMIs can be used to identify individual molecular binders that bind to a specific polypeptide. For example, UMIs can be used to identify the number of individual binding events of a single amino acid-specific binding agent that occur to a particular peptide molecule.

[0050] As used herein, the terms "universal priming site" or "universal primer" or "universal priming sequence" refer to a nucleic acid molecule that can be used in library amplification and / or sequencing reactions. Universal priming sites include, but are not limited to, priming sites (primer sequences) for PCR amplification, flow cell adapter sequences that anneal to complementary oligonucleotides on the flow cell surface to enable bridge amplification in some next-generation sequencing platforms, sequencing priming sites, or combinations thereof. Universal priming sites can also be used for other types of amplification, including those commonly used in conjunction with next-generation digital sequencing. For example, extended recording tag molecules can be circularized and the universal priming site can be used in rolling circle amplification to form DNA nanoballs that can be used as sequencing templates (Drmanac et al., 2009, Science 327:78-81). Alternatively, the recording tag molecule can be circularized and sequenced directly by polymerase extension from the universal priming site (Korlach et al., 2008, Proc. Natl. Acad. Sci. 105:1176-1181). The term "forward" when used in reference to a "universal priming site" or "universal primer" can also be referred to as "5" or "sense." The term "reverse" when used in reference to a "universal priming site" or "universal primer" can also be referred to as "3" or "antisense."

[0051] As used herein, the term "extended recording tag" refers to a recording tag to which the information of at least one binding agent's coding tag (or its complementary sequence) has been transferred following binding of the binding agent to a macromolecule (e.g., a polypeptide). The coding tag information can be transferred to the recording tag directly (e.g., by ligation) or indirectly (e.g., by primer extension). The coding tag information can be transferred to the recording tag enzymatically or chemically. The extended record tag may contain binding agent information of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 125, 150, 175, 200 or more coding tags. The base sequences of the extended record tags may reflect the temporal and sequential order of binding of the binding agents identified by those coding tags, may reflect the sequential order of some of the binding of the binding agents identified by the coding tags, or may not reflect any order of binding of the binding agents identified by the coding tags. In certain embodiments, the coding tag information present in the extended recording tag represents the polypeptide sequence being analyzed with at least 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identity. In certain embodiments where the extended recording tag does not represent the polypeptide sequence being analyzed with 100% identity, the error may be due to off-target binding by the binding agent, or a "failure" of the binding cycle (e.g., due to a failure of the primer extension reaction due to the inability of the binding agent to bind to the polypeptide during the binding cycle), or both.

[0052] As used herein, the term "extended coding tag" refers to a coding tag to which the information of at least one recording tag (or its complementary sequence) has been transferred after binding of a binding agent to which the coding tag is attached to a polypeptide with which the recording tag is associated. The information of the recording tag can be transferred to the coding tag directly (e.g., by ligation) or indirectly (e.g., by primer extension). The information of the recording tag can be transferred enzymatically or chemically. In certain embodiments, the extended coding tag contains the information of one recording tag reflecting one binding event. As used herein, the term "ditag" or "ditag construct" or "ditag molecule" refers to a nucleic acid molecule to which the information of at least one recording tag (or its complementary sequence) and at least one coding tag (or its complementary sequence) has been transferred after binding of a binding agent to which the coding tag is attached to a polypeptide with which the recording tag is associated. The recording tag and the information of the coding tag can be transferred to the ditag indirectly (e.g., by primer extension). The information of the recording tag can be transferred enzymatically or chemically. In certain embodiments, the ditag comprises a UMI of the recording tag, a compartment tag of the recording tag, a universal priming site of the recording tag, a UMI of the coding tag, an encoder sequence of the coding tag, a binding cycle-specific barcode, a universal priming site of the coding tag, or any combination thereof.

[0053] As used herein, the terms "solid support," "solid surface," "solid substrate," "sequencing substrate," or "substrate" refer to any solid material, including porous and non-porous materials, to which a polypeptide can be directly or indirectly associated by any means known in the art, including covalent and non-covalent interactions, or any combination thereof. A solid support can be two-dimensional (e.g., planar) or three-dimensional (e.g., gel matrix or beads). A solid support can be any support surface, including, but not limited to, beads, microbeads, arrays, glass surfaces, silicon surfaces, plastic surfaces, filters, membranes, nylon, silicon wafer chips, flow-through chips, flow cells, biochips including signal transduction electronics, channels, microtiter wells, ELISA plates, spinning interferometry discs, nitrocellulose membranes, nitrocellulose-based polymer surfaces, polymer matrices, nanoparticles, or microspheres. Solid support materials include, but are not limited to, acrylamide, agarose, cellulose, nitrocellulose, glass, gold, quartz, polystyrene, polyethylene vinyl acetate, polypropylene, polymethacrylate, polyethylene, polyethylene oxide, polysilicate, polycarbonate, Teflon, fluorocarbon, nylon, silicone rubber, polyanhydrides, polyglycolic acid, polylactic acid, polyorthoesters, functionalized silanes, polypropyl fumerate, collagen, glycosaminoglycans, polyamino acids, dextran, or any combination thereof. Solid supports further include shaped polymers such as thin films, membranes, bottles, dishes, fibers, woven fibers, tubes, particles, beads, microspheres, microparticles, or any combination thereof. For example, when the solid surface is a bead, the bead can include, but is not limited to, ceramic beads, polystyrene beads, polymer beads, methylstyrene beads, agarose beads, acrylamide beads, solid core beads, porous beads, paramagnetic beads, glass beads, or controlled pore beads.Beads may be spherical or irregularly shaped. Beads or supports may be porous. Bead sizes may range from nanometers, e.g., 100 nm, to several millimeters, e.g., up to 1 mm. In certain embodiments, bead sizes range from about 0.2 microns to about 200 microns, or from about 0.5 microns to about 5 microns. In some embodiments, beads may be about 1, 1.5, 2, 2.5, 2.8, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 15, or 20 μm in diameter. In certain embodiments, a "beaded" solid support may refer to an individual bead or a plurality of beads. In some embodiments, the solid surface is a nanoparticle. In certain embodiments, the size of the nanoparticles ranges from about 1 nm to about 500 nm in diameter, e.g., from about 1 nm to about 20 nm, from about 1 nm to about 50 nm, from about 1 nm to about 100 nm, from about 10 nm to about 50 nm, from about 10 nm to about 100 nm, from about 10 nm to about 200 nm, from about 50 nm to about 100 nm, from about 50 nm to about 150 nm, from about 50 nm to about 200 nm, from about 100 nm to about 200 nm, or from about 200 nm to about 500 nm. In some embodiments, the nanoparticles can be about 10 nm, about 50 nm, about 100 nm, about 150 nm, about 200 nm, about 300 nm, or about 500 nm in diameter. In some embodiments, the nanoparticles are less than about 200 nm in diameter.

[0054] As used herein, the terms "nucleic acid molecule" or "polynucleotide" refer to single- or double-stranded polynucleotides comprising deoxyribonucleotides or ribonucleotides linked by 3'-5' phosphodiester bonds, and polynucleotide analogs. Nucleic acid molecules include, but are not limited to, DNA, RNA, and cDNA. Polynucleotide analogs may have backbones other than the standard phosphodiester linkages found in natural polynucleotides and, optionally, modified sugar moieties other than ribose or deoxyribose. Polynucleotide analogs contain bases capable of hydrogen bonding to standard polynucleotide bases through Watson-Crick base pairing, with the analog backbone presenting the bases in a manner that allows such hydrogen bonding in a sequence-specific manner between the oligonucleotide analog molecule and the bases of a standard polynucleotide. Examples of polynucleotide analogs include, but are not limited to, heterologous nucleic acids (XNAs), bridged nucleic acids (BNAs), glycol nucleic acids (GNAs), peptide nucleic acids (PNAs), gamma-PNAs, morpholino polynucleotides, locked nucleic acids (LNAs), threose nucleic acids (TNAs), 2'-O-methyl polynucleotides, 2'-O-alkylribosyl-substituted polynucleotides, phosphorothioate polynucleotides, and boronophosphate polynucleotides. Polynucleotide analogs may contain purine or pyrimidine analogs, including universal base analogs that can pair with any base, including, for example, 7-deazapurine analogs, 8-halopurine analogs, 5-halopyrimidine analogs, or hypoxanthine, nitroazole, isocarbostyril analogs, azolecarboxamide, and aromatic triazole analogs, or base analogs with additional functionality, such as a biotin moiety for affinity binding. In some embodiments, the nucleic acid molecule or oligonucleotide is a modified oligonucleotide. In some embodiments, the nucleic acid molecule or oligonucleotide is DNA with pseudocomplementary bases, DNA with protected bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, a γPNA molecule, or a morpholino DNA, or a combination thereof.In some embodiments, the nucleic acid molecule or oligonucleotide has a backbone modification, a sugar modification, or a nucleobase modification. In some embodiments, the nucleic acid molecule or oligonucleotide has a nucleobase protecting group such as Alloc, an electrophilic protecting group such as thiamine, an acetyl protecting group, a nitrobenzyl protecting group, a sulfonate protecting group, or a conventional base-labile protecting group.

[0055] As used herein, "nucleic acid sequencing" means determining the order of nucleotides in a nucleic acid molecule or a sample of nucleic acid molecules.

[0056] As used herein, "next-generation sequencing" refers to a high-throughput sequencing method that enables parallel sequencing of millions to billions of molecules. Examples of next-generation sequencing methods include sequencing by synthesis, sequencing by ligation, sequencing by hybridization, polony sequencing, ion semiconductor sequencing, and pyrosequencing. By attaching a primer to a solid substrate and a complementary sequence to a nucleic acid molecule, the nucleic acid molecule can be hybridized to the solid substrate via the primer, and then amplified using a polymerase to generate multiple copies in separate regions on the solid substrate (these groupings are sometimes called polymerase colonies or polonies). As a result, during the sequencing process, nucleotides at specific positions can be sequenced multiple times (e.g., hundreds or thousands of times). This depth of coverage is called "deep sequencing." Examples of high-throughput nucleic acid sequencing technologies include platforms offered by Illumina, BGI, Qiagen, Thermo-Fisher, and Roche, as reviewed by Service (Science 311:1544-1546, 2006), and include formats such as parallel bead arrays, sequencing-by-synthesis, sequencing-by-ligation, capillary electrophoresis, electronic microchips, "biochips," microarrays, parallel microchips, and single molecule arrays.

[0057] As used herein, "single molecule sequencing" or "third-generation sequencing" refers to next-generation sequencing methods in which reads from a single molecule sequencing instrument are generated by sequencing a single molecule of DNA. Unlike next-generation sequencing methods that rely on amplification to clone many DNA molecules in parallel for sequencing in a stepwise approach, single molecule sequencing interrogates a single molecule of DNA and does not require amplification or synchronization. Single molecule sequencing includes methods that require pausing the sequencing reaction after each base incorporation ("wash-and-scan" cycles) and methods that do not require pausing between read steps. Examples of single molecule sequencing methods include single-molecule real-time sequencing (Pacific Biosciences), nanopore-based sequencing (Oxford Nanopore), duplex interrupted nanopore sequencing, and direct imaging of DNA using advanced microscopy.

[0058] As used herein, "analyzing" a macromolecule refers to identifying, quantifying, characterizing, distinguishing, or a combination thereof, all or a portion of the components of the macromolecule. For example, analyzing a peptide, polypeptide, or protein includes determining all or a portion of the peptide's amino acid sequence (contiguous or non-contiguous). Analysis of a macromolecule also includes partial identification of the components of the macromolecule. For example, partial identification of amino acids in a macromolecular protein sequence can identify amino acids in the protein as belonging to a subset of possible amino acids. Analysis typically begins with analysis of the nth NTAA and proceeds to the next amino acid of the peptide (i.e., n-1, n-2, n-3, etc.). This is accomplished by cleaving the nth NTAA, thereby converting the (n-1)th amino acid of the peptide to the N-terminal amino acid (referred to herein as the "(n-1)th NTAA"). Analysis of a peptide may also include determining the presence and frequency of post-translational modifications of the peptide. This may or may not include information regarding the order of post-translational modifications of the peptide. Analysis of a peptide may also include determining the presence and frequency of epitopes in the peptide. This may or may not include information regarding the order or location of epitopes within the peptide. Analysis of peptides may involve a combination of different types of analysis, for example obtaining epitope information, amino acid sequence information, post-translational modification information, or any combination thereof.

[0059] It is understood that aspects and embodiments of the invention described herein encompass "consisting of" and / or "consisting essentially of" aspects and embodiments.

[0060] Throughout this disclosure, various aspects of the present invention are presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the present invention. Accordingly, the description of a range should be considered to specifically disclose all possible subranges and individual numerical values ​​within that range. For example, the description of a range such as 1 to 6 should be considered to specifically disclose subranges such as 1 to 3, 1 to 4, 1 to 5, 2 to 4, 2 to 6, 3 to 6, etc., and individual numbers within that range (e.g., 1, 2, 3, 4, 5, and 6). This applies regardless of the width of the range.

[0061] Other objects, advantages and features of the present invention will become apparent from the following specification taken in conjunction with the accompanying drawings.

[0062] I. Methods for analyzing macromolecules Provided herein is a method for analyzing macromolecules, comprising: providing a spatial sample containing a macromolecule associated with a recording tag at a spatial location; assessing the spatial location of the macromolecule in situ within the spatial sample; binding a molecular probe containing a probe tag to the macromolecule in the spatial sample or a portion thereof proximate to the macromolecule; extending the recording tag by transferring information from the probe tag in the molecular probe to the recording tag, where transferring information from the probe tag to the recording tag generates an extended recording tag; determining the sequence of at least the probe tag in the extended recording tag; and correlating the determined sequence of the probe tag with the molecular probe and / or spatial location assessed in situ. In some cases, the method includes correlating the determined sequence of the probe tag with the molecular probe (e.g., identity or binding information / characteristics related to the bound molecular probe). This method can be used to associate information from the determined sequence of the extended recording tag, or a portion thereof, with the spatial location assessed in situ. In some embodiments, assessing the spatial location of macromolecules within a spatial sample in situ is performed using imaging-based approaches, such as fluorescence imaging, combinatorial hybridization-based approaches, and / or in situ NGS sequencing.

[0063] In some embodiments, the recording tag can include spatial information. For example, the recording tag can include a spatial tag. The recording tag that provides spatial information can be in the form of a UMI. In some embodiments, the method includes a first step of providing a spatial sample containing a macromolecule associated with the recording tag, where the recording tag includes spatial information such as the spatial tag. The spatial tag can be directly or indirectly associated with or attached to the recording tag. The method can also include analyzing or evaluating the spatial tag in situ. The analysis or evaluation of the spatial tag can be performed using a microscope-based method. In some cases, the analysis or evaluation of the spatial tag includes sequencing, for example, sequencing by ligation, single molecule sequencing, single molecule fluorescence sequencing, or sequencing by probe detection.

[0064] Generally, the provided methods include obtaining spatial information about the location of a macromolecule or a portion proximate to the macromolecule by decoding the spatial tag in situ, or, for example, by evaluating, e.g., observing, a detectable label. The spatial information can be in the form of providing a spatial tag to the sample, and the spatial tag is transferred to the macromolecule, such as a recording tag associated with the macromolecule. In some embodiments, decoding the spatial tag can be performed before or after transferring the spatial tag to the recording tag. In some particular cases, decoding the spatial tag includes evaluating the spatial location of the macromolecule in situ within the spatial sample.

[0065] In some embodiments, assessing the spatial location of a macromolecule within a spatial sample is performed by providing a spatial probe containing a spatial tag to the spatial sample and evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample. As described in Section II, both methods, by observing a detectable label on a molecular probe or by evaluating the spatial tag of a spatial probe in situ, enable a method of observing (e.g., by imaging) the spatial location of a macromolecule within a sample.

[0066] In some embodiments, assessing the spatial location of a macromolecule within a spatial sample in situ is performed by binding a molecular probe comprising a detectable label and a probe tag to a macromolecule or a moiety proximal to the macromolecule within the spatial sample, as described in Section III, and assessing, e.g., observing, the detectable label to obtain spatial information about the molecular probe.

[0067] In some embodiments, the present disclosure provides a recording method for incorporating multiple information sources, including spatial information and information from one or more molecular probes, into a recording tag. The methods of the present invention also enable simultaneous detection, analysis, and / or sequencing of multiple peptides (two or more peptides), e.g., multiplexing. Simultaneous, as used herein, refers to the detection, quantification, or sequencing of multiple peptides in the same assay. The multiple peptides being evaluated can be present in the same sample, e.g., a biological sample, or different samples. The multiple peptides being evaluated can be different peptides, or the same peptide in different samples. A plurality can be 10 or more peptides, 50 or more peptides, 100 or more peptides, 500 or more peptides, 1000 or more peptides, 10,000 or more peptides, 100,000 or more peptides, or 1,000,000 or more peptides. In some embodiments, the provided methods allow for the release and processing of a sample (or a portion thereof) after evaluating or determining spatial information, and further allow for other steps to be performed on the sample after release.

[0068] II. Analyzing Macromolecules Using Spatial Probes Provided herein is a method for analyzing macromolecules (e.g., proteins, polypeptides, or peptides), comprising: (a) providing a spatial sample containing the macromolecule associated with a recording tag; (b1) providing a spatial probe containing the spatial tag to the spatial sample; (b2) evaluating the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; (b3) extending the recording tag by transferring information from the spatial tag in the spatial probe to the recording tag; (c1) binding a molecular probe containing a probe tag to the macromolecule or a portion proximate to the macromolecule within the spatial sample; and (c2) attaching the probe tag in the molecular probe to the macromolecule. (b2) includes (a) extending the recording tag by transferring information from the spatial tag and / or probe tag to the recording tag, where transferring information from the spatial tag and / or probe tag to the recording tag generates an extended recording tag; (d) determining the sequence of at least the probe tag and spatial tag within the extended recording tag; and (e) correlating the sequence of the spatial tag or a portion thereof, e.g., information from the spatial tag and / or probe tag determined in step (d), with the spatial tag evaluated in step (b2), thereby associating information from the sequence of the extended recording tag determined in step (d) with the spatial location of the spatial probe evaluated in step (b2). In some embodiments, the macromolecule is a polypeptide. In some aspects, multiple macromolecules within the spatial sample are provided with recording tags in step (a). In some embodiments, the recording tag may be directly or indirectly associated with or attached to a macromolecule or other moiety within the spatial sample. In some other embodiments, the recording tag is not directly or indirectly associated with or attached to a macromolecule or other moiety within the spatial sample, but is held in place within a matrix, scaffold, or substance that is applied to the spatial sample.

[0069] In some embodiments, the method includes determining the sequence of at least the probe tag and spatial tag within the extended recording tag. In some embodiments, a series of probe tags (e.g., barcodes) and the sequence of the series of probe tags (e.g., barcodes) are used to associate the information contained in the extended recording tag with the spatial location of the associated macromolecule. In some embodiments, information about the molecular probe, including the target of the molecular probe and other characteristics of the macromolecule bound by the molecular probe, can be associated with the spatial location of the spatial tag being evaluated in situ. In some embodiments, the sample is sequentially bound by two or more molecular probes, and the previous probe is removed before binding of any subsequent probe.

[0070] Some of the steps of the provided methods can be reversed or performed in various orders. For example, step (b2) can be performed before or after step (b3). In some embodiments, one or more of the steps can be repeated. In a preferred embodiment, binding of the molecular probe and extending the recording tag by transferring information from the probe tag associated with the molecular probe to the recording tag are performed before providing the spatial probe containing the spatial tag to the spatial sample. For example, steps (c1) and (c2) can be repeated two or more times in sequence before performing steps (d) and (e). In one example, steps (a), (c1), (c2), (b1), (b2), (b3), (d), and (e) occur in sequence. The method may include removing any spatial probes before providing the spatial probes to the spatial sample, or removing any spatial probes from the sample before combining the sample with the molecular probes. In some embodiments, the method includes removing the molecular probes from the spatial sample before repeating step (c1). In some embodiments, step (a) is performed before steps (b1), (b2), (b3), (c1), (c2), (d), and (e). Optionally, step (b1) is performed before steps (b2), (d), and (e). In some examples, steps (c1) and (c2) are performed before steps (d) and (e). In some aspects, steps (c1) and (c2) are performed before or after steps (b1), (b2), and / or (b3). Optionally, step (d) is performed before step (e). In some embodiments, step (b2) is performed after steps (a), (b1), (b3), (c1), and / or (c2). In some embodiments, step (e) is performed after steps (a), (b1), (b2), (b3), (c1), (c2), and (d). In some embodiments, no macromolecular analysis assay is performed.In some embodiments, the method includes performing a macromolecular analysis assay after steps (b1), (b2), (b3), (c1), and (c2). In some embodiments, the macromolecular analysis assay is performed before steps (d) and (e).

[0071] In some embodiments, the extended recording tag being analyzed contains information from multiple probe tags that are sequentially transferred to the recording tag. In some embodiments, the extended recording tag contains information from at least one probe tag and a spatial tag. In some further embodiments, the extended recording tag contains information transferred from at least one probe tag, at least one spatial tag, and at least one coding tag.

[0072] In some of the provided embodiments, the binding of a molecular probe to a spatial sample and the transfer of information from the probe tag to the recording tag can be repeated one or more times. In some embodiments, any previous molecular probes can be removed after transferring information from the probe tag to the recording tag and before binding the sample with any subsequent molecular probes. In some embodiments of the provided methods, a molecular probe binds to a spatial sample by binding to a macromolecule in the spatial sample or by binding to a moiety proximate to a macromolecule in the spatial sample. In some embodiments, a molecular probe binds to a moiety that binds to, associates with, or forms a complex with a macromolecule in the spatial sample. In some embodiments, multiple molecular probes are applied to the spatial sample. In some embodiments, a molecular probe is capable of selective and / or specific binding. In some embodiments, a molecular probe binds to a macromolecule in a complex with another macromolecule. For example, a molecular probe can bind to a nucleic acid in a complex with a polypeptide, and the polypeptide is associated with a recording tag. In some specific embodiments, a molecular probe binds to a polypeptide with which the recording tag is associated.

[0073] In some embodiments, the molecular probe comprises a probe tag that can comprise any sequenceable molecule. In some examples, the probe tag comprises a barcode. The information of the probe tag is transferred to the recording tag in any suitable manner. In some embodiments, information from one probe tag can be transferred to two or more recording tags. In some embodiments, information from two or more probe tags can be transferred to one recording tag.

[0074] In some embodiments, multiple spatial probes are applied to the spatial sample. In some embodiments, the spatial probes comprise spatial tags attached to a support (e.g., beads) via a cleavable linker. In some embodiments, the spatial probes do not exhibit selective and / or specific binding. For example, multiple spatial probes are randomly dispersed on the spatial sample to transfer the spatial tags to recording tags. In some embodiments, the spatial probes nonspecifically associate with the sample through adhesive forces such as charge interactions, DNA hybridization, or reversible chemical coupling. In some embodiments, the spatial probes dispersed or applied to the spatial sample are densely packed in a limited space or region. In some examples, the spatial probes are provided as an array of immobilized beads. For example, the spatial tags associate with the recording tags through hybridization of a sequence complementary to the recording tag contained in the spatial tag (or a portion thereof). The spatial probes comprise spatial tags, which can comprise any sequencible molecule. In some examples, the spatial tags comprise barcodes. The information in the spatial tags is transferred to the recording tags by any suitable method.

[0075] In some embodiments, the spatial sample comprises a biological sample. For example, the spatial sample may comprise macromolecules, cells, and / or tissues obtained from a subject. In some examples, the spatial sample is derived from a sample such as an intact tissue or a liquid sample. For example, the liquid sample can be spread and deposited on a surface before performing the method. In some examples, the spatial sample is processed before the molecular or spatial probes bind to the spatial sample, for example, by treating the sample with permeabilization, fixation, and / or cross-linking reagents.

[0076] In some embodiments, after generating an extended recording tag containing information from the probe tag and spatial tag, the sample containing multiple macromolecules can be treated to allow for the release of the macromolecules. Optionally, the spatial sample, or any portion thereof, can be removed from the solid support after transferring information from at least one probe tag and spatial tag to the recording tag. Accordingly, the disclosed methods can include washing the solid support to remove macromolecules, cells, tissues, or other materials from the spatial sample. Removal of the spatial sample, or any portion thereof, can be performed using any suitable technique and will depend on the sample. In some cases, the solid support can be washed with water containing various additives, such as surfactants, detergents, enzymes (e.g., proteases and collagenases), cleavage reagents, etc., to facilitate specimen removal. In some embodiments, the solid support is treated with a solution containing a proteinase enzyme. In some embodiments, the macromolecules are released during or after the specimen is removed from the solid support. Release of the sample from the solid support can be performed by physical or chemical treatment, including, but not limited to, trypsin digestion, scraping, chemical dissociation, etc. In some embodiments, after generating an extended recording tag containing information from the probe tag and the spatial tag (and optionally from the coding tag), the extended recording tag is released from the spatial sample. In some embodiments, after generating an extended recording tag containing information from the probe tag and the spatial tag (and optionally from the coding tag), the extended recording tag is amplified. In some embodiments, the released macromolecules attached to the extended recording tag can be used in a macromolecular analysis assay.

[0077] In some embodiments, the method further includes performing a macromolecule analysis assay. In some embodiments, the macromolecule (e.g., polypeptide or polynucleotide) analysis assay is performed in situ. In some other embodiments, the macromolecule analysis assay is performed after the macromolecule with an associated recording tag is released from the spatial sample. In some examples, the macromolecule analysis assay includes a polypeptide analysis assay. In some of any such embodiments, the macromolecule analysis assay includes one or more cycles of contacting the macromolecule with a binding agent capable of binding to the macromolecule, where the binding agent includes a coding tag having identifying information about the binding agent, and transferring information from the coding tag to the recording tag to generate an extended recording tag. The identifying information from the binding agent is transferred to the recording tag associated with the polypeptide, which also includes information transferred from the probe tag and spatial tag. Thus, in some embodiments, the extended recording tag includes information from one or more probe tags, one or more spatial tags, one or more coding tags, and, optionally, any other nucleic acid components.

[0078] In some embodiments, the macromolecule analysis assay includes determining the sequence of at least a portion of the macromolecule (e.g., a polypeptide or polynucleotide). In some cases, the analysis method can include performing any of the methods described in International Patent Publication No. 2017 / 192633. In some cases, the sequence of the polypeptide is analyzed by constructing an extended nucleic acid sequence representing the polypeptide sequence or a portion thereof, such as an extended nucleic acid on a recording tag (or any additional barcode or tag attached thereto). In some embodiments, the method further includes determining at least a portion of the sequence of the macromolecule or the identity of the macromolecule and associating it with the spatial location evaluated in step (b2).

[0079] An exemplary workflow for analyzing polypeptides may include the following: a spatial sample of a tissue section is provided on a solid support; macromolecules (e.g., proteins) of the spatial sample are labeled with recording tags; the recording tags may include universal priming sites useful for subsequent amplification; multiple molecular probes, each containing a probe tag, are applied to the spatial sample and bind to the sample; information from the probe tags is transferred to the recording tags attached to the proteins by a suitable method, such as ligation or extension; after transferring information from the probe tags, the molecular probes can be removed, released, or washed; Optionally, additional rounds of binding with molecular probes and transferring information from the probe tags to the recording tags can be performed; multiple spatial probes, each containing beads with multiple probe tags (including barcodes) attached to the beads via photocleavable linkers, are randomly distributed on the spatial sample; the spatial tags on the spatial probes (e.g., beads) are determined in situ to provide information on the spatial location of the spatial tags within the sample. The barcode is cleaved from other components of the spatial probe (e.g., beads), diffuses into the tissue section, and hybridizes with complementary DNA on the recording tag attached to the protein. The tissue section is exposed to a polymerase extension mixture to transfer the barcode information from the hybridized barcode, which serves as a template, to the DNA recording tag. After transferring the information from the probe tag and spatial tag to the extended recording tag, the polypeptide and the attached recording tag are released from the spatial sample. In an optional step, the polypeptide is digested, and a polypeptide analysis assay can optionally be performed, where the polypeptide and associated recording tag (including information from the spatial tag and probe tag) can be randomly immobilized on a single-molecule sequencing substrate (e.g., beads) with appropriate intramolecular spacing. When a polypeptide analysis assay is performed on the polypeptide associated with the extended recording tag, additional identifying information from the coding tag is transferred to the extended recording tag. At least a portion of the sequence of the extended recording tag (including information from the spatial tag and probe tag) is determined.Using this workflow, information about a polypeptide associated with an extended recording tag is associated with the spatial location of the polypeptide within the spatial sample in which it originated.

[0080] The methods described herein can include one or more steps of acquiring an image of a spatial sample (e.g., a biological specimen). In some embodiments, two or more images of the spatial sample or a portion thereof are acquired. In some cases, the method includes comparing, aligning, and / or overlaying the two or more images. The imaging can be performed on the spatial sample in contact with a solid support. The images can be acquired using detection devices known in the art. Examples include microscopes configured for light, bright field, dark field, phase contrast, fluorescence, reflectance, interference, or confocal imaging. The biological specimen can be stained prior to imaging to provide contrast between different regions or cells. In some embodiments, multiple stains can be used to image different aspects of the specimen (e.g., different regions of tissue, different cells, specific subcellular components, etc.). In other embodiments, the biological specimen can be imaged without staining. In some embodiments, the method includes overlaying two or more images obtained from the spatial sample to generate a composite image.

[0081] Detection systems, including microscopes configured for optical, bright-field, dark-field, phase-contrast, fluorescent, reflectance, interference, and / or confocal imaging, can be used in conjunction with one or more steps of the method. The detection system can include an electron spin resonance (ESR) detection system, a charge-coupled device (CCD) detection system (e.g., for radioisotopes), a fluorescent detection system, an electrical detection system, a photographic film detection system, a chemiluminescent detection system, an enzymatic detection system, an atomic force microscope (AFM) detection system (for detecting microbeads), a scanning tunneling microscope (STM) detection system (for detecting microbeads), an optical detection system, a near-field detection system, or a total internal reflection (TIR) ​​detection system.

[0082] In some embodiments, the method includes correlating the location of the sample in the image with the spatial tag. Other characteristics of the spatial sample, including biological specimens identifiable in the image, can be obtained. For example, any of a variety of morphological characteristics can be obtained, including cell shape, cell size, tissue shape, staining pattern, the presence of specific proteins (e.g., detected by immunohistochemical staining), or other characteristics routinely evaluated in pathology or research applications. Thus, the biological state of the tissue or its components as determined by visual observation can also be obtained.

[0083] A. Sample In one aspect, the present disclosure relates to the analysis of macromolecules from a sample. Macromolecules can be large molecules composed of smaller subunits. In certain embodiments, the macromolecules are proteins, protein complexes, polypeptides, peptides, nucleic acid molecules, carbohydrates, lipids, macrocycles, or chimeric macromolecules. In some embodiments, the macromolecules are proteins, polypeptides, or peptides.

[0084] In some embodiments, macromolecules (e.g., proteins, polypeptides, or peptides) are obtained from a sample that is a biological sample. In some embodiments, the sample includes, but is not limited to, mammalian or human cells, yeast cells, and / or bacterial cells. In some embodiments, the sample includes cells derived from a sample obtained from a multicellular organism. For example, the sample may be isolated from an individual. In some embodiments, the sample may include a single cell type or multiple cell types. In some embodiments, the sample may be obtained from a mammalian organism or a human, for example, by puncture or other collection or sampling procedure. In some embodiments, the sample includes two or more cells.

[0085] The sample may be a spatial sample, from which information regarding the spatial arrangement and / or location of anatomical, morphological, cellular, and / or subcellular features may be desired. In some embodiments, the sample is further processed by methods known in the art. For example, the sample is processed to remove, remove, or isolate cellular material (e.g., by centrifugation, filtration, etc.). A spatial sample may refer to a biological sample arranged such that components, portions, or regions of the sample can be spatially referenced (e.g., arranged in a planar format, such as a tissue section on a slide).

[0086] In some embodiments, biological samples can include whole cells and / or viable cells and / or cell debris. In some examples, suitable sources or samples can include, but are not limited to, biological samples from virtually any organism, such as biopsies, cell cultures, cells (both primary cells and cultured cell lines), samples containing organelles or vesicles, tissues, and tissue extracts. For example, suitable sources or samples include biopsies; fecal material; body fluids (blood, whole blood, serum, plasma, urine, lymph, bile, aqueous humor, breast milk, earwax, chyle, chyme, endolymph, perilymph, exudate, cerebrospinal fluid, interstitial fluid, aqueous or vitreous humor, colostrum, phlegm, amniotic fluid, saliva, anal and vaginal secretions, gastric acid, gastric juice, lymph, mucus (including nasal secretions and phlegm), pericardial fluid, peritoneal fluid, pleural fluid, pus, mucosal secretions, saliva, sebum (skin oil), sputum, um), synovial fluid, sweat and semen, transudate, vomit and mixtures of one or more thereof, exudate (e.g., fluid obtained from an abscess or any other site of infection or inflammation) or preferably a mammalian-derived sample containing a microbiome-containing sample, and particularly preferably a human-derived sample containing a microbiome-containing sample, can be used to study fluids obtained from the joints of virtually any organism (either normal joints or joints affected by rheumatoid arthritis, osteoarthritis, Examples of biological samples include, but are not limited to, environmental samples (air, agricultural, water, and soil samples); microbial samples, including microbial biofilms and / or microbial communities, and samples derived from bacterial spores; tissue samples, including tissue sections; research samples, including extracellular fluids, extracellular supernatants from cell cultures, inclusion bodies within bacteria, and cellular components, including mitochondria and periplasm. In some embodiments, the biological sample comprises or is derived from a bodily fluid, and the bodily fluid is obtained from a mammal or human. In some embodiments, the sample comprises a bodily fluid or a cell culture from a bodily fluid. In some of the provided embodiments, a sample, such as a fluid sample, can be deposited on a surface. For example, a liquid sample can be processed to prepare cells for spreading on a solid surface, such as a slide.In some embodiments, the sample or a portion thereof (such as an analyte or cells obtained from the sample) can be deposited in a polymeric resin. In some cases, the polymeric resin comprises a natural or synthetic polymer that forms a hydrogel.

[0087] In some embodiments, the sample is a tissue sample. The tissue can be prepared in any convenient or desired manner for use in any of the methods described herein. Fresh, frozen, fixed, or unfixed tissue can be used. The tissue can be prepared, fixed, or embedded using methods described herein or known in the art (Fischer et al., CSH Protoc (2008) pdb prot4991; Fischer et al., CSH Protoc (2008) pdb top36; Fischer et al., CSH Protoc. (2008) pdb.prot4988). The tissue can be freshly excised from an organism or previously preserved, for example, by freezing, embedding in a material such as paraffin (e.g., formalin-fixed paraffin-embedded samples), formalin fixation, infiltration, dehydration, etc. In some instances, a matrix-forming material can be used to encapsulate a biological sample, such as a tissue sample. In some cases, the sample is embedded in a paraffin block. For example, the spatial sample may be a formalin-fixed paraffin-embedded (FFPE) section. Optionally, the tissue section may be attached to a solid support using, for example, the techniques and compositions exemplified herein for attaching nucleic acids, cells, viruses, beads, etc. to a solid support (Ramos-Vera et al., J Vet Diagn Invest. (2008) 20(4): 393-413). As a further option, the tissue may be permeabilized and its cells lysed while in contact with the solid support. Standard conditions and reagents may be used for tissue permeabilization, including incubation with any suitable detergent, Triton X-100, ethoxylated nonylphenol (Tergitol type NP-40), Tween 20, saponin, digitonin, or acetone (Fischer et al., CSH Protoc (2008) pdb top36).

[0088] In some embodiments, the sample is a "planar sample" that is substantially planar, i.e., two-dimensional. In some embodiments, the sample is deposited on a substrate or on a solid surface. In some embodiments, the sample is a three-dimensional sample. In some examples, the material or substrate (e.g., glass, metal, ceramic, organic polymer surface, or gel) can contain cells or any combination of cell-derived biomolecules, such as proteins, nucleic acids, lipids, oligo / polysaccharides, biomolecular complexes, organelles, extracellular vesicles, cell debris, or waste products. In some embodiments, a planar cell sample can be generated, for example, by depositing cells or portions thereof on a flat surface, cutting the three-dimensional object containing the cells into slices, e.g., by centrifugation, and mounting the slices on a flat surface, i.e., producing a tissue section. In some embodiments, the sample is a tissue section, which refers to a small piece of tissue obtained from a subject, fixed, sectioned (e.g., cryosectioned), and mounted on a flat surface, e.g., a microscope slide.

[0089] In some embodiments, the spatial sample (e.g., specimen or tissue sample) is treated to elongate the sample. In some aspects, the spatial sample is isotropically preserved and elongated using a chemical process. For example, tissue samples can be processed to attach anchors to biomolecules within the tissue sample, perform polymer synthesis in situ, perform mechanical homogenization, and perform specimen elongation (e.g., Zhao et al., Nature Biotechnology (2017) 35(8):757-764; Chang et al., Nature Methods (2017) 14:593-599; Chang et al., Nature Methods (2016) 13(8):679-84; Tillberg et al., Nature Biotechnology (2016) 34:987-992; Chen et al., Science (2015) 347(6221):543-548; Asano et al., Current Protocols in Cell Biology (2018) 80(1):e56; Wassie et al., Nature Methods (2018) 16(1):33-41; Boyden et al. al.,Mater.Horiz.,(2019)6,11-13, Alon et al.,FEBS J.2019 Apr;286(8):1482-1494.Karagiannis et al.,Current Opinion in Neurobiology(2018)50:56-63, Gao et al.,BMC (See Biology (2017) 15(1):50).

[0090] In some embodiments, the method involves obtaining and preparing macromolecules (e.g., polypeptides and proteins) from a single cell type or multiple cell types. In some embodiments, the sample comprises a population of cells. In some embodiments, the macromolecules (e.g., proteins, polypeptides, or peptides) are derived from a cell or intracellular component, extracellular vesicle, organelle, or organized subcomponent thereof. In some embodiments, the polypeptide is from one or more packagings of molecules (e.g., a separate component of a single cell, or a separate component isolated from a population of cells, such as an organelle or vesicle). The macromolecules (e.g., proteins, polypeptides, or peptides) may be derived from an organelle, such as a mitochondria, nucleus, or vesicle. In one embodiment, one or more specific types of single cells or subtypes thereof may be isolated. In some embodiments, the spatial sample may include, but is not limited to, organelles (e.g., nucleus, Golgi apparatus, ribosomes, mitochondria, endoplasmic reticulum, chloroplasts, cell membranes, vesicles, etc.).

[0091] 1. Fixation and Permeabilization In some embodiments, the methods provided herein further include one or more fixation (e.g., crosslinking) and / or permeabilization steps. In certain embodiments, samples containing macromolecules (e.g., proteins, polypeptides, or peptides) for analysis can be fixed and / or permeabilized. For example, holes or openings can be formed in the membrane of cells and / or any intracellular components. Cells, intracellular structures and components, or biomolecules can be fixed using any number of reagents, including, but not limited to, formalin, methanol, ethanol, paraformaldehyde, formaldehyde, methanol:acetic acid, glutaraldehyde, bifunctional crosslinkers such as bis(succinimidyl) suberate, bis(succinimidyl) polyethylene glycol, and the like.

[0092] In some examples, the methods of processing proteins and analyzing proteins provided herein can include fixing the sample at any step of the method. In some cases, fixation of the sample is performed before permeabilizing the sample (e.g., permeabilizing a cell or other membrane). In some examples, fixation of the sample is performed after permeabilizing the sample. In some embodiments, the sample is fixed or crosslinked before providing recording tags to proteins in the spatial sample. In some embodiments, the sample is permeabilized before combining the spatial sample with one or more molecular probes.

[0093] In some embodiments, the sample may be fixed or crosslinked so that cells and subcellular components are immobilized or held in place. In some embodiments, macromolecules (e.g., DNA, RNA, proteins, polypeptides, lipids) within the sample may be fixed or crosslinked so that the molecules contained therein are immobilized within the cells or subcellular components. In some embodiments, the sample (e.g., cells and subcellular components) is fixed so that the spatial location of molecules within the sample is maintained.

[0094] In some cases, samples can be fixed to crosslink proteins and stabilize lipid membranes within tissues or cellular structures. In some instances, samples are fixed using formaldehyde in phosphate-buffered saline (PBS). Standard methods of fixation are known and include incubation with 0.5-5% formaldehyde in 1x PBS for 10-30 minutes. In some embodiments, samples are fixed by incubation in methanol or ethanol. In some embodiments, after fixation, samples are permeabilized and treated to allow access to the interior of structural components by enzymes and DNA tags (e.g., recording tags, probe tags, spatial tags or copies thereof, barcodes, or other nucleic acids).

[0095] In some embodiments, one or more washing steps are performed before and / or after fixation and / or permeabilization. Commercially available fixation and permeabilization kits can be used to prepare samples. In some embodiments, fixation or crosslinking of the sample can be reversed.

[0096] In some embodiments, fixation or reversal of cross-linking of the sample is performed before isolating the macromolecule (e.g., protein, polypeptide, or peptide) and associated recording tag from the spatial sample. In some embodiments, fixation or reversal of cross-linking of the sample is performed after isolating the macromolecule (e.g., protein, polypeptide, or peptide) and associated recording tag from the spatial sample. For example, cross-linking can be reversed by incubating the cross-linked sample in high salt (approximately 200 mM NaCl) at 65°C for about 4 hours or more.

[0097] In some embodiments, tissue samples are treated to remove embedding material from the sample (e.g., remove paraffin or formalin) before releasing, capturing, or processing macromolecules (e.g., proteins, polypeptides, or peptides) from the tissue sample. This can be accomplished by contacting the sample with an appropriate solvent (e.g., xylene and ethanol washes). Treatment can occur before contacting the tissue sample with a solid support described herein, or treatment can occur while the tissue sample is on the solid support.

[0098] 2. Provide a recording tag The methods provided herein include providing a spatial sample containing one or more macromolecules (e.g., proteins, polypeptides, or peptides) having recording tags. In some embodiments, the spatial sample is provided with multiple recording tags. In some embodiments, multiple macromolecules in the spatial sample are provided with recording tags. The recording tags can be directly or indirectly associated with or attached to macromolecules or other moieties in the spatial sample. In some embodiments, the recording tags are attached to the macromolecules using any suitable means. In some embodiments, the macromolecules can be associated with one or more recording tags. In some embodiments, the recording tags can be any suitable sequencible moiety capable of transferring information from the probe tag, the spatial tag, and optionally the identification information of one or more coding tags. The recording tag functions as a moiety capable of transferring or recording information, such as information from a molecular probe or a spatial probe.

[0099] In some other embodiments, the recording tag is not directly or indirectly associated with or attached to a macromolecule or other moiety within the spatial sample, but is held in place within a matrix applied to the spatial sample. In some embodiments, the spatial sample is exposed to a matrix (e.g., a polymer matrix), scaffold, or other substance that contains the recording tag. See, e.g., Gao et al., BMC Biology (2017) 15:50. For example, the matrix may include hydrogel polymer chains. In some embodiments, the spatial sample (e.g., biological tissue or specimen) is treated with a compound that binds to macromolecules so that the biomolecules are chemically fixed and tethered to the hydrogel polymer chains. For example, a hydrogel made of closely spaced, densely crosslinked, highly charged monomers is polymerized uniformly throughout the cells or tissue within the spatial sample, intercalating between and around the macromolecules and biomolecules within the spatial sample. In some cases, the embedded spatial sample may be subjected to a mechanical homogenization step that involves denaturing and / or digesting structural molecules. In some embodiments, the spatial sample comprises a specimen-hydrogel composite.

[0100] In some embodiments of the provided methods, information from one or more probe tags, spatial tags, and / or coding tags is transferred to a recording tag. The recording tag may include other nucleic acid components. In some embodiments, the recording tag may include a unique molecular identifier, a compartment tag, a partition barcode, a sample barcode, a fraction barcode, information transferred from a probe tag, information transferred from a spatial tag, a spacer sequence, a universal priming site, or any combination thereof. In some embodiments, the recording tag may further include other information, including information from a macromolecular analysis assay, such as a binder identifier (e.g., from a coding tag), a cycle identifier (e.g., from a coding tag), etc.

[0101] In some embodiments, at least one recording tag is directly or indirectly associated with or co-localized with a macromolecule (e.g., a polypeptide). In certain embodiments, a single recording tag is attached to the polypeptide, preferably via attachment to the N- or C-terminal amino acid. In other embodiments, multiple recording tags are attached to the polypeptide, for example, to lysine residues or the peptide backbone. In some embodiments, a polypeptide labeled with multiple recording tags is fragmented or digested into smaller peptides, each of which is labeled with, on average, one recording tag.

[0102] In some embodiments, the density or number of macromolecules with recording tags is controlled or titrated. In other embodiments, a matrix or substance containing recording tags applied to a spatial sample is titrated for a desired density of recording tags. For example, it may be desirable to appropriately position recording tags in or on a spatial sample to accommodate a method used to assess the spatial location of macromolecules. In some cases, the amount or density of recording tags associated with macromolecules in a spatial sample is titrated on the surface of the sample or within the volume of the sample.

[0103] In some examples, the desired spacing, density, and / or quantity of recording tags within a sample can be titrated by providing a diluted or controlled number of recording tags. In some examples, the desired spacing, density, and / or quantity of recording tags can be achieved by spiking in competing or "dummy" competitor molecules when providing, associating, and / or attaching recording tags. In some cases, the "dummy" competitor molecules react in the same way as recording tags associated with or attached to macromolecules within the sample, but the competitor molecules do not function as recording tags. In some specific examples, if the desired density is one functional recording tag per 1,000 sites available for attachment within the sample, spiking in one functional recording tag for every 1,000 "dummy" competitor molecules is used to achieve the desired spacing. In some examples, the ratio of functional recording tags is adjusted based on the reaction rate of the functional recording tag compared to the reaction rate of the competitor molecules.

[0104] The recording tag may comprise DNA, RNA, or polynucleotide analogs, including PNA, γPNA, GNA, BNA, XNA, TNA, other polynucleotide analogs, or combinations thereof. The recording tag may be single-stranded, or partially or completely double-stranded. The recording tag may have blunt ends or overhanging ends. The recording tag may comprise an amino acid sequence, which may have a length of at least, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 40, 50, 75, or 100 amino acids. In some embodiments, the recording tag may comprise a peptide or amino acid sequence. In some cases, the recording tag is a moiety that allows for the attachment or addition of an amino acid sequence (e.g., a peptide barcode).

[0105] In certain embodiments, all or a substantial amount (e.g., at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 100%) of the macromolecules in a sample are labeled with a recording tag. In other embodiments, a subset of the macromolecules in a sample are labeled with a recording tag. In certain embodiments, a subset of the macromolecules from a sample undergoes targeted (analyte-specific) labeling with a recording tag. For example, targeted recording tag labeling of proteins can be achieved using target protein-specific binding agents (e.g., antibodies, aptamers, etc.). In some embodiments, the recording tag is attached to the macromolecule in situ within the sample. In some embodiments, the recording tag is attached to the macromolecule prior to providing the sample on the solid support. In some embodiments, the recording tag is attached to the macromolecule after providing the sample on the solid support.

[0106] In some embodiments, the recording tag can also include a sample identifying barcode. Sample barcodes are useful for multiplexed analysis of a set of samples in a single reaction vessel or immobilized on a single solid substrate or collection of solid substrates (e.g., a flat slide, a collection of beads contained in a single tube or vessel, etc.). For example, macromolecules from many different samples can be labeled with recording tags bearing sample-specific barcodes, and then all samples can be pooled together prior to immobilization on a solid support, periodic binding of a binder, and recording tag analysis. Alternatively, samples can be separated until after the creation of a DNA-encoded library, with sample barcodes attached during PCR amplification of the DNA-encoded library, and then mixed together prior to sequencing. This approach can be useful for assaying analytes (e.g., proteins) of different abundance classes.

[0107] In certain embodiments, the recording tag includes an optional unique molecular identifier (UMI), which provides a unique identifier tag for each associated macromolecule (e.g., polypeptide). The UMI can be about 3 to about 40 bases, about 3 to about 30 bases, about 3 to about 20 bases, or about 3 to about 10 bases, or about 3 to about 8 bases. In some embodiments, the UMI is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 16 bases, 17 bases, 18 bases, 19 bases, 20 bases, 25 bases, 30 bases, 35 bases, or 40 bases in length. The UMI can be used to deconvolute sequencing data from multiple extended recording tags to identify sequence reads from individual macromolecules. In some embodiments, within a library of polymers, each polymer is associated with a single recording tag, and each recording tag contains a unique UMI. In other embodiments, multiple copies of a recording tag are associated with a single polymer, and each copy of the recording tag contains the same UMI. In some embodiments, the UMI has a different base sequence from the spacer or encoder sequence in the binding agent coding tag to facilitate distinguishing these components during sequence analysis. In some embodiments, the UMI can serve as a positional identifier and can also provide information in polymer analysis assays. For example, the UMI can be used to identify molecules that are of the same lineage and therefore derived from the same initial molecule. In some embodiments, this information can be used to correct for amplification variations and to detect and correct sequencing errors.

[0108] In some embodiments, the recording tag may include spatial information, for example, the recording tag may include a UMI, which may in some cases function as a spatial tag.

[0109] In certain embodiments, the recording tag comprises a universal priming site, e.g., a forward or 5' universal priming site. A universal priming site is a nucleic acid sequence that can be used for priming and / or sequencing a library amplification reaction. Universal priming sites include, but are not limited to, priming sites for PCR amplification, flow cell adapter sequences that anneal to complementary oligonucleotides on the flow cell surface (e.g., Illumina next-generation sequencing), sequencing priming sites, or combinations thereof. The universal priming site can be from about 10 bases to about 60 bases. In some embodiments, the universal priming site comprises an Illumina P5 primer (5'-AATGATACGGCGACCACCGA-3'-SEQ ID NO: 1) or an Illumina P7 primer (5'-CAAGCAGAAGACGGCATACGAGAT-3'-SEQ ID NO: 2).

[0110] The recording tag may contain a reactive moiety for a cognate reactive moiety present on a target macromolecule, such as a target protein (e.g., click chemistry label, photoaffinity label). For example, the recording tag may contain an azide moiety for interacting with an alkyne-derivatized protein, or a benzophenone for interacting with a native protein, etc. Upon binding of the target protein by a target protein-specific binding agent, the recording tag and the target protein are coupled via their corresponding reactivities. After labeling the target protein with the recording tag, the target protein-specific binding agent may be removed by digestion of a DNA capture probe linked to the target protein-specific binding agent. For example, the DNA capture probe may be designed to contain a uracil base and then targeted for digestion with a uracil-specific cleavage reagent (e.g., USER™). The target protein-specific binding agent may be dissociated from the target protein. In some embodiments, other types of linkages besides hybridization can be used to link the recording tag to the macromolecule. Suitable linkers can be attached to various positions of the recording tag, such as the 3' end at an internal position, or within a linker attached to the 5' end of the recording tag.

[0111] B. Molecular Probes The methods provided herein include binding one or more molecular probes to a spatial sample. In some embodiments, the molecular probes include probe tags. After providing one or more recording tags to a spatial sample containing one or more macromolecules, the methods include applying and binding one or more molecular probes to the spatial sample. In some embodiments, the spatial sample is treated with a blocking agent before binding the spatial sample with one or more molecular probes. The molecular probes may bind to macromolecules within the spatial sample or to moieties adjacent to the macromolecules within the spatial sample.

[0112] In some embodiments, two or more molecular probes are applied to the spatial sample. When multiple molecular probes are used, molecular probes of the same identity can be associated with the same probe tag. One or more molecular probes can be applied sequentially, or multiple molecular probes can be applied simultaneously. In some cases, the method can include decoding the combined information from the sequential transfer of two or more probe tags to a recording tag. In some embodiments, multiple polymers and associated extended recording tags can include the same barcode transferred from the probe tag.

[0113] A molecular probe can be composed of any composition suitable for binding a spatial sample. In some examples, a molecular probe comprises a nucleic acid, peptide, polypeptide, protein, carbohydrate, or small molecule that binds to, associates with, integrates with, recognizes, or combines with a spatial sample. A molecular probe can form a covalent or non-covalent association with a spatial sample or a component of a spatial sample. In some embodiments, a molecular probe can form a reversible association with a spatial sample or a component of a spatial sample. A molecular probe can be a chimeric molecule composed of two or more types of molecules, such as a nucleic acid molecule-peptide chimeric molecular probe or a carbohydrate-peptide chimeric molecular probe. A molecular probe can be a naturally occurring, synthetically produced, or recombinantly expressed molecule. A molecular probe can bind to a linear molecule or a molecule with a three-dimensional structure (also called a conformation).

[0114] In some examples, the molecular probe comprises an antibody, an antigen-binding antibody fragment, a single domain antibody (sdAb), a recombinant heavy chain-only antibody (VHH), a single chain antibody (scFv), a shark-derived variable domain (vNAR), an Fv, a Fab, a Fab', a F(ab')2, a linear antibody, a diabody, an aptamer, a peptidomimetic molecule, a fusion protein, a reactive or non-reactive small molecule, or a synthetic molecule.

[0115] In some embodiments, the molecular probe is a microprotein (cysteine ​​knot protein, knottin), DARPin; Tetranectin; Affibody; Affimer; Transbody; Anticalin; AdNectin; Affilin; Microbody; Peptide aptamer; Alterase; Plastic antibody; phylomer; Stradobody; Maxibody ody); evibody; fynomer, armadillo repeat protein, Kunitz domain, avimer, atrimer, probody, immunobody, triomab, troybody; pepbody; vaccibody, UniBody; DuoBody, Fv, Fab, Fab', F(ab')2, peptidomimetic molecule, or synthetic molecule (e.g., Nelson, MAbs (2010) 2(1):77-78; Goltsev et al., Cell. 2018 Aug 9;174(4):968-981, or as described in U.S. Patent Nos. 5,475,096, 5,831,012, 6,818,418, 7,166,697, 7,250,297, 7,417,130, 7,838,629, U.S. Patent Publication Nos. 2004 / 0209243, and / or 2010 / 0239633).

[0116] In some embodiments, the molecular probe can be chemically, covalently, and / or reversibly bound to the spatial sample. In some embodiments, the molecular probe binds to a moiety that binds to, associates with, or forms a complex with a macromolecule in the spatial sample. In some examples, the molecular probe binds to a macromolecule (e.g., a target macromolecule), a moiety proximate to the macromolecule, or a moiety that associates with or binds to a macromolecule in the spatial sample. In some embodiments, the molecular probe binds to a moiety proximate to the macromolecule, thereby allowing transfer of information from the probe tag to the recording tag, enabling association with the molecular probe. For example, the distance between the polymer and the moiety adjacent to the polymer can be about 10 nm to 100 nm, about 10 nm to 500 nm, about 10 nm to 1,000 nm, about 10 nm to 5,000 nm, about 100 nm to 300 nm, about 100 nm to 600 nm, about 100 nm to 1,000 nm, about 100 nm to 5,000 nm, about 300 nm to 600 nm, about 300 nm to 1,000 nm, or about 300 nm to 5,000 nm. In some cases, regardless of where the molecular probe is attached to the polymer, the proximity of the recording tag to the probe tag can result in information transfer from the probe tag to the recording tag. In some embodiments, the molecular probe is attached to the probe tag via a linker, which can be of various lengths. In some cases, the length of the linker between the molecular probe and the probe tag can increase the distance between the moiety adjacent to the molecular probe and the molecular probe, allowing for association with the molecular probe. In some embodiments, the proximity of a moiety to a macromolecule may depend on the length of any linker used in the molecular probe to attach the probe tag.

[0117] In some instances, the targeting moiety is configured to bind to a macromolecule, including, but not limited to, a nucleic acid, a carbohydrate, a lipid, a polypeptide, a post-translational modification of a polypeptide, or any combination thereof. In some embodiments, the targeting moiety is a protein-specific targeting moiety, an epitope-specific targeting moiety, or a nucleic acid-specific targeting moiety. In some instances, the molecular probe is configured to bind to a cell surface marker. In some embodiments, the targeting moiety binds to a post-translational modification (PTM) of a polypeptide or amino acid. Examples of PTMs include, but are not limited to, phosphorylation, ubiquitination, methylation, acetylation, glycosylation, oxidation, lipidation, nitrosylation, sumoylation, ubiquitination, etc.

[0118] In some embodiments, the molecular probe comprises a targeting moiety capable of specific or partially specific binding. In some embodiments, the molecular probe comprises a targeting moiety capable of specific and / or selective binding. Examples of structure-specific binders can include protein-specific molecules capable of binding to protein targets. Examples of suitable protein-specific molecules can include antibodies and antibody fragments, nucleic acids (e.g., aptamers that recognize protein targets), or protein substrates. In some embodiments, the target of the targeting moiety can include an antigen, and the molecular probe can comprise an antibody. Suitable antibodies can include monoclonal antibodies, polyclonal antibodies, multispecific antibodies (e.g., bispecific antibodies), or antibody fragments, as long as they specifically bind to the target antigen. In some embodiments, the molecular probe comprises a moiety or nucleic acid component configured to specifically bind to a nucleic acid, such as a specific target nucleic acid sequence.

[0119] The molecular probes provided herein may optionally include a suitable detectable label, including, but not limited to, radioisotopes, fluorescent labels, colorimetric labels, and various enzyme substrate labels known in the art. In some embodiments, the signal from the detectable label can be amplified by attaching a secondary probe to the primary molecular probe. For example, the secondary probe can be fluorescently labeled or conjugated to an enzyme that can then amplify the signal. In some embodiments, the detectable label or secondary probe is visually detectable by microscopy or using an imager. In some embodiments, one or more steps of the method can be performed using a system, such as an automated system, including the application of the molecular probe. In some embodiments, a microfluidic system for cell analysis can be used to deliver and apply reagents for the provided methods. In some embodiments, the system for performing one or more steps of the method can be multiplexed. For example, a multiplexed tissue processing platform can be utilized. In some embodiments, a microfluidic flow cell can be used to spatially attach the molecular probe to the sample.

[0120] In some embodiments, the signal intensity, wavelength, position, frequency, or shift of the optional detectable label associated with the molecular probe is observed. In some embodiments, the observation of the detectable label can be performed before transferring information from the probe tag to the recording tag. In some cases, the observation of the detectable label can be performed after transferring information from the probe tag to the recording tag. In some embodiments, one or more of the aforementioned characteristics of the signal can be observed, measured, and recorded.

[0121] In the methods provided herein, the molecular probe comprises a probe tag comprising information to be transferred to a recording tag associated with a macromolecule (e.g., a protein, polypeptide, or peptide). In the methods provided herein, the molecular probe comprises a probe tag comprising information to be transferred to a recording tag contained in a matrix applied to a spatial sample. In some embodiments, information from multiple probe tags is transferred to multiple recording tags. In some embodiments, information from one probe tag is transferred to two or more recording tags. In some embodiments, information from multiple probe tags is transferred to a recording tag. In some embodiments, the probe tag comprises a barcode. In some embodiments, the information transferred from the probe tag to the recording tag may also be referred to as the probe tag. In some embodiments, the extended recording tag comprises a probe tag sequence.

[0122] In some embodiments, the use of molecular probes can include adjustments useful for subsampling and / or adjusting the dynamic range. In some cases, the concentration of molecular probes provided to a sample can be adjusted and regulated. For example, for single molecule detection, the concentration of molecular probes provided can be reduced. In some embodiments, a sample is provided with multiple molecular probes, some of which are labeled with probe tags and some of which are not labeled with probe tags (e.g., "dummy molecular probes"). In some cases, a sample is provided with multiple molecular probes (e.g., "dummy molecular probes"), including at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, or 99% of the molecular probes that are not labeled with probe tags. In some embodiments, a sample is provided with multiple molecular probes, and two or more of the same molecular probes are associated with different probe tags.

[0123] Multiple macromolecules in a spatial sample can be labeled with probe tags or can contain information transferred from probe tags containing the same barcode. In some embodiments, multiple recording tags adjacent to a probe tag associated with a molecular probe can be extended by transferring information from the probe tag. As long as the recording tag is adjacent to the probe tag, the recording tag need not be attached to or associated with the moiety bound by the molecular probe. For example, the distance between the recording tag and the moiety or macromolecule bound by the molecular probe containing the probe tag can be about 10 nm to 100 nm, about 10 nm to 500 nm, about 10 nm to 1,000 nm, about 10 nm to 5,000 nm, about 100 nm to 300 nm, about 100 nm to 600 nm, about 100 nm to 1,000 nm, about 100 nm to 5,000 nm, about 300 nm to 600 nm, about 300 nm to 1,000 nm, or 300 nm to 5,000 nm. In some examples, multiple macromolecules within a cell may be labeled with probe tags or may contain information transferred from probe tags that include the same barcode. In some examples, multiple macromolecules within an organelle may be labeled with probe tags or may contain information transferred from probe tags that include the same barcode.

[0124] In some embodiments, the probe tag is a nucleic acid or amino acid tag that includes a barcode that is transferred to the recording tag. In some cases, the recording tag may be associated with a macromolecule or suspended in a matrix or substance applied to the spatial sample. In some embodiments, the probe tag information is transferred to the recording tag by generating a sequence in situ on the recording tag associated with the macromolecule in the spatial sample, thereby generating an extended recording tag. By transferring information from the probe tag to the recording tag, in some embodiments, the extended recording tag includes the probe tag. In some examples, the method includes generating a sequence in situ on the recording tag that includes a barcode sequence from the probe tag. In some embodiments, the probe tag is physically transferred to the recording tag. In some cases, extending the recording tag by transferring information from the probe tag associated with the molecular probe to the recording tag is performed using any suitable chemical / enzymatic reaction, such as ligation or polymerase extension. For example, ligation (e.g., enzymatic or chemical ligation, splint ligation, sticky end ligation, single-stranded (ss) ligation such as ssDNA ligation, or any combination thereof), a polymerase-mediated reaction (e.g., primer extension of single-stranded or double-stranded nucleic acids), or any combination thereof can be used to transfer information from a probe tag to a recording tag to generate an extended recording tag.

[0125] In certain embodiments, the probe tag includes an optional unique molecular identifier (UMI), which provides a unique identifier tag for each associated macromolecule (e.g., polypeptide). The UMI can be about 3 to about 40 bases, about 3 to about 30 bases, about 3 to about 20 bases, or about 3 to about 10 bases, or about 3 to about 8 bases. In some embodiments, the UMI is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 16 bases, 17 bases, 18 bases, 19 bases, 20 bases, 25 bases, 30 bases, 35 bases, or 40 bases in length.

[0126] The probe tag can be any suitable tag. In some examples, the probe tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, or a γPNA molecule. In some embodiments, the probe tag comprises a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. In some embodiments, the probe tag is a nucleic acid. In some embodiments, the probe tag comprises a nucleic acid molecule of about 3 to about 40 bases in length (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 bases). The probe tag may comprise a barcode sequence, optionally flanked on one side by a spacer or on both sides by spacers. The probe tag may be single-stranded or double-stranded. A double-stranded probe tag may comprise a blunt end, a protruding end, or both. The probe tag may refer to a probe tag directly attached to a molecular probe, a complementary sequence of a probe tag directly attached to a probe agent, or probe tag information present in an extended recording tag.

[0127] In certain embodiments, the probe tag comprises a barcode. The barcode is a nucleic acid molecule about 3 to about 30 bases, about 3 to about 25 bases, about 3 to about 20 bases, about 3 to about 10 bases, about 3 to about 10 bases, or about 3 to about 8 bases in length. In some embodiments, the barcode is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 20 bases, 25 bases, or 30 bases in length. In one embodiment, the barcode enables multiplexed sequencing of multiple samples or libraries. The barcodes can be used to deconvolute multiplexed sequence data and identify sequence reads from individual samples or libraries. In some embodiments, the probe tag comprises multiple barcodes. For example, a probe tag can be composed of a string of two or more tags, each of which is a barcode. In some embodiments, the concatenated string of barcodes can increase the variety of barcodes for labeling or identification. For example, if 10 different tags (e.g., barcodes) are used and randomly concatenated into a string of 3 tags as a barcode, the concatenated barcode can be 10 by using 10 tags arranged in combination. 3 = 1000 possible sequences. In some embodiments, a series of probe tags used in combination can be used to provide information about one or more molecular probes. For example, a recording tag can include a series of information from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more probe tags.

[0128] In some embodiments, the probe tag comprises a spacer. In some embodiments, the spacer on the probe tag is configured to hybridize to a sequence comprised by the recording tag. Optionally, the probe tag comprises a spacer at its 5' end. Optionally, the probe tag comprises a spacer at its 3' end. In some embodiments, the probe tag comprises a universal priming site. In some embodiments, the probe tag further comprises another nucleic acid moiety. In some embodiments, the probe tag further comprises a universal priming site.

[0129] In some embodiments, the probe tag comprises a peptide or amino acid barcode, which includes a sequence of amino acids that may be at least, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 40, 50, 75, or 100 amino acids in length. A particular peptide barcode that can be distinguished from other peptide barcodes may have different physical properties (amino acid sequence, sequence length, charge, size, molecular weight, hydrophobicity, reverse-phase separation, affinity, or other separable properties). See, for example, International Patent Publications 2016 / 145416 and 2018 / 078167. The probe tag may comprise a barcode associated with one or more molecular probes. The molecular probes may be associated with or attached to the peptide barcode using any suitable means, including, but not limited to, any enzymatic or chemical attachment means. The peptide barcode information of the probe tag can be transferred to the recording tag using any suitable means, including, but not limited to, any enzymatic or chemical attachment method. See, for example, Miyamoto et al., PLoS One. (2019) 14(4):e0215993; Wroblewska et al., Cell. (2018) 175(4):1141-1155. e16. In some embodiments, a linker, typically made with a flexible amino acid sequence, can be used to allow attachment of two different polypeptides. For example, a linear linking peptide can be made of 2-25 amino acids, 2-15 amino acids, or a longer linker can be used.

[0130] Information from the probe tag can be transferred to the recording tag in any suitable manner. In some embodiments, the method includes extending the recording tag by transferring information from one or more probe tags associated with the molecular probe to the recording tag. For example, information from the probe tag can be transferred to the recording tag by extension or ligation. In some embodiments, transferring information from the probe tag to the recording tag includes contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the recording tag. In some cases, the probe tag associated with the molecular probe serves as a template for extension. In certain embodiments, information from the probe tag is transferred to the recording tag via primer extension (see, e.g., Chan et al., Curr Opin Chem Biol. (2015) 26:55-61). A spacer sequence on the end of the recording tag anneals to a complementary spacer sequence on the opposite side of the probe tag, and a polymerase (e.g., a strand-displacing polymerase) extends the recording tag sequence using the annealed probe tag as a template.

[0131] In some embodiments, information from a probe tag can be transferred to any recording tag in close proximity to the probe tag. The recording tag does not need to be attached to or associated with the moiety bound (directly or indirectly) by the molecular probe, as long as the recording tag is in close proximity to the probe tag for information transfer. The distance that allows probe tag information to be transferred to the recording tag can depend on the distance the probe tag and the recording tag can reach. For example, the molecular probe can be a nucleic acid that binds to a target nucleic acid, and the target nucleic acid is bound to a polymerase. In this example, the polymerase is attached to a recording tag, which is near the probe tag attached to the target nucleic acid. In another example, a recording tag included in a matrix applied to a spatial sample can be in close proximity to a probe tag attached to a molecular probe bound to a polypeptide within the spatial sample.

[0132] The transfer of information from the probe tag to the recording tag can occur directly from the probe tag associated with the molecular probe, or indirectly through a copy of the probe tag. In some embodiments, the probe tag associated with the molecular probe is copied one or more times before transferring the probe tag information to the recording tag. For example, the probe tag associated with the molecular probe can be amplified before transferring the probe tag information to the recording tag. In some cases, the amplification of the probe tag is linear amplification. In some embodiments, the amplification of the probe tag is performed using RNA polymerase. If the probe tag copy comprises RNA, the transfer of the probe tag to the recording tag can be performed using reverse transcription. In one example, the molecular probe can bind to a cell surface marker, and the recording tag is located within the cell. In this case, a copy of the probe tag attached to the molecular probe bound to the outside of the cell is created, and then the copy of the probe tag diffuses into the cell, allowing the transfer of information from the copy of the probe tag to the recording tag within the cell.

[0133] C. Spatial Probe The methods provided herein include binding one or more spatial probes to a spatial sample. In some embodiments, the spatial probe includes a spatial tag. In some cases, the spatial tag may include one or more nucleic acid components including a barcode and, optionally, a spacer and / or a universal priming site. After providing one or more recording tags to a spatial sample containing one or more macromolecules, the method includes providing one or more spatial probes to the spatial sample. In some examples, the method includes providing multiple spatial probes to the spatial sample. In some embodiments, information from the spatial probes is transferred to the recording tag, thereby generating an extended recording tag. In some embodiments, the method includes (b1) providing a spatial probe including a spatial tag to the spatial sample; (b2) determining the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample; and (b3) extending the recording tag by transferring information from the spatial tag associated with the spatial probe to the recording tag. In some embodiments, information from the spatial tag (e.g., a barcode) can be transferred to any recording tag in proximity to the spatial probe.

[0134] Exemplary steps involving spatial probes may include providing spatial probes containing spatial tags to multiple polypeptides; attaching DNA barcodes to the beads via photocleavable, chemical, or enzymatic linkers to allow for barcode removal and subsequent diffusional transfer to the tissue section; providing barcoded beads to the spatial sample, which may nonspecifically attach or associate with the tissue surface through adhesive forces such as charge interactions, DNA hybridization, or reversible chemical coupling; decoding or sequencing the barcoded DNA beads attached to the tissue; releasing the DNA barcodes by enzymatic, chemical, or photocleavage of the cleavable linker; allowing the barcodes to penetrate the tissue slice and anneal to DNA recording tags attached to macromolecules, such as proteins within the tissue slice; and performing a reaction (e.g., polymerase extension) to transfer the barcodes to the recording tags on the macromolecules within the spatial sample. In some embodiments, the barcoded beads may be provided in any suitable format, including those described herein.

[0135] In some embodiments, the spatial probe comprises a nucleic acid, a support, a polypeptide, a small molecule, and / or a chemical moiety. In some embodiments, the spatial probe comprises a support, e.g., a solid support, and a spatial tag comprising a nucleic acid. In some preferred embodiments, the spatial probe comprises a support (e.g., spatial tags) attached to multiple nucleic acids. For example, the support is a bead or a microparticle. Any suitable bead material and size can be used to deliver barcodes to polypeptides within a sample, including, but not limited to, porous or non-solid beads. In some embodiments, the spatial probe comprises barcoded beads. In some instances, the beads are porous to accommodate higher barcode loading on the beads. In some cases, the spatial probe comprises two or more copies of the same barcode. In some embodiments, the beads are polystyrene beads, polyacrylate beads, cellulose beads, dextran beads, polymer beads, agarose beads, acrylamide beads, solid core beads, porous beads, paramagnetic beads, glass beads, or controlled porosity beads, or any combination thereof.

[0136] In some embodiments, the spatial sample labeled with a spatial tag from a spatial probe is determined by the size of the spatial probe. For example, a single molecule or multiple molecules within a region can be labeled with a spatial tag from the spatial probe. In some aspects, the size of the spatial probe can be selected and adjusted based on the desired resolution. Other characteristics of the spatial probe, including packing, stability, layering, etc., can also be considered. In some embodiments, the size or type of the spatial probe is selected based on the ability to optically resolve the probe, for example, image resolution or sensor resolution. In some examples, spatial probes (e.g., beads or nanoparticles) have diameters ranging from about 50 nm to about 10 μm, from about 50 nm to about 1 μm, from about 50 nm to about 100 nm, from about 100 nm to about 1 μm, from about 100 nm to about 10 μm, from about 0.1 μm to about 100 μm, from about 0.1 μm to about 50 μm, from about 10 μm to about 50 μm, from about 5 μm to about 10 μm, from about 0.5 μm to about 100 μm, from about 0.5 μm to about 50 μm, from about 0.5 μm to about 10 μm, from about 0.5 μm to about 5 μm, or from about 0.5 μm to about 1 μm. In some examples, beads have diameters ranging from about 50 nm to about 10 μm.

[0137] In some embodiments, the probes contain one or more spatial tags attached to the support with a cleavable linker. In some embodiments, the DNA barcodes are attached to the beads via photocleavable, chemical, or enzymatic linkers, allowing for barcode removal and subsequent diffusional transfer to tissue sections. The DNA barcodes may be released by enzymatic, chemical, or photocleavage of the cleavable linker. Various methods can be used to generate and apply barcoded beads to samples, including the split-pool synthesis strategy described in Klein et al., Lab Chip (2017) 17(15):2540-2541, coating a surface with DNA-barcoded beads described in Rodriques et al., Science (2019) 363(6434):1463-1467, or using spatially barcoded bead arrays described in Vickovic et al. (2019) Nat Methods 16(10):987-990. For example, the use of spatially indexed beads can include barcode locations that correlate with the distribution and spatial location of beads on a plane. In some embodiments, each bead has a single population of DNA barcodes. The DNA barcodes are attached to the beads using any suitable method. In some cases, the spatial tag (e.g., barcode) is cleaved from the bead and transferred to the polypeptide. In some embodiments, the barcode is cleaved from the bead via photocleavage, such as by exposure to long-wavelength UV. The cleaved barcode diffuses into the tissue section of the spatial sample and hybridizes to the recording tag. The released barcode can be transferred to the recording tag using any suitable method, including, but not limited to, ligation or extension.For example, ligation (e.g., enzymatic or chemical ligation, splint ligation, sticky end ligation, single-stranded (ss) ligation such as ssDNA ligation, or any combination thereof), a polymerase-mediated reaction (e.g., primer extension of single-stranded or double-stranded nucleic acids), or any combination thereof can be used to transfer information from a spatial tag to a recording tag to generate an extended recording tag. In some embodiments, a polymerase extension mixture is added to the spatial sample to transfer barcode information from the hybridized barcode to a DNA recording tag.

[0138] In some embodiments, the spatial tag is evaluated in situ in the spatial sample or after association with a macromolecule within the spatial sample. For example, randomly dispersed barcodes are provided to the spatial sample, and the barcodes are decoded or evaluated in situ. In some embodiments, the barcode can be decoded or evaluated in situ before or after transfer to the recording tag. In some embodiments, the barcode can be decoded or evaluated in situ after being placed in a spatial location and position for transfer to a surface on which the spatial sample is immobilized. For example, the barcode of the spatial tag can be decoded or evaluated while attached to the spatial probe or after being transferred to the recording tag. In some embodiments, the barcode is unknown before being decoded or evaluated in situ. In some aspects, the spatial tag is evaluated before releasing the macromolecule of the sample for further macromolecule analysis.

[0139] In one example, the barcode beads form an array that is spatially indexed before transferring the barcodes to the polypeptide (see, e.g., Rodriques et al., Science (2019) 363(6434):1463-1467). In some cases, the method includes determining the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample. In some embodiments, determining the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample is performed while the spatial tag is attached to the support. In some embodiments, determining the spatial tag in situ to obtain the spatial location of the spatial tag within the spatial sample is performed after the spatial tag has been released or cleaved from the support.

[0140] In some other embodiments, spatial samples are labeled with barcodes that reflect the spatial location of molecules within the surface-mounted cellular tissue, and the spatial distribution of protein analytes within the tissue slice can then be later reconstructed after sequence analysis, most commonly performed for spatial transcriptomics (e.g., Stahl et al. 2016 Science 353(6294):78-82; Crosetto et al. Nat Rev Genet. 2015 Jan;16(1):57-66). In another embodiment, molecules within organelles and cellular / subcellular compartments can be labeled (Christoforou et al., 2016, Nat. Commun. 7:8992; Lundberg et al., (2019) Nat Rev Mol Cell Biol 20(5):285-302, incorporated by reference in their entirety). Several approaches can be used to provide intracellular barcodes that attach to proximal proteins. Several methods of spatial cell labeling are described in the review by Marx, 2015, Nat Methods 12:815-819, which is incorporated by reference in its entirety.

[0141] In one embodiment, macromolecules (e.g., polypeptides) in a spatial sample are provided with a recording tag comprising at least a portion of the spatial tag or a sequence of nucleotides complementary to a portion thereof. In some embodiments, the spatial tag comprises a barcode and a sequence of nucleotides complementary to the recording tag. In some embodiments, the complementary sequence shared by the recording tag and the spatial tag is useful for transferring a barcode from the spatial tag to the recording tag. In some cases, the complementary sequence can associate the barcode from the spatial tag with the recording tag. In some embodiments for providing and transferring a spatial tag to a recording tag attached to a polypeptide, the barcode on the bead is flanked by an upstream spacer sequence and a downstream primer extension sequence complementary to at least a portion of the recording tag attached to the polypeptide.

[0142] The spatial tag can be any suitable tag. In some examples, the spatial tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, or a γPNA molecule. In some embodiments, the spatial tag comprises a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. In some embodiments, the spatial tag is a nucleic acid. In some embodiments, the spatial tag comprises a nucleic acid molecule of about 3 to about 40 bases in length (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 bases). A spatial tag may include a barcode sequence, optionally flanked on one side by a spacer or on both sides by spacers. A spatial tag may be single-stranded or double-stranded. A double-stranded spatial tag may include a blunt end, an overhanging end, or both. A spatial tag may refer to a spatial tag associated with a spatial probe (e.g., a bead), a complementary sequence to a spatial tag directly attached to a spatial probe (e.g., a bead), or spatial tag information present in an extended recording tag.

[0143] In certain embodiments, the spatial tag comprises a barcode. See, e.g., Weinstein et al., Cell. 2019 Jun 27;178(1):229-241. The barcode is a nucleic acid molecule about 3 to about 30 bases, about 3 to about 25 bases, about 3 to about 20 bases, about 3 to about 10 bases, about 3 to about 10 bases, or about 3 to about 8 bases in length. In some embodiments, the barcode is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 20 bases, 25 bases, or 30 bases in length. In one embodiment, the barcode enables multiplexed sequencing of multiple samples or libraries. The barcodes can be used to deconvolute multiplexed sequence data and identify sequence reads from individual samples or libraries. In some embodiments, a spatial tag comprises multiple barcodes. For example, a spatial tag can be composed of a string of two or more tags, each of which is a barcode. In some embodiments, a concatenated string of barcodes can increase the versatility of the barcode for labeling or identification. In some embodiments, a series of spatial tags used in combination can be used to provide information about one or more molecular probes.

[0144] In certain embodiments, the spatial tag includes an optional unique molecular identifier (UMI), which provides a unique identifier tag for each macromolecule (e.g., polypeptide) with which it is associated. The UMI can be about 3 to about 40 bases, about 3 to about 30 bases, about 3 to about 20 bases, or about 3 to about 10 bases, or about 3 to about 8 bases. In some embodiments, the UMI is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 16 bases, 17 bases, 18 bases, 19 bases, 20 bases, 25 bases, 30 bases, 35 bases, or 40 bases in length.

[0145] In some embodiments, the spatial tag comprises a spacer. In some embodiments, the spacer on the spatial tag is configured to hybridize to a sequence comprised by the recording tag. Optionally, the spatial tag comprises a spacer at the 5' end. Optionally, the spatial tag comprises a spacer at the 3' end. In some embodiments, the spatial tag comprises a universal priming site. In some embodiments, the spatial tag further comprises other nucleic acid components. In some embodiments, the spatial tag further comprises a universal priming site.

[0146] In some embodiments, spatial tags (e.g., barcodes) are transferred from a solid substrate to a sample using various methods. For example, barcodes are transferred from microparticles (e.g., beads) to polymers within the sample. In some examples, a tissue sample on a surface is exposed to multiple beads with barcodes attached, and the barcodes are transferred to polymers (e.g., polypeptides). Each bead may contain multiple barcodes of the same sequence. In some examples, barcodes from the barcoded beads are randomly attached to polymers in the spatial sample. In some embodiments, beads are delivered to the spatial sample by embedding the barcoded beads in a hydrogel coated on the tissue section surface. In some embodiments, a capillary gap flow cell can be used to deliver or distribute barcoded beads to the spatial sample.

[0147] In some embodiments, spatial tags comprise peptide or amino acid barcodes, which include a sequence of amino acids that may be at least, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 40, 50, 75, or 100 amino acids in length. Particular peptide barcodes that are distinguishable from other peptide barcodes may have different physical properties (amino acid sequence, sequence length, charge, size, molecular weight, hydrophobicity, reverse-phase separation, affinity, or other separable properties). See, e.g., International Patent Publications 2016 / 145416 and 2018 / 078167. Spatial probes may be associated with or attached to peptide barcodes using any suitable means, including, but not limited to, any enzymatic or chemical attachment means. The peptide barcode information of the spatial tag can be transferred to the recording tag using any suitable means, including, but not limited to, any enzymatic or chemical attachment method. See, for example, Miyamoto et al., PLoS One. (2019) 14(4): e0215993; Wroblewska et al., Cell. (2018) 175(4): 1141-1155. e16. In some embodiments, a linker, typically made with a flexible amino acid sequence, can be used to allow attachment of two different polypeptides. For example, a linear linking peptide can be made of 2-25 amino acids, 2-15 amino acids, or a longer linker can be used.

[0148] In other embodiments, the method includes a step in which the barcode is evaluated, determined, detected, and / or analyzed in situ. In some cases, the barcode is randomly transferred to the spatial sample, and then analyzed, decoded, and / or sequenced in situ. For example, a spatial tag attached to a spatial probe (e.g., a bead) is determined in situ to provide information about the spatial location of the spatial tag within the sample. In this case, the spatial tag is evaluated before being released from the bead. In other examples, the barcode can be determined after being released from the bead. Spatial decoding of the barcode bead on the tissue sample can be performed before the barcode is attached to the recording tag. The assembled barcoded beads can be spatially decoded in situ using fluorescent imaging and combinatorial hybridization-based approaches or in situ NGS sequencing (see, e.g., Gunderson et al., Genome Res (2004) 14(5):870-877; Lee et al., Nat Protoc. (2015) 10(3):442-458; Rodriques et al., Science (2019) 363(6434):1463-1467; Goltsev et al., Cell. 2018 Aug 9;174(4):968-981; U.S. Patent Application Publication No. 2014 / 0066318). In some embodiments, decoding of the barcoded beads is performed to generate a sequence containing information of its location within the spatial sample, as described herein.

[0149] The transfer of the barcode from the bead to the polypeptide can be carried out by any suitable method, such as by enzymatic means, including ligation or extension. In some cases, the extension of the recording tag by transferring information from the space to the recording tag can be carried out using any suitable chemical / enzymatic reaction, such as ligation or polymerase extension. For example, ligation (e.g., enzymatic or chemical ligation, splint ligation, sticky end ligation, single-stranded (ss) ligation such as ssDNA ligation, or any combination thereof), polymerase-mediated reaction (e.g., primer extension of single-stranded or double-stranded nucleic acid), or any combination thereof can be used. In some embodiments, the bead is released after transferring the barcode to the recording tag.

[0150] In some embodiments, determining the spatial tag to obtain the spatial location of the spatial tag within the spatial sample is performed in situ. For example, determining the spatial tag in situ is performed using a microscope-based method. In some cases, determining the spatial tag in situ is performed using a fluorescence-based method. In some cases, determining the spatial tag in situ is performed using a multiplexed microscope and / or a fluorescence-based method. In some embodiments, determining the spatial tag in situ generates a visual signal. In some embodiments, the method includes in situ sequencing or labeling of the protein. In some examples, determining the spatial tag in situ provides spatial tag position information (e.g., spatial position information with reference to the spatial sample). For single molecule decoding, several rounds of hybridization of pooled fluorescently labeled decoding oligonucleotides can be used (see, e.g., Gunderson et al., Genome Res (2004) 14(5):870-877). In some embodiments, determining the spatial tag in situ includes using one or more decoders, wherein the decoder includes one or more detectable labels and a sequence complementary to the spatial tag or a portion thereof. In some examples, the detectable label comprises a radioisotope, a fluorescent label, a colorimetric label, or an enzyme substrate label. For example, two or more decoders are used to detect one or more of the spatial tags.

[0151] In some embodiments, determining spatial tags in situ to obtain the spatial location of the spatial tags within a spatial sample includes, but is not limited to, next-generation sequencing methods such as chain termination sequencing (Sanger sequencing); sequencing by synthesis, sequencing by ligation, sequencing by hybridization, polony sequencing, ion semiconductor sequencing, and pyrosequencing; and third-generation sequencing methods such as single-molecule real-time sequencing, nanopore-based sequencing, duplex interrupted sequencing, and direct imaging of DNA using advanced microscopes.

[0152] In some of any such embodiments, the method includes using any microscopy method known in the art and as described herein. For example, fluorescently labeled decoding oligonucleotides can be imaged. Multiple images may be acquired. In some embodiments, the method includes correlating the spatial location of the spatial tag with the barcode sequence of the spatial tag.

[0153] III. Analyzing Macromolecules Using Molecular Probes with Detectable Labels Provided herein is a method for analyzing a macromolecule (e.g., a polypeptide or polynucleotide), comprising: (a) providing a recording tag to a spatial sample containing the macromolecule; (b) binding a molecular probe comprising a detectable label and a probe tag to the macromolecule or a portion thereof proximate to the macromolecule within the spatial sample; (c) transferring information from the probe tag in the molecular probe to the recording tag to generate an extended recording tag; (d) evaluating, e.g., observing, the detectable label to obtain spatial information of the molecular probe; (e) determining the sequence of at least the probe tag within the extended recording tag; and (f) correlating the sequence of the probe tag determined in step (e) with the molecular probe, thereby associating information from the sequence determined in step (e) with its spatial information determined in step (d).

[0154] Provided herein are methods for analyzing macromolecules (e.g., polypeptides or polynucleotides), including providing a recording tag to a spatial sample containing the macromolecule; binding a molecular probe comprising a detectable label and a probe tag to the spatial sample, e.g., by binding to the macromolecule or a portion proximate to the macromolecule in the spatial sample; transferring information from the associated probe tag in the molecular probe to the recording tag to generate an extended recording tag; and evaluating, e.g., observing, the detectable label to obtain spatial information about the molecular probe. The steps of binding the molecular probe to the sample, transferring information from the probe tag, and evaluating, e.g., observing, the detectable label can be repeated one or more times. In some embodiments, the method further includes determining the sequence of the extended recording tag comprising one or more probe tags. In some embodiments, the sequence of a series of probe tags (e.g., barcodes) correlates with the molecular probes bound to the sample. In some embodiments, information about the molecular probe, including the target of the molecular probe and other characteristics of the macromolecule bound by the molecular probe, can be correlated with spatial information from evaluating, e.g., observing, the detectable label associated with the molecular probe. In some embodiments, the sample is sequentially bound by two or more molecular probes. In some cases, the molecular probe is removed or the detectable label is inactivated after the detectable label is observed.

[0155] In some embodiments, the macromolecule is a polypeptide. In some examples, the macromolecule analytical assay comprises a polypeptide analytical assay.

[0156] Some of the steps of the provided methods can be reversed or performed in various orders. In some embodiments, a macromolecular analysis assay is not performed. In some examples, steps (a), (b), (c), (d), (e), and (f) occur sequentially. In other examples, steps (a), (b), (d), (c), (e), and (f) occur sequentially. In some examples, steps (a), (b), (c), (d), (e), and (f) occur sequentially. In some examples, steps (a), (b), (d), (c), (e), and (f) occur sequentially. In some cases, one or more steps of the method are repeated. In some embodiments, step (d) is repeated two or more times. In some cases, the method includes sequentially repeating step (b) and step (c) two or more times. In some examples, the method includes removing the molecular probe from the spatial sample before repeating step (b). In some cases, evaluation, e.g., observation, of the detectable label is repeated for methods involving binding of two or more molecular probes. In some embodiments, steps (b), (c), and (d) are repeated sequentially two or more times before performing steps (e) and (f). In some cases, steps (b), (c), and (d) are repeated sequentially two or more times before performing a macromolecular analysis assay. In some embodiments, steps (b), (d), and (c) are repeated sequentially two or more times before performing steps (e) and (f). In some cases, steps (b), (d), and (c) are repeated sequentially two or more times before performing a macromolecular analysis assay. In methods involving performing a macromolecular analysis assay, the assay can be performed after steps (a), (b), (c), and (d). In methods involving performing a macromolecular analysis assay, the assay can be performed before steps (e) and (f).

[0157] In some embodiments, the extended recording tag that is analyzed contains information from multiple probe tags that are sequentially transferred to the recording tag. In some embodiments, the extended recording tag contains information from one or more probe tags and one or more coding tags. In some cases, the extended recording tag contains information from two or more probe tags and two or more coding tags. In some embodiments, the recording tag (e.g., the extended recording tag) is directly or indirectly attached to a polymer. In some embodiments, the extended recording tag is not attached to a polymer.

[0158] In some embodiments of the provided methods, a molecular probe binds to the spatial sample by binding to a macromolecule within the spatial sample. In some embodiments of the provided methods, a molecular probe binds to the spatial sample by binding to a moiety proximate to the macromolecule within the spatial sample. In some embodiments, multiple molecular probes are applied to the spatial sample. In some embodiments, the molecular probe is capable of selective and / or specific binding. In some embodiments, the molecular probe binds to a macromolecule in a complex with another macromolecule. For example, the molecular probe may bind to a nucleic acid in a complex with a polypeptide of interest. In some particular embodiments, the molecular probe binds to a polypeptide to which a recording tag is associated or attached. In some particular embodiments, the molecular probe binds to a macromolecule, and the binding brings the probe tag within the molecular probe into proximity with the recording tag applied to the spatial sample.

[0159] The molecular probe comprises a probe tag, which may comprise any sequenceable molecule. In some examples, the probe tag comprises a barcode. The information of the probe tag is transferred to the recording tag in any suitable manner. In some embodiments, the information transferred from one or more probe tags to a particular recording tag links the information from one or more molecular probes to the spatial information of the molecular probe and binding position. In some embodiments, the information from one probe tag can be transferred to two or more recording tags. In some embodiments, the information from two or more probe tags can be transferred to one recording tag.

[0160] In some embodiments, the spatial sample comprises a biological sample. For example, the spatial sample may comprise macromolecules, cells, and / or tissues obtained from a subject. In some instances, the spatial sample is derived from a sample such as an intact tissue or a liquid sample. For example, the liquid sample may be spread and deposited on a surface prior to performing the method. In some instances, the spatial sample is processed, for example, by treating the sample with permeabilization, fixation, and / or cross-linking reagents, before the molecular probes bind to the spatial sample. In some embodiments, the spatial sample is exposed to a matrix or other material comprising recording tags. For example, the matrix may comprise hydrogel polymer chains.

[0161] In some embodiments, the method further comprises performing a macromolecule (e.g., polypeptide or polynucleotide) analytical assay in situ. In some other embodiments, the macromolecule analytical assay is performed after the macromolecule is released from the spatial sample. In some embodiments that further comprise performing a macromolecule analytical assay, the macromolecule is attached to or associated with one or more recording tags. In some of any such embodiments, the macromolecule analytical assay comprises one or more cycles of contacting the macromolecule with a binding agent capable of binding to the macromolecule, where the binding agent comprises a coding tag having identifying information about the binding agent, transferring information from the coding tag to the recording tag, and extending the recording tag. The identifying information from the binding agent is transferred to the recording tag associated with the polypeptide, which also includes information transferred from the probe tag. Thus, in some embodiments, the extended recording tag includes information from one or more probe tags and, optionally, one or more coding tags. In some embodiments, the method further comprises determining at least a portion of the sequence of the macromolecule or the identity of the macromolecule and associating it with the spatial location of the molecular probe determined in step (d).

[0162] In some embodiments, a macromolecule analysis assay involves determining the sequence of at least a portion of a macromolecule (e.g., a polypeptide or polynucleotide). In some cases, the analysis method can include performing any of the methods described in International Patent Publication No. 2017 / 192633. In some cases, the sequence of a polypeptide is analyzed by constructing an extended nucleic acid sequence representing the polypeptide sequence or a portion thereof, such as an extended nucleic acid on a recording tag (or any additional barcode or tag attached thereto).

[0163] An exemplary workflow for analyzing polypeptides may include the following: a spatial sample is provided on a solid support; the polypeptides of the spatial sample are labeled with recording tags, or the spatial sample is exposed to a matrix containing recording tags; the recording tags may contain universal priming sites useful for subsequent amplification; multiple molecular probes, each containing a detectable label and a probe tag, are applied to the spatial sample and bind to the sample; information from the probe tag is transferred to the recording tag by a suitable method, such as ligation or extension; after transferring information from the probe tag, the molecular probe can be removed, released, or washed; Optionally, additional rounds of binding with the molecular probe and transferring information from the probe tag to the recording tag can be performed; the detectable label of the molecular probe is evaluated and / or observed, for example, by using imaging. In some embodiments, where multiple cycles of binding with the molecular probe are performed, observing the detectable label may include multiple imaging steps; after evaluating or observing the detectable label, the recording tag can be released and collected for analysis, for example, for sequencing. If a macromolecular analysis assay is further performed, after the transfer of information from the probe tag, the polypeptide attached to the recording tag is used and released from the spatial sample. In an optional step, the polypeptide is digested. Before performing the polypeptide analysis assay, the polypeptide and the associated recording tag (containing information from the probe tag) can be randomly immobilized on a single-molecule sequencing substrate (e.g., beads) at appropriate intramolecular intervals. A polypeptide analysis assay is performed on the polypeptide associated with the recording tag, thereby adding further information to the extended recording tag. At least a portion of the sequence of the extended recording tag (containing information from the probe tag) is determined. The sequence of the information from the probe tag determined from the extended recording tag is correlated with the molecular probe associated with the same probe tag, thereby correlating the information from the sequence determined from the extended recording tag with its spatial information determined from evaluating, e.g., observing, the detectable label associated with the molecular probe.Any information about the sample bound by the molecular probe can also be correlated with spatial information, including tissue / cell phenotype, state, and the presence or absence of specific markers. Using this workflow, the information in the extension recording tag is associated with the spatial location of the molecular probe.

[0164] A. Sample In one aspect, the present disclosure relates to the analysis of macromolecules from a sample. Macromolecules can be large molecules composed of smaller subunits. In certain embodiments, the macromolecules are proteins, protein complexes, polypeptides, peptides, nucleic acid molecules, carbohydrates, lipids, macrocycles, or chimeric macromolecules. In some embodiments, the macromolecules are proteins, polypeptides, or peptides.

[0165] In some embodiments, macromolecules (e.g., proteins, polypeptides, or peptides) are obtained from a sample that is a biological sample. In some embodiments, the sample includes, but is not limited to, mammalian or human cells, yeast cells, and / or bacterial cells. In some embodiments, the sample includes cells derived from a sample obtained from a multicellular organism. For example, the sample may be isolated from an individual. In some embodiments, the sample may include a single cell type or multiple cell types. In some embodiments, the sample may be obtained from a mammalian organism or a human, for example, by puncture or other collection or sampling procedure. The sample may be a spatial sample, from which information regarding the spatial arrangement and / or location of anatomical, morphological, cellular, and / or subcellular features may be desired. In some embodiments, the sample is further processed by methods known in the art. For example, the sample is processed to remove, remove, or isolate cellular material (e.g., by centrifugation, filtration, etc.). A spatial sample may refer to a biological sample arranged such that components, portions, or regions of the sample can be spatially referenced (e.g., arranged in a planar format, such as a tissue section on a slide). In some embodiments, the sample comprises two or more cells.

[0166] In some embodiments, biological samples can include whole cells and / or viable cells and / or cell debris. In some examples, suitable sources or samples can include, but are not limited to, biological samples from virtually any organism, such as biopsies, cell cultures, cells (both primary cells and cultured cell lines), samples containing organelles or vesicles, tissues, and tissue extracts. For example, suitable sources or samples include biopsies; fecal material; body fluids (blood, whole blood, serum, plasma, urine, lymph, bile, aqueous humor, breast milk, earwax, chyle, chyme, endolymph, perilymph, exudate, cerebrospinal fluid, interstitial fluid, aqueous or vitreous humor, colostrum, phlegm, amniotic fluid, saliva, anal and vaginal secretions, gastric acid, gastric juice, lymph, mucus (including nasal secretions and phlegm), pericardial fluid, peritoneal fluid, pleural fluid, pus, mucosal secretions, saliva, sebum (skin oil), sputum, um), synovial fluid, sweat and semen, transudate, vomit and mixtures of one or more thereof, exudate (e.g., fluid obtained from an abscess or any other site of infection or inflammation) or preferably a mammalian-derived sample containing a microbiome-containing sample, and particularly preferably a human-derived sample containing a microbiome-containing sample, can be used to study fluids obtained from the joints of virtually any organism (either normal joints or joints affected by rheumatoid arthritis, osteoarthritis, Examples of biological samples include, but are not limited to, environmental samples (air, agricultural, water, and soil samples); microbial samples, including microbial biofilms and / or microbial communities, and samples derived from bacterial spores; tissue samples, including tissue sections; research samples, including extracellular fluids, extracellular supernatants from cell cultures, inclusion bodies within bacteria, and cellular components, including mitochondria and periplasm. In some embodiments, the biological sample comprises or is derived from a bodily fluid, and the bodily fluid is obtained from a mammal or human. In some embodiments, the sample comprises a bodily fluid or a cell culture from a bodily fluid. In some of the provided embodiments, a sample, such as a fluid sample, can be deposited on a surface. For example, a liquid sample can be processed to prepare cells for spreading on a solid surface, such as a slide.In some embodiments, the sample or a portion thereof (such as an analyte or cells obtained from the sample) can be deposited in a polymeric resin. In some cases, the polymeric resin comprises a natural or synthetic polymer that forms a hydrogel.

[0167] In some embodiments, the sample is a tissue sample. The tissue can be prepared in any convenient or desired manner for use in any of the methods described herein. Fresh, frozen, fixed, or unfixed tissue can be used. The tissue can be prepared, fixed, or embedded using methods described herein or known in the art (Fischer et al., CSH Protoc (2008) pdb prot4991; Fischer et al., CSH Protoc (2008) pdb top36; Fischer et al., CSH Protoc. (2008) pdb.prot4988). The tissue can be freshly excised from an organism or previously preserved, for example, by freezing, embedding in a material such as paraffin (e.g., formalin-fixed paraffin-embedded samples), formalin fixation, infiltration, dehydration, etc. In some instances, a matrix-forming material can be used to encapsulate a biological sample, such as a tissue sample. In some cases, the sample is embedded in a paraffin block. For example, the spatial sample may be a formalin-fixed paraffin-embedded (FFPE) section. Optionally, the tissue section may be attached to a solid support using, for example, the techniques and compositions exemplified herein for attaching nucleic acids, cells, viruses, beads, etc. to a solid support (Ramos-Vera et al., J Vet Diagn Invest. (2008) 20(4): 393-413). As a further option, the tissue may be permeabilized and its cells lysed while in contact with the solid support. Standard conditions and reagents may be used for tissue permeabilization, including incubation with any suitable detergent, Triton X-100, ethoxylated nonylphenol (Tergitol type NP-40), Tween 20, saponin, digitonin, or acetone (Fischer et al., CSH Protoc (2008) pdb top36).

[0168] In some embodiments, the sample is a "planar sample" that is substantially planar, i.e., two-dimensional. In some embodiments, the sample is deposited on a substrate or solid surface. In some embodiments, the sample is a three-dimensional sample. In some examples, the material or substrate (e.g., glass, metal, ceramic, organic polymer surface, or gel) can contain cells or any combination of cell-derived biomolecules, such as proteins, nucleic acids, lipids, oligo / polysaccharides, biomolecule complexes, organelles, extracellular vesicles (exosomes, microvesicles), cell debris, or excretory products. In some embodiments, a planar cell sample can be generated, for example, by depositing cells or portions thereof on a flat surface, cutting the three-dimensional object containing the cells into slices, e.g., by centrifugation, and mounting the slices on a flat surface, i.e., producing a tissue section. In some embodiments, the sample is a tissue section, which refers to a small piece of tissue obtained from a subject, fixed, sectioned (e.g., cryosectioned), and mounted on a flat surface, e.g., a microscope slide.

[0169] In some embodiments, the spatial sample (e.g., specimen or tissue sample) is treated to elongate the sample. In some aspects, the spatial sample is isotropically preserved and elongated using a chemical process. For example, tissue samples can be processed to attach anchors to biomolecules within the tissue sample, perform polymer synthesis in situ, perform mechanical homogenization, and perform specimen elongation (e.g., Zhao et al., Nature Biotechnology (2017) 35(8):757-764; Chang et al., Nature Methods (2017) 14:593-599; Chang et al., Nature Methods (2016) 13(8):679-84; Tillberg et al., Nature Biotechnology (2016) 34:987-992; Chen et al., Science (2015) 347(6221):543-548; Asano et al., Current Protocols in Cell Biology (2018) 80(1):e56; Wassie et al., Nature Methods (2018) 16(1):33-41; Boyden et al. al., Mater. Horiz., (2019) 6, 11-13, Alon et al., FEBS J.2019 Apr;286(8):1482-1494. Karagiannis et al., Current Opinion in Neurobiology (2018) 50:56-63, Gao et al., BMC Biology (2017) 15:50).

[0170] In some embodiments, the method involves obtaining and preparing macromolecules (e.g., polypeptides and proteins) from a single cell type or multiple cell types. In some embodiments, the sample comprises a population of cells. In some embodiments, the macromolecules (e.g., proteins, polypeptides, or peptides) are derived from a cell or intracellular component, extracellular vesicle, organelle, or organized subcomponent thereof. In some embodiments, the polypeptide is from one or more packagings of molecules (e.g., a separate component of a single cell, or a separate component isolated from a population of cells, such as an organelle or vesicle). The macromolecules (e.g., proteins, polypeptides, or peptides) may be derived from an organelle, such as a mitochondria, nucleus, or vesicle. In one embodiment, one or more specific types of single cells or subtypes thereof may be isolated. In some embodiments, the spatial sample may include, but is not limited to, organelles (e.g., nucleus, Golgi apparatus, ribosomes, mitochondria, endoplasmic reticulum, chloroplasts, cell membranes, vesicles, etc.).

[0171] 1. Fixation and Permeabilization In some embodiments, the methods provided herein further include one or more fixation (e.g., crosslinking) and / or permeabilization steps. In certain embodiments, a sample containing a macromolecule (e.g., a protein, polypeptide, or peptide) for analysis may be fixed and / or permeabilized. In some embodiments, fixation, crosslinking, and / or permeabilization of the spatial sample is performed before providing the spatial sample with a recording tag. In some embodiments, fixation, crosslinking, and / or permeabilization of the spatial sample is performed before binding a molecular probe to the macromolecule or a portion proximal to the macromolecule within the spatial sample. For example, holes or openings may be formed in the membrane of a cell and / or any intracellular component. Cells, intracellular structures and components, or biomolecules may be fixed using any number of reagents, including, but not limited to, formalin, methanol, ethanol, paraformaldehyde, formaldehyde, methanol:acetic acid, glutaraldehyde, bifunctional crosslinkers such as bis(succinimidyl) suberate, bis(succinimidyl) polyethylene glycol, and the like.

[0172] In some examples, the methods of processing proteins and analyzing proteins provided herein can include fixing the sample at any step of the analysis method. In some cases, fixation of the sample is performed before permeabilizing the sample (e.g., permeabilizing a cell or other membrane). In some examples, fixation of the sample is performed after permeabilizing the sample. In some embodiments, the sample is fixed or crosslinked before providing recording tags to proteins in the spatial sample. In some embodiments, the sample is permeabilized before combining the spatial sample with one or more molecular probes.

[0173] In some embodiments, the sample may be fixed or crosslinked so that cells and subcellular components are immobilized or held in place. In some embodiments, macromolecules (e.g., DNA, RNA, proteins, polypeptides, lipids) within the sample may be fixed or crosslinked so that the molecules contained therein are immobilized within the cells or subcellular components. In some embodiments, the sample (e.g., cells and subcellular components) is fixed so that the spatial location of molecules within the sample is maintained.

[0174] In some cases, samples can be fixed to crosslink proteins and stabilize lipid membranes within tissues or cellular structures. In some instances, samples are fixed using formaldehyde in phosphate-buffered saline (PBS). Standard methods of fixation are known and include incubation with 0.5-5% formaldehyde in 1x PBS for 10-30 minutes. In some embodiments, samples are fixed by incubation in methanol or ethanol. In some embodiments, after fixation, samples are permeabilized and treated to allow access to the interior of structural components by enzymes and DNA tags (e.g., recording tags, probe tags or copies thereof, barcodes, or other nucleic acids).

[0175] In some embodiments, one or more washing steps are performed before and / or after fixation and / or permeabilization. Commercially available fixation and permeabilization kits can be used to prepare samples. In some embodiments, fixation or crosslinking of the sample can be reversed.

[0176] In some embodiments, fixation or reversal of cross-linking of the sample is performed before isolating the macromolecule (e.g., protein, polypeptide, or peptide) and associated recording tag from the spatial sample. In some embodiments, fixation or reversal of cross-linking of the sample is performed after isolating the macromolecule (e.g., protein, polypeptide, or peptide) and associated recording tag from the spatial sample. For example, cross-linking can be reversed by incubating the cross-linked sample in high salt (approximately 200 mM NaCl) at 65°C for about 4 hours or more.

[0177] In some embodiments, tissue samples are treated to remove embedding material from the sample (e.g., remove paraffin or formalin) before releasing, capturing, or processing macromolecules (e.g., proteins, polypeptides, or peptides) from the tissue sample. This can be accomplished by contacting the sample with an appropriate solvent (e.g., xylene and ethanol washes). Treatment can occur before contacting the tissue sample with a solid support described herein, or treatment can occur while the tissue sample is on the solid support.

[0178] 2. Provide a recording tag The methods provided herein include providing a spatial sample containing one or more macromolecules (e.g., proteins, polypeptides, or peptides) having recording tags. In some embodiments, the spatial sample is provided with multiple recording tags. In some aspects, multiple macromolecules within the spatial sample are provided with recording tags. The recording tags can be directly or indirectly associated with or attached to macromolecules or other moieties within the spatial sample. In some embodiments, the recording tags are attached to the macromolecules using any suitable means. In some embodiments, the macromolecules can be associated with one or more recording tags. In some aspects, the recording tags can be any suitable sequencible moiety capable of transferring information from the probe tags and, optionally, information from one or more coding tags. The recording tags function as moieties that can transfer or record information, such as information about molecular probes.

[0179] In some other embodiments, the recording tag is not directly or indirectly associated with or attached to a macromolecule or other moiety within the spatial sample, but is held in place within a matrix, scaffold, or substance applied to the spatial sample. In some embodiments, the spatial sample is exposed to a matrix (e.g., a polymer matrix), scaffold, or other substance containing the recording tag. See, e.g., Gao et al., BMC Biology (2017) 15:50. For example, the matrix may include hydrogel polymer chains. In some embodiments, the spatial sample (e.g., biological tissue or specimen) is treated with a compound that binds to macromolecules so that they are chemically fixed and biomolecules are tethered to the hydrogel polymer chains. For example, a hydrogel made of closely spaced, densely crosslinked, highly charged monomers is polymerized uniformly throughout the cells or tissue within the spatial sample, intercalating between and around the macromolecules and biomolecules within the spatial sample. In some cases, the embedded spatial sample may be subjected to a mechanical homogenization step involving denaturation and / or digestion of structural molecules. In some embodiments, the spatial sample comprises a specimen-hydrogel composite.

[0180] In some embodiments of the provided methods, information from the probe tag is transferred to a recording tag. The recording tag may include other nucleic acid components. In some embodiments, the recording tag may include a unique molecular identifier, a compartment tag, a partition barcode, a sample barcode, a fraction barcode, information transferred from the probe tag, a spacer sequence, a universal priming site, or any combination thereof.

[0181] In embodiments of the method involving a macromolecular analysis assay, at least one recording tag is directly or indirectly associated with or co-localized with a macromolecule (e.g., a polypeptide). In certain embodiments, a single recording tag is attached to the polypeptide, preferably via attachment to the N- or C-terminal amino acid. In other embodiments, multiple recording tags are attached to the polypeptide, for example, to lysine residues or the peptide backbone. In some embodiments, a polypeptide labeled with multiple recording tags is fragmented or digested into smaller peptides, each of which is labeled with, on average, one recording tag.

[0182] In some embodiments, the density or number of macromolecules with recording tags is controlled or titrated. In other embodiments, a matrix or substance containing recording tags applied to a spatial sample is titrated for a desired density of recording tags. For example, it may be desirable to appropriately position recording tags in or on a spatial sample to accommodate a method used to assess the spatial location of macromolecules. In some cases, the amount or density of recording tags associated with macromolecules in a spatial sample is titrated on the surface of the sample or within the volume of the sample.

[0183] In some examples, the desired spacing, density, and / or quantity of recording tags within a sample can be titrated by providing a diluted or controlled number of recording tags. In some examples, the desired spacing, density, and / or quantity of recording tags can be achieved by spiking in competing or "dummy" competitor molecules when providing, associating, and / or attaching recording tags. In some cases, the "dummy" competitor molecules react in the same way as recording tags associated with or attached to macromolecules within the sample, but the competitor molecules do not function as recording tags. In some specific examples, if the desired density is one functional recording tag per 1,000 sites available for attachment within the sample, spiking in one functional recording tag for every 1,000 "dummy" competitor molecules is used to achieve the desired spacing. In some examples, the ratio of functional recording tags is adjusted based on the reaction rate of the functional recording tag compared to the reaction rate of the competitor molecules.

[0184] The recording tag may comprise DNA, RNA, or polynucleotide analogs, including PNA, γPNA, GNA, BNA, XNA, TNA, other polynucleotide analogs, or combinations thereof. The recording tag may be single-stranded, or partially or completely double-stranded. The recording tag may have blunt ends or overhanging ends. In some embodiments, the recording tag may comprise a peptide or amino acid sequence. In some cases, the recording tag is a moiety that allows for the attachment or addition of an amino acid sequence (e.g., a peptide barcode).

[0185] In certain embodiments, all or a substantial amount (e.g., at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 100%) of the macromolecules in a sample are labeled with a recording tag. In other embodiments, a subset of the macromolecules in a sample are labeled with a recording tag. In certain embodiments, a subset of the macromolecules from a sample undergoes targeted (analyte-specific) labeling with a recording tag. For example, targeted recording tag labeling of proteins can be achieved using target protein-specific binding agents (e.g., antibodies, aptamers, etc.). In some embodiments, the recording tag is attached to the macromolecule in situ within the sample. In some embodiments, the recording tag is attached to the macromolecule prior to providing the sample on the solid support. In some embodiments, the recording tag is attached to the macromolecule after providing the sample on the solid support. In some other embodiments, the recording tag is not directly or indirectly associated with or attached to a macromolecule or other moiety within the spatial sample, but is provided within a matrix, scaffold, or substance that is applied to the spatial sample.

[0186] In some embodiments, the recording tag can also include a sample identifying barcode. Sample barcodes are useful for multiplexed analysis of a set of samples in a single reaction vessel or immobilized on a single solid substrate or collection of solid substrates (e.g., a flat slide, a collection of beads contained in a single tube or vessel, etc.). For example, macromolecules from many different samples can be labeled with recording tags bearing sample-specific barcodes, and then all samples can be pooled together prior to immobilization on a solid support, periodic binding of a binder, and recording tag analysis. Alternatively, samples can be separated until after the creation of a DNA-encoded library, with sample barcodes attached during PCR amplification of the DNA-encoded library, and then mixed together prior to sequencing. This approach can be useful for assaying analytes (e.g., proteins) of different abundance classes.

[0187] In certain embodiments, the recording tag includes an optional unique molecular identifier (UMI), which provides a unique identifier tag for each associated macromolecule (e.g., polypeptide). The UMI can be about 3 to about 40 bases, about 3 to about 30 bases, about 3 to about 20 bases, or about 3 to about 10 bases, or about 3 to about 8 bases. In some embodiments, the UMI is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 16 bases, 17 bases, 18 bases, 19 bases, 20 bases, 25 bases, 30 bases, 35 bases, or 40 bases in length. The UMI can be used to deconvolute sequencing data from multiple extended recording tags to identify sequence reads from individual macromolecules. In some embodiments, within a library of polymers, each polymer is associated with a single recording tag, and each recording tag contains a unique UMI. In other embodiments, multiple copies of a recording tag are associated with a single polymer, and each copy of the recording tag contains the same UMI. In some embodiments, the UMI has a different base sequence from the spacer or encoder sequence in the binding agent coding tag to facilitate distinguishing these components during sequence analysis. In some embodiments, the UMI can serve as a positional identifier and can also provide information in polymer analysis assays. For example, the UMI can be used to identify molecules that are of the same lineage and therefore derived from the same initial molecule. In some embodiments, this information can be used to correct for amplification variations and to detect and correct sequencing errors.

[0188] In certain embodiments, the recording tag comprises a universal priming site, e.g., a forward or 5' universal priming site. A universal priming site is a nucleic acid sequence that can be used for priming and / or sequencing a library amplification reaction. Universal priming sites include, but are not limited to, priming sites for PCR amplification, flow cell adapter sequences that anneal to complementary oligonucleotides on the flow cell surface (e.g., Illumina next-generation sequencing), sequencing priming sites, or combinations thereof. The universal priming site can be from about 10 bases to about 60 bases. In some embodiments, the universal priming site comprises an Illumina P5 primer (5'-AATGATACGGCGACCACCGA-3'-SEQ ID NO: 1) or an Illumina P7 primer (5'-CAAGCAGAAGACGGCATACGAGAT-3'-SEQ ID NO: 2).

[0189] The recording tag may contain a reactive moiety for a cognate reactive moiety present on a target macromolecule, such as a target protein (e.g., click chemistry label, photoaffinity label). For example, the recording tag may contain an azide moiety for interacting with an alkyne-derivatized protein, or a benzophenone for interacting with a native protein, etc. Upon binding of the target protein by a target protein-specific binding agent, the recording tag and the target protein are coupled via their corresponding reactivities. After labeling the target protein with the recording tag, the target protein-specific binding agent may be removed by digestion of a DNA capture probe linked to the target protein-specific binding agent. For example, the DNA capture probe may be designed to contain a uracil base and then targeted for digestion with a uracil-specific cleavage reagent (e.g., USER™). The target protein-specific binding agent may be dissociated from the target protein. In some embodiments, other types of linkages besides hybridization can be used to link the recording tag to the macromolecule. Suitable linkers can be attached to various positions of the recording tag, such as the 3' end at an internal position, or within a linker attached to the 5' end of the recording tag.

[0190] B. Molecular Probes The methods provided herein include binding one or more molecular probes to a spatial sample. In some embodiments, the molecular probes include a detectable label and a probe tag. After providing one or more recording tags to a spatial sample containing one or more macromolecules, the method includes applying and binding one or more molecular probes to the spatial sample. The spatial sample can include any sample of interest, as described above and optionally processed. In some embodiments, the spatial sample is treated with a blocking agent before binding to one or more molecular probes.

[0191] In some embodiments, two or more molecular probes are applied to the spatial sample. When multiple molecular probes are used, molecular probes of the same identity are associated with the same probe tag. In some embodiments, each molecular probe in the multiple molecular probes is associated with a unique detectable label. In some embodiments, two or more probes are associated with the same detectable label. One or more molecular probes can be applied sequentially, or multiple molecular probes can be applied simultaneously. In some cases, molecular probes of different identities are associated with the same probe tag. In some cases, molecular probes of different identities are associated with the same detectable label. In some embodiments, molecular probes of different identities may be associated with the same detectable label due to a limited number of available detectable labels. In some cases, the method may include decoding combined information from sequentially transferring two or more probe tags to a recording tag. In some specific embodiments, a sample is provided with multiple molecular probes, some of which are associated with detectable labels and some of which are not (e.g., "dummy molecular probes").

[0192] A molecular probe can be composed of any composition suitable for binding a spatial sample. In some examples, a molecular probe comprises a nucleic acid, peptide, polypeptide, protein, carbohydrate, or small molecule that binds to, associates with, integrates with, recognizes, or combines with a spatial sample. A molecular probe can form a covalent or non-covalent association with a spatial sample or a component of a spatial sample. In some embodiments, a molecular probe can form a reversible association with a spatial sample or a component of a spatial sample. A molecular probe can be a chimeric molecule composed of two or more types of molecules, such as a nucleic acid molecule-peptide chimeric molecular probe or a carbohydrate-peptide chimeric molecular probe. A molecular probe can be a naturally occurring, synthetically produced, or recombinantly expressed molecule. A molecular probe can bind to a linear molecule or a molecule with a three-dimensional structure (also called a conformation).

[0193] In some examples, the molecular probe comprises an antibody, an antigen-binding antibody fragment, a single domain antibody (sdAb), a recombinant heavy chain-only antibody (VHH), a single chain antibody (scFv), a shark-derived variable domain (vNAR), an Fv, a Fab, a Fab', a F(ab')2, a linear antibody, a diabody, an aptamer, a peptidomimetic molecule, a fusion protein, a reactive or non-reactive small molecule, or a synthetic molecule.

[0194] In some embodiments, the molecular probe is a microprotein (cysteine ​​knot protein, knottin), DARPin; Tetranectin; Affibody; Affimer; Transbody; Anticalin; AdNectin; Affilin; Microbody; Peptide aptamer; Alterase; Plastic antibody; phylomer; Stradobody; Maxibody ody); evibody; fynomer, armadillo repeat protein, Kunitz domain, avimer, atrimer, probody, immunobody, triomab, troybody; pepbody; vaccibody, UniBody; DuoBody, Fv, Fab, Fab', F(ab')2, peptidomimetic molecule, or synthetic molecule (e.g., Nelson, MAbs (2010) 2(1):77-78; Goltsev et al., Cell. 2018 Aug 9;174(4):968-981, or as described in U.S. Patent Nos. 5,475,096, 5,831,012, 6,818,418, 7,166,697, 7,250,297, 7,417,130, 7,838,629, U.S. Patent Publication Nos. 2004 / 0209243, and / or 2010 / 0239633).

[0195] In some embodiments, the molecular probe can be chemically, covalently, and / or reversibly bound to the spatial sample. In some embodiments, the molecular probe binds to a moiety that binds to, associates with, or forms a complex with a macromolecule in the spatial sample. In some examples, the molecular probe binds to a macromolecule (e.g., a target macromolecule), a moiety proximate to the macromolecule, or a moiety that associates with or binds to a macromolecule in the spatial sample. In some embodiments, the molecular probe binds to a moiety proximate to the macromolecule, thereby allowing transfer of information from the probe tag to the recording tag, enabling association with the molecular probe. For example, the distance between the polymer and the moiety adjacent to the polymer can be about 10 nm to 100 nm, about 10 nm to 500 nm, about 10 nm to 1,000 nm, about 10 nm to 5,000 nm, about 100 nm to 300 nm, about 100 nm to 600 nm, about 100 nm to 1,000 nm, about 100 nm to 5,000 nm, about 300 nm to 600 nm, about 300 nm to 1,000 nm, or about 300 nm to 5,000 nm. In some cases, regardless of where the molecular probe is attached to the polymer, the proximity of the recording tag to the probe tag can result in information transfer from the probe tag to the recording tag. In some embodiments, the molecular probe is attached to the probe tag via a linker, which can be of various lengths. In some cases, the length of the linker between the molecular probe and the probe tag can increase the distance between the moiety adjacent to the molecular probe and the molecular probe, allowing for association with the molecular probe. In some embodiments, the proximity of a moiety to a macromolecule may depend on the length of any linker used in the molecular probe to attach the probe tag.

[0196] In some instances, the targeting moiety is configured to bind to a macromolecule, including, but not limited to, a nucleic acid, a carbohydrate, a lipid, a polypeptide, a post-translational modification of a polypeptide, or any combination thereof. In some embodiments, the targeting moiety is a protein-specific targeting moiety, an epitope-specific targeting moiety, or a nucleic acid-specific targeting moiety. In some instances, the molecular probe is configured to bind to a cell surface marker. In some embodiments, the targeting moiety binds to a post-translational modification (PTM) of a polypeptide or amino acid. Examples of PTMs include, but are not limited to, phosphorylation, ubiquitination, methylation, acetylation, glycosylation, oxidation, lipidation, nitrosylation, sumoylation, ubiquitination, etc.

[0197] In some embodiments, the molecular probe comprises a targeting moiety capable of specific and / or selective binding. In some embodiments, the molecular probe comprises a targeting moiety capable of specific or partially specific binding. Examples of structure-specific binders can include protein-specific molecules capable of binding to protein targets. Examples of suitable protein-specific molecules can include antibodies and antibody fragments, nucleic acids (e.g., aptamers that recognize protein targets), or protein substrates. In some embodiments, the target of the targeting moiety can include an antigen, and the molecular probe can comprise an antibody. Suitable antibodies can include monoclonal antibodies, polyclonal antibodies, multispecific antibodies (e.g., bispecific antibodies), or antibody fragments, as long as they specifically bind to the target antigen. In some embodiments, the molecular probe comprises a moiety or nucleic acid component configured to specifically bind to a nucleic acid, such as a specific target nucleic acid sequence.

[0198] The molecular probes provided herein may contain any suitable detectable label, including, but not limited to, radioisotopes, fluorescent labels, colorimetric labels, and various enzyme substrate labels known in the art. In some embodiments, the signal from the detectable label can be amplified by binding a secondary probe to the primary molecular probe. For example, the secondary probe may be fluorescently labeled or conjugated to an enzyme that can then amplify the signal.

[0199] In some embodiments, the detectable label or secondary probe can be visually detectable by microscopy or using an imager. In certain cases, the fluorophores used can be coumarins, cyanines, benzofurans, quinolines, quinazolinones, indoles, benzazoles, borapolyazaindacenes, and / or xanthenes, including fluoresceins, rhodamines, and rhodols. In multiplexed embodiments, the fluorophores can be selected so that they are distinguishable from one another, i.e., independently detectable, meaning that even when the labels are mixed, they can be detected and measured independently. In other words, the amount of label (e.g., the amount of fluorescence) present in each label can be determined separately, even when the labels are in the same location (e.g., in the same tube or in the same region of a section). Specific fluorescent dyes of interest include xanthene dyes, such as fluorescein and rhodamine dyes, such as fluorescein isothiocyanate (FITC), 6-carboxyfluorescein (commonly known by the abbreviations FAM and F), 6-carboxy-2',4',7',4,7-hexachlorofluorescein (HEX), 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein (JOE or J), N,N,N',N'-tetramethyl-6-carboxyrhodamine (TAMRA or T), 6-carboxy-X-rhodamine (ROX or R), 5-carboxyrhodamine-6G (R6G), and 6-carboxy-X-rhodamine (XR6G). 5 or G 5 ), 6-carboxyrhodamine-6G (R6G 6 or G 6), and rhodamine 110; cyanine dyes such as Cy3, Cy5, and Cy7 dyes; coumarins such as umbelliferone; benzimide dyes such as Hoechst 33258; phenanthridine dyes such as Texas Red; ethidium dyes; acridine dyes; carbazole dyes; phenoxazine dyes; porphyrin dyes; polymethine dyes such as BODIPY dyes and quinoline dyes. Specific fluorophores of interest commonly used in targeted applications include pyrene, coumarin, diethylaminocoumarin, FAM, fluorescein chlorotriazinyl, fluorescein, R110, eosin, JOE, R6G, tetramethylrhodamine, TAMRA, Lissamine, naphthofluorescein, Texas Red, Cy3, and Cy5.

[0200] In some embodiments, the method comprises one or more cycles of binding a molecular probe to a spatial sample and evaluating, e.g., observing, the detectable label of the molecular probe. In some embodiments, the binding of the molecular probe and evaluating, e.g., observing, the detectable label of the molecular probe can be performed using a system, such as an automated system. In some embodiments, a microfluidic system for cell analysis can be used to deliver and apply reagents for the provided methods. In some embodiments, the system for performing one or more steps of the method can be multiplexed. For example, a multiplexed tissue processing platform can be utilized. In some embodiments, a microfluidic flow cell can be used for binding a molecular probe to a spatial sample and / or observing the detectable label (e.g., Cell DIVE™ from GE Research).

[0201] In some embodiments, the method may include evaluating, for example, observing, some of the detectable labels of the provided molecular probes. In some specific cases, the spatial sample is provided with one or more molecular probes that are not labeled with a detectable signal. In some cases, the method does not require detecting all of the molecular probes that are in contact with the spatial sample. For example, the probe tag of a molecular probe can be transferred to a recording tag without observing any detectable label associated with the molecular probe.

[0202] In some embodiments, the signal intensity, signal wavelength, signal position, signal frequency, or signal shift of a detectable label associated with a molecular probe is observed. In some embodiments, the observation of the detectable label can be performed before transferring information from the probe tag to the recording tag. In some cases, the observation of the detectable label can be performed after transferring information from the probe tag to the recording tag. In some embodiments, one or more of the aforementioned characteristics of the signal can be observed, measured, and recorded. In some embodiments, the detectable label can include a fluorophore, and the fluorescence wavelength or fluorescence intensity can be determined using a fluorescence detection system.

[0203] The signal from the detectable label can be detected using a detection system. Examples include microscopes configured for light, bright-field, dark-field, phase contrast, fluorescence, reflectance, interference, and / or confocal imaging. Detection systems can include electron spin resonance (ESR) detection systems, charge-coupled device (CCD) detection systems (e.g., for radioisotopes), fluorescence detection systems, electrical detection systems, photographic film detection systems, chemiluminescence detection systems, enzyme detection systems, atomic force microscope (AFM) detection systems (for detecting microbeads), scanning tunneling microscope (STM) detection systems (for detecting microbeads), optical detection systems, near-field detection systems, or total internal reflection (TIR) ​​detection systems.

[0204] In some embodiments, evaluating, e.g., observing, the detectable label may include capturing an image of the spatial sample. In some examples, evaluating, e.g., observing, the detectable label may include acquiring a digital image of the spatial sample or a portion thereof. In some embodiments, a microscope connected to an imaging device may be used as a detection system in accordance with the methods disclosed herein. In some embodiments, the detectable label (e.g., a fluorophore) may be excited, and the resulting signal (e.g., a fluorescent signal) may be observed and recorded in the form of a digital signal (e.g., a digitized image). The same procedure may be repeated for different detectable labels (e.g., if present on multiple molecular probes) bound to the sample using appropriate fluorescence filters. In some embodiments, the method may include overlaying all images to generate an image showing the pattern of binding of all molecular probes to the sample.

[0205] In some embodiments of the methods provided herein, the method includes acquiring at least one image of the spatial sample. In some cases, two or more digital images of the spatial sample are acquired. For example, the two or more digital images may provide combined spatial information of multiple molecular probes. In some embodiments, the method may also include comparing, aligning, and / or overlaying at least two of the images. Evaluation, e.g., observation, may be performed on the spatial sample in contact with a solid support. The image may include an image of a detectable label and / or spatial information of the sample. Detection devices known in the art and as described above may be used to acquire the image. Spatial samples containing biological specimens may be stained prior to imaging to provide morphological or anatomical information, including visualizing various regions or cells. In some embodiments, multiple stains may be used to image different aspects of the specimen (e.g., different regions of tissue, different cells, specific subcellular components, etc.). In other embodiments, spatial samples containing biological specimens may be imaged without staining. In some cases, different images may be registered to each other (including correcting for distortion or warping of the images and / or sample) by utilizing image features. For example, fiducial registration markers can be introduced for this purpose, or other types of markers that are detectable across the image can be used.

[0206] In some examples, the provided methods can be used in conjunction with other methods to identify features of a spatial sample, such as optical images of the spatial sample and / or images of histological stains. In some examples, the sample can be stained using a cytological stain before or after performing the above-described methods. In these embodiments, the stain can be, for example, phalloidin, gadodiamide, acridine orange, Bismarck brown, varmin, Coomassie blue, Bressil violet, Bristol violet, DAPI, hematoxylin, eosin, ethidium bromide, acid fuchsin, hematoxylin, Hoechst stain, iodine, malachite green, methyl green, methylene blue, neutral red, Nile blue, Nile red, osmium tetroxide (official name: osmium tetroxide), rhodamine, safranine, limonene, or the like. Stains can be phosphotungstic acid, osmium tetroxide, ruthenium tetroxide, ammonium molybdate, cadmium iodide, carbohydrazide, ferric chloride, hexamine, indium trichloride, lanthanum nitrate, lead acetate, lead citrate, lead(II) nitrate, periodic acid, phosphomolybdic acid, potassium ferricyanide, potassium ferrocyanide, ruthenium red, silver nitrate, silver proteinate, sodium chloroaurate, thallium nitrate, thiosemicarbazide, uranyl acetate, uranyl nitrate, vanadyl sulfate, or any derivative thereof. Stains can be specific to any feature of interest: proteins or classes of proteins, phospholipids, DNA (e.g., dsDNA, ssDNA), RNA, organelles (e.g., cell membranes, mitochondria, endoplasmic reticulum, Golgi apparatus, nuclear envelope, etc.), and cellular compartments (e.g., cytosol, nuclear fraction, etc.). Stains can enhance contrast or imaging of intracellular or extracellular structures. In some embodiments, samples may be stained with hematoxylin and eosin (H&E). By combining other types of information, a richer spatial context for interpreting protein information may be useful.

[0207] In some embodiments, the method includes correlating the location of the sample in the image with a probe tag associated with the molecular probe. Thus, characteristics of a spatial sample containing a biological specimen identifiable in the image can be correlated with molecular probes bound to the same location in the spatial sample. For example, any of a variety of morphological characteristics can be used in such correlations, including cell shape, cell size, tissue shape, staining patterns, the presence of specific proteins (e.g., detected by immunohistochemical staining), or other characteristics routinely evaluated in pathology or research applications. Thus, the biological state of a tissue or its components determined by visual observation can be correlated with molecular probe and macromolecule information from macromolecule analysis assays.

[0208] In some embodiments, the method includes inactivating the detectable label after evaluating or observing the detection of the label. For example, chemical inactivation of the fluorescent dye can be performed after each round of image acquisition. In some embodiments, the molecular probe is removed after detecting the detectable label. In one example, the method includes cycles of binding the molecular probe to the spatial sample, observing the detectable label, and washing to remove the molecular probe. In some embodiments, the detectable label is inactivated before binding a new molecular probe to the sample. In some examples, the sample is treated with an inactivation solution to inactivate the detectable label. For example, the sample can be treated with alkaline oxidation chemistry to inactivate the dye. See, e.g., Gerdes et al., Proc Natl Acad Sci USA. (2013) 110(29):11982-11987.

[0209] C. Transfer of probe tag information In the methods provided herein, the molecular probe comprises a probe tag that includes information to be transferred to a recording tag. In some embodiments, information from multiple probe tags is transferred to multiple recording tags. In some embodiments involving the transfer of information from multiple probe tags to recording tags, information from each probe tag is transferred sequentially to the recording tag. In some embodiments, information from one probe tag is transferred to two or more recording tags. In some embodiments, information from multiple probe tags is transferred to a recording tag. In some embodiments, the probe tag comprises at least one barcode. In some embodiments, the information transferred from the probe tag to the extended recording tag is sometimes referred to as the probe tag. In some embodiments, the extended recording tag comprises a probe tag sequence. In some cases, the transferred probe tag sequence may be complementary to a probe tag sequence associated with or attached to the molecular probe.

[0210] In some embodiments, the use of molecular probes can include adjustments useful for subsampling and / or adjusting the dynamic range. In some cases, the concentration of molecular probes provided to a sample can be adjusted and regulated. For example, for single molecule detection, the concentration of molecular probes provided can be reduced. In some embodiments, a sample is provided with multiple molecular probes, some of which are labeled with probe tags and some of which are not labeled with probe tags (e.g., "dummy molecular probes"). In some cases, a sample is provided with multiple molecular probes (e.g., "dummy molecular probes"), including at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, or 99% of the molecular probes that are not labeled with probe tags. In some embodiments, a sample is provided with multiple molecular probes, and two or more of the same molecular probes are associated with different probe tags.

[0211] Multiple macromolecules in a spatial sample can be labeled with probe tags or can contain information transferred from probe tags containing the same barcode. In some embodiments, multiple recording tags adjacent to a probe tag associated with a molecular probe can be extended by transferring information from the probe tag. As long as the recording tag is adjacent to the probe tag, the recording tag does not need to be attached to or associated with the moiety bound by the molecular probe. In some embodiments, the information of the probe tag can be transferred to the adjacent recording tag, and the probe tag is indirectly associated with the moiety bound by the molecular probe. For example, the distance between the recording tag and the moiety or macromolecule bound by the molecular probe containing the probe tag can be about 10 nm to 100 nm, about 10 nm to 500 nm, about 10 nm to 1,000 nm, about 10 nm to 5,000 nm, about 100 nm to 300 nm, about 100 nm to 600 nm, about 100 nm to 1,000 nm, about 100 nm to 5,000 nm, about 300 nm to 600 nm, about 300 nm to 1,000 nm, or about 300 nm to 5,000 nm. In some examples, multiple macromolecules within a cell can be labeled with probe tags or contain information transferred from probe tags containing the same barcode. In some examples, multiple macromolecules within an organelle can be labeled with probe tags or contain information transferred from probe tags containing the same barcode.

[0212] In some embodiments, the probe tag is a nucleic acid tag containing a barcode that is transferred to a recording tag associated with a macromolecule in the spatial sample. In some embodiments, the probe tag information is transferred to the recording tag by generating a sequence in situ on the recording tag associated with the macromolecule in the spatial sample. By transferring information from the probe tag to the recording tag, in some embodiments, the recording tag includes the probe tag. In some examples, the method includes generating a sequence in situ on the recording tag that includes a barcode sequence from the probe tag. In some embodiments, the probe tag is physically transferred to the recording tag. In some cases, the probe tag is generated or attached to the recording tag using a chemical / enzymatic reaction such as ligation, polymerase, or primer extension.

[0213] In certain embodiments, the probe tag includes an optional unique molecular identifier (UMI), which provides a unique identifier tag for each associated macromolecule (e.g., polypeptide). The UMI can be about 3 to about 40 bases, about 3 to about 30 bases, about 3 to about 20 bases, or about 3 to about 10 bases, or about 3 to about 8 bases. In some embodiments, the UMI is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 16 bases, 17 bases, 18 bases, 19 bases, 20 bases, 25 bases, 30 bases, 35 bases, or 40 bases in length.

[0214] The probe tag can be any suitable tag. In some examples, the probe tag comprises a DNA molecule, a DNA with pseudo-complementary bases, an RNA molecule, a BNA molecule, an XNA molecule, an LNA molecule, a PNA molecule, or a γPNA molecule. In some embodiments, the probe tag comprises a non-nucleic acid sequenceable polymer, such as a polysaccharide, a polypeptide, a peptide, or a polyamide, or a combination thereof. In some embodiments, the probe tag is a nucleic acid. In some embodiments, the probe tag comprises a nucleic acid molecule of about 3 to about 40 bases in length (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 bases). The probe tag may comprise a barcode sequence, optionally flanked on one side by a spacer or on both sides by spacers. The probe tag may be single-stranded or double-stranded. A double-stranded probe tag may comprise a blunt end, a protruding end, or both. The probe tag may refer to a probe tag directly attached to a molecular probe, a complementary sequence of a probe tag directly attached to a probe agent, or probe tag information present in an extended recording tag.

[0215] In certain embodiments, the probe tag comprises a barcode. The barcode is a nucleic acid molecule about 3 to about 30 bases, about 3 to about 25 bases, about 3 to about 20 bases, about 3 to about 10 bases, about 3 to about 10 bases, or about 3 to about 8 bases in length. In some embodiments, the barcode is about 3 bases, 4 bases, 5 bases, 6 bases, 7 bases, 8 bases, 9 bases, 10 bases, 11 bases, 12 bases, 13 bases, 14 bases, 15 bases, 20 bases, 25 bases, or 30 bases in length. In one embodiment, the barcode enables multiplexed sequencing of multiple samples or libraries. The barcodes can be used to deconvolute multiplexed sequence data and identify sequence reads from individual samples or libraries. In some embodiments, the probe tag comprises multiple barcodes. For example, a probe tag can be composed of a string of two or more tags, each of which is a barcode. In some embodiments, the concatenated string of barcodes can increase the variety of barcodes for labeling or identification. For example, if 10 different tags (e.g., barcodes) are used and randomly concatenated into a string of 3 tags as a barcode, the concatenated barcode can be 10 by using 10 tags arranged in combination. 3 = 1000 possible sequences. In some embodiments, a series of probe tags used in combination can be used to provide information about one or more molecular probes. For example, a recording tag can include a series of information from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more probe tags.

[0216] In some embodiments, the probe tag comprises a peptide or amino acid barcode, which includes a sequence of amino acids that may be at least, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 40, 50, 75, or 100 amino acids in length. A particular peptide barcode that can be distinguished from other peptide barcodes may have different physical properties (amino acid sequence, sequence length, charge, size, molecular weight, hydrophobicity, reverse-phase separation, affinity, or other separable properties). See, for example, International Patent Publications 2016 / 145416 and 2018 / 078167. The probe tag may comprise a barcode associated with one or more molecular probes. The molecular probes may be associated with or attached to the peptide barcode using any suitable means, including, but not limited to, any enzymatic or chemical attachment means. The peptide barcode information of the probe tag can be transferred to the recording tag using any suitable means, including, but not limited to, any enzymatic or chemical attachment method. See, for example, Miyamoto et al., PLoS One. (2019) 14(4):e0215993; Wroblewska et al., Cell. (2018) 175(4):1141-1155. e16. In some embodiments, a linker, typically made with a flexible amino acid sequence, can be used to allow attachment of two different polypeptides. For example, a linear linking peptide can be made of 2-25 amino acids, 2-15 amino acids, or a longer linker can be used.

[0217] In some embodiments, the probe tag comprises a spacer. In some embodiments, the spacer on the probe tag is configured to hybridize to a sequence comprised by the recording tag. In some embodiments, the probe tag comprises a universal priming site. In some embodiments, the probe tag further comprises another nucleic acid moiety. In some embodiments, the probe tag further comprises a universal priming site.

[0218] The information from the probe tag can be transferred to the recording tag by any suitable method. For example, the information from the probe tag can be transferred to the recording tag by extension or ligation. In some cases, the information from the probe tag can be transferred to the recording tag using ligation (e.g., enzymatic or chemical ligation, splint ligation, sticky end ligation, single-stranded (ss) ligation such as ssDNA ligation, or any combination thereof), polymerase-mediated reaction (e.g., primer extension of single-stranded or double-stranded nucleic acid), or any combination thereof, to generate an extended recording tag. In some embodiments, transferring the information from the probe tag to the recording tag includes contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the recording tag. In some cases, the probe tag in the molecular probe serves as a template for extension. In certain embodiments, the information from the probe tag is transferred to the recording tag via primer extension (Chan et al., Curr Opin Chem Biol. (2015) 26:55-61). The spacer sequence at the 3' end of the recording tag anneals to the complementary spacer sequence at the 3' end of the probe tag, and a polymerase (e.g., a strand-displacing polymerase) extends the recording tag sequence using the annealed probe tag as a template.

[0219] In some embodiments, information from a probe tag can be transferred to any recording tag that is close to the probe tag. The distance between the location in the spatial sample bound by the molecular probe and the recording tag that allows the probe tag information to be transferred to the recording tag can depend on the distance that the probe tag and the recording tag can reach. For example, the molecular probe can be a nucleic acid that binds to a target nucleic acid, and the target nucleic acid is bound to a polymerase. In this example, the polymerase is attached to a recording tag, and the recording tag is near the probe tag attached to the target nucleic acid. In another example, a recording tag included in a matrix applied to the spatial sample can be close to a probe tag attached to a molecular probe that is bound to a polypeptide in the spatial sample.

[0220] The transfer of information from the probe tag to the recording tag can occur directly from the probe tag in the molecular probe, or indirectly through a copy of the probe tag. In some embodiments, the probe tag in the molecular probe is copied one or more times before transferring the probe tag information to the recording tag. For example, the probe tag in the molecular probe can be amplified before transferring the probe tag information to the recording tag. In some cases, the amplification of the probe tag is linear amplification. In some embodiments, the amplification of the probe tag is performed using RNA polymerase. If the probe tag copy contains RNA, the transfer of the probe tag to the recording tag can be performed using reverse transcription. In one example, the molecular probe can bind to a cell surface marker, and a polypeptide within the cell is associated with the recording tag. In this case, a copy of the probe tag attached to the molecular probe bound to the outside of the cell is made, and the copy of the probe tag diffuses into the cell, allowing information to be transferred from the copy of the probe tag to the recording tag attached to the macromolecule within the cell.

[0221] Following the transfer of information from the probe tag to the recording tag, the macromolecule associated with the recording tag containing information from one or more probe tags is used in a macromolecule analysis assay. In some embodiments, the macromolecule analysis assay is a polypeptide analysis assay. In some embodiments, the probe tag includes a barcode that can be used to provide or derive information about the spatial location of the protein within a spatial sample. The barcode can enable multiplex sequencing of multiple samples or libraries from tissue sections.

[0222] Optionally, the spatial sample, or any portion thereof, can be removed from the solid support after transferring information from one or more probe tags to the recording tags and after obtaining one or more images of the detectable labels. Accordingly, the disclosed methods can include washing the solid support to remove macromolecules, cells, tissues, or other materials from the spatial sample. Removal of the spatial sample, or any portion thereof, can be performed using any suitable technique and will depend on the sample. In some cases, the solid support can be washed with water containing various additives, such as surfactants, detergents, enzymes (e.g., proteases and collagenases), cleavage reagents, etc., to facilitate specimen removal. In some embodiments, the solid support is treated with a solution containing a proteinase enzyme. In some embodiments, the macromolecules are released during or after the specimen is removed from the solid support. In some embodiments, the method includes releasing and / or collecting an extended recording tag from the spatial sample. In some embodiments, the released and / or collected extended recording tag comprises at least one probe tag.

[0223] IV. Macromolecular Analysis Assays In the provided methods, a macromolecule (e.g., a polypeptide) associated with a recording tag containing information transferred from one or more probe tags and spatial tags is optionally used in a macromolecule analysis assay. In some embodiments, a macromolecule having an associated and / or attached recording tag (containing information transferred from one or more probe tags and spatial tags) is subjected to a polypeptide analysis assay. In some examples, the macromolecule analysis assay is performed on a macromolecule released from a spatial sample. In preferred embodiments, a macromolecule having an extended recording tag attached is released from the sample before performing the macromolecule analysis assay. The macromolecule analysis assay is performed to identify or determine at least a portion of a sequence or to evaluate the macromolecule. In some embodiments, the provided methods provide spatial information along with information obtained from performing the macromolecule analysis assay.

[0224] In an exemplary preparation method, a sample is prepared for spatial analysis by fixing and embedding the tissue sample in paraffin (e.g., FFPE (formalin-fixed, paraffin-embedded sample)), followed by sectioning the embedded tissue sample. Planar sections can then be attached to or provided on slides. During sample preparation, macromolecules within the spatial sample are provided with recording tags. The spatial sample is provided with a plurality of molecular probes, each comprising a probe tag and, optionally, a detectable label. The molecular probes bind to the spatial sample, and information from the probe tags associated with the molecular probes is transferred to recording tags associated with macromolecules within the sample. Evaluating the spatial location of the macromolecules within the sample can include 1) evaluating the detectable labels of the molecular probes, including observing the detectable labels one or more times to obtain spatial information of the molecular probes, as shown in Figures 1A-D, or 2) evaluating spatial tags provided to the spatial sample in situ to obtain the spatial location of the spatial tag within the spatial sample, as shown in Figures 2A-2F. The macromolecules with associated recording tags (including information transferred from one or more probe tags) are subjected to a macromolecular analysis assay.

[0225] In some embodiments, the macromolecular analytical assay is a next-generation protein assay (NGPA) that uses multiple binding agents and enzymatically mediated sequential information transfer. In some cases, the analytical assay is performed on immobilized protein molecules that are simultaneously bound by two or more cognate binding agents (e.g., antibodies). After multiple cognate antibody binding events, a combined primer extension and DNA nicking step is used to transfer information from the coding tags of the bound antibodies to a recording tag. In some cases, polyclonal antibodies (or a mixed population of monoclonal antibodies) directed against multiple epitopes on a protein can be used in the assay. See, for example, International Patent Publication No. 2017 / 192633. In some specific embodiments, a polypeptide analytical assay can be performed to assay peptide barcodes (e.g., from probe tags and / or spatial tags).

[0226] In some embodiments, the macromolecule is a polypeptide, and a polypeptide analysis assay is performed. The macromolecule analysis assay may include contacting the macromolecule with a binding agent capable of binding to the macromolecule, where the binding agent includes a coding tag having identifying information about the binding agent, and transferring the coding tag information to a recording tag to generate an extended recording tag (including probe tag information). Contacting the macromolecule with a binding agent capable of binding to the macromolecule (where the binding agent includes a coding tag having identifying information about the binding agent), and transferring the coding tag information to the recording tag and extending the recording tag may be repeated one or more times. In some embodiments, transferring information from a probe tag in a molecular probe to a recording tag can be performed before or after evaluating, e.g., observing, a detectable label to obtain spatial information about the molecular probe. In some cases, the polypeptide analysis assay is performed on the polypeptide in situ without releasing the polypeptide from the spatial sample. In some cases, the polypeptide analysis assay is performed on the polypeptide released from the spatial sample. In some cases, the polypeptide analysis assay is performed on the polypeptide in situ without releasing the polypeptide from the spatial sample. In some embodiments, the identity of the sequence (or a portion of the sequence) and / or protein is determined using a polypeptide analysis assay. In some embodiments, the protein from the spatial sample can be treated or further processed, for example, with one or more enzymes and / or reagents.

[0227] In some examples, a polypeptide analysis assay involves assessing at least a partial sequence or identity of a polypeptide using a suitable technique or procedure. For example, at least a partial sequence of a polypeptide can be assessed by N-terminal amino acid analysis or C-terminal amino acid analysis. In some embodiments, at least a partial sequence of a polypeptide can be assessed using a ProteoCode assay. In some examples, at least a partial sequence of a polypeptide can be assessed by the techniques or procedures disclosed and / or claimed in U.S. Provisional Patent Applications Nos. 62 / 330,841, 62 / 339,071, 62 / 376,886, 62 / 579,844, 62 / 582,312, 62 / 583,448, 62 / 579,870, 62 / 579,840, and 62 / 582,916, and International Patent Publication Nos. 2017 / 192633, 2019 / 089836, and 2019 / 089851.

[0228] In embodiments of methods for analyzing peptides or polypeptides, the methods generally involve contacting and binding of a binding agent to a terminal amino acid (e.g., NTAA) of the peptide and transferring the coding tag information of the binding agent to a recording tag associated with the peptide, thereby generating a primary extended recording tag. The terminal amino acid bound by the binding agent can be a chemically labeled or modified terminal amino acid. In some embodiments, the terminal amino acid (e.g., NTAA) is removed. The removed terminal amino acid can be a chemically labeled or modified terminal amino acid. Removal of the NTAA by contact with an enzyme or chemical reagent converts the penultimate amino acid of the peptide into a terminal amino acid. Polypeptide analysis can include one or more cycles of binding additional binding agents to the terminal amino acid, transferring information from the additional binding agent to the extended nucleic acid, thereby generating a higher-order extended recording tag containing information from two or more coding tags, and periodically removing the terminal amino acid. Additional binding, transfer, labeling, and removal occur as described above for up to n amino acids, generating n-order extended nucleic acids that collectively represent the peptide. In some embodiments, the step involving NTAA in the described exemplary approach can instead be performed using a C-terminal amino acid (CTAA).

[0229] In some embodiments, the order of steps in the process of peptide or polypeptide sequencing assay by degradation can be reversed or performed in a different order, for example, in some embodiments, terminal amino acid labeling can be performed before and / or after conjugation of the polypeptide to a binding agent.

[0230] In some embodiments, the method optionally includes collecting proteins having associated extended recording tags (containing information from the probe tag and / or spatial tag) before performing a protein (e.g., polypeptide) analysis assay. In some embodiments, the method optionally includes releasing the proteins from the spatial sample. The polypeptide analysis assay can further utilize the extended recording tag by transferring information thereto.

[0231] In some embodiments, the method includes fragmenting proteins obtained from the spatial sample. In some embodiments, the fragmentation is performed prior to the polypeptide analysis assay. In some instances, the proteins are derived from a proteolytic digest or have been treated with a protease. In some cases, the protease is trypsin, LysN, or LysC. In some embodiments, the proteins remain intact. In some embodiments, the protein analysis assay is performed on the intact spatial sample. In some embodiments, the protein analysis assay includes a binding agent for the target protein (or portion thereof).

[0232] In some embodiments, macromolecules (e.g., polypeptides) released from a spatial sample are conjugated to the surface of a solid support prior to performing a polypeptide analysis assay. The solid support can be any support surface, including, but not limited to, beads, microbeads, arrays, glass surfaces, silicon surfaces, plastic surfaces, filters, membranes, PTFE membranes, nylon, silicon wafer chips, flow cells, flow-through chips, biochips including signal transduction electronics, microtiter wells, ELISA plates, spin interference disks, nitrocellulose membranes, nitrocellulose-based polymer surfaces, nanoparticles, or microspheres. Solid support materials include, but are not limited to, acrylamide, agarose, cellulose, dextran, nitrocellulose, glass, gold, quartz, polystyrene, polyethylene vinyl acetate, polypropylene, polyester, polymethacrylate, polyacrylate, polyethylene, polyethylene oxide, polysilicate, polycarbonate, polyvinyl alcohol (PVA), Teflon, fluorocarbon, nylon, silicone rubber, silica, polyanhydrides, polyglycolic acid, polyvinyl chloride, polylactic acid, polyorthoesters, functionalized silanes, polypropyl fumerate, collagen, glycosaminoglycans, polyamino acids, or any combination thereof. In certain embodiments, the solid support is a bead, such as a polystyrene bead, a polymeric bead, a polyacrylate bead, agarose bead, cellulose bead, dextran bead, acrylamide bead, solid core bead, porous bead, paramagnetic bead, glass bead, silica-based bead, or controlled pore bead, or any combination thereof.

[0233] As used herein, the terms "solid support," "solid surface," "solid substrate," "sequencing substrate," or "substrate" refer to any solid material, including porous and non-porous materials, to which a macromolecule, e.g., a polypeptide, can be associated, directly or indirectly, by any means known in the art, including covalent and non-covalent interactions, or any combination thereof. A solid support can be two-dimensional (e.g., planar) or three-dimensional (e.g., gel matrix or bead). A solid support can be any support surface, including, but not limited to, beads, microbeads, arrays, glass surfaces, silicon surfaces, plastic surfaces, filters, membranes, PTFE membranes, PTFE membranes, nitrocellulose membranes, nitrocellulose-based polymer surfaces, nylon, silicon wafer chips, flow-through chips, flow cells, biochips including signal transduction electronics, channels, microtiter wells, ELISA plates, spin interference disks, polymer matrices, nanoparticles, or microspheres. Solid support materials include, but are not limited to, acrylamide, agarose, cellulose, dextran, nitrocellulose, glass, gold, quartz, polystyrene, polyethylene vinyl acetate, polypropylene, polyester, polymethacrylate, polyacrylate, polyethylene, polyethylene oxide, polysilicate, polycarbonate, polyvinyl alcohol (PVA), Teflon, fluorocarbon, nylon, silicone rubber, polyanhydrides, polyglycolic acid, polyvinyl chloride, polylactic acid, polyorthoesters, functionalized silanes, polypropyl fumerate, collagen, glycosaminoglycans, polyamino acids, dextran, or any combination thereof. Solid supports further include shaped polymers such as thin films, membranes, bottles, dishes, fibers, woven fibers, tubes, particles, beads, microspheres, microparticles, or any combination thereof.For example, when the solid surface is a bead, the bead can include, but is not limited to, ceramic beads, polystyrene beads, polymer beads, polyacrylate beads, methylstyrene beads, agarose beads, cellulose beads, dextran beads, acrylamide beads, solid core beads, porous beads, paramagnetic beads, glass beads, controlled pore beads, silica-based beads, or any combination thereof. The beads can be spherical or irregularly shaped. The beads or support can be porous. The size of the beads can range from nanometers, e.g., 100 nm, to several millimeters, e.g., up to 1 mm. In certain embodiments, the size of the beads ranges from about 0.2 microns to about 200 microns, or from about 0.5 microns to about 5 microns. In some embodiments, the beads can be about 1, 1.5, 2, 2.5, 2.8, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 15, or 20 μm in diameter. In certain embodiments, a "beaded" solid support may refer to an individual bead or a plurality of beads. In some embodiments, the solid surface is a nanoparticle. In certain embodiments, the size of the nanoparticles ranges from about 1 nm to about 500 nm in diameter, e.g., from about 1 nm to about 20 nm, from about 1 nm to about 50 nm, from about 1 nm to about 100 nm, from about 10 nm to about 50 nm, from about 10 nm to about 100 nm, from about 10 nm to about 200 nm, from about 50 nm to about 100 nm, from about 50 nm to about 150 nm, from about 50 nm to about 200 nm, from about 100 nm to about 200 nm, or from about 200 nm to about 500 nm. In some embodiments, the nanoparticles may be about 10 nm, about 50 nm, about 100 nm, about 150 nm, about 200 nm, about 300 nm, or about 500 nm in diameter. In some embodiments, the nanoparticles are less than about 200 nm in diameter.

[0234] A variety of reactions can be used to attach a polypeptide to a solid support. The polypeptide can be attached directly or indirectly to the solid support. In some cases, the polypeptide is attached to the solid support via a nucleic acid. Exemplary reactions include the copper-catalyzed reaction of azides and alkynes to form triazoles (Husgen 1,3-dipolar cycloaddition), strain-promoted azide-alkyne cycloaddition (SPAAC), reactions of dienes and dienophiles (Diels-Alder), strain-promoted alkyne-nitrone cycloaddition, reactions of strained alkenes with azides, tetrazines, or tetrazoles, alkene and azide [3 + 2] cycloaddition, alkene and tetrazine inverse electron demand Diels-Alder (IEDDA) reactions (e.g., m-tetrazine (mTet) or phenyltetrazine (pTet) and trans-cyclooctene (TCO); or pTet and alkenes), alkene and tetrazole photoreactions, the Staudinger reaction, the Staudinger ligation of azides and phosphines, and various substitution reactions such as the displacement of leaving groups by nucleophilic attack on an electrophilic atom (Horisawa 2014, Knall, Hollauf et al. al. 2014). Exemplary substitution reactions include reactions of amines with activated esters, N-hydroxysuccinimide esters, isocyanates, isothiocyanates, aldehydes, epoxides, and the like.

[0235] In some embodiments, multiple proteins are attached to a solid support prior to polypeptide analysis assays. In certain embodiments where multiple proteins are immobilized on the same solid support, the proteins can be appropriately spaced apart to accommodate the analytical method used to evaluate the proteins. For example, it may be advantageous to optimally space the proteins so that a nucleic acid-based method for evaluating and sequencing the proteins can be performed. In some embodiments, the method for evaluating and sequencing the proteins includes a binding agent that binds to the protein, and the binding agent includes a coding tag (e.g., a recording tag) that carries information that is transferred to the nucleic acid attached to the protein. In some cases, the information transfer from the coding tag of the binding agent bound to one protein can reach an adjacent protein.

[0236] In some embodiments, the surface of the solid support is passivated (blocked). A "passivated" surface refers to a surface that has been treated with an outer layer of material. Methods for passivating surfaces include polyethylene glycol (PEG) (Pan et al., 2015, Phys. Biol. 12:045006), polysiloxanes (e.g., Pluronic F-127), star polymers (e.g., star PEG) (Groll et al., 2010, Methods Enzymol. 472:1-18), hydrophobic dichlorodimethylsilane (DDS) plus self-assembled Tween-20 (Hua et al., 2014, Nat. Methods 11:1233-1236), diamond-like carbon (DLC), DLC plus PEG (Stavis et al., 2011, Proc. Natl. Acad. Sci. USA 108:983-988), and zwitterionic moieties (e.g., U.S. Patent Application Publication No. 2006 / 0183863). In addition to covalent surface modification, many passivating agents can be used as well, including surfactants such as Tween-20, polysiloxanes (Pluronic series) in solution, polyvinyl alcohol (PVA), and proteins such as BSA and casein. Alternatively, the density of an analyte (e.g., a protein, polypeptide, or peptide) can be titrated on the surface or within the volume of a solid substrate by spiking a competitor or "dummy" reactive molecule when the protein, polypeptide, or peptide is immobilized on the solid substrate.

[0237] To control protein spacing on a solid support, the density of functional coupling groups (e.g., TCO or carboxyl groups (COOH)) for attaching proteins can be titrated on the substrate surface. In some embodiments, multiple polypeptides are spaced on the surface or within a volume of a solid support (e.g., a porous support) so that adjacent proteins are separated by a distance of about 50 nm to about 500 nm, or about 50 nm to about 400 nm, or about 50 nm to about 300 nm, or about 50 nm to about 200 nm, or about 50 nm to about 100 nm. In some embodiments, multiple polypeptides are spaced apart on the surface of the solid support by an average distance of at least 50 nm, at least 60 nm, at least 70 nm, at least 80 nm, at least 90 nm, at least 100 nm, at least 150 nm, at least 200 nm, at least 250 nm, at least 300 nm, at least 350 nm, at least 400 nm, at least 450 nm, or at least 500 nm. In some embodiments, the plurality of polypeptides are spaced apart on the surface of the solid support by an average distance of at least 50 nm. In some embodiments, the proteins are spaced apart on the surface or within the volume of the solid support such that, empirically, the relative frequency of intermolecular events versus intramolecular events (e.g., information transfer) is <1:10, <1:100, <1:1,000, or <1:10,000.

[0238] In some embodiments, the plurality of proteins may be about 50 to 100 nm, about 50 to 250 nm, about 50 to 500 nm, about 50 to 750 nm, about 50 to 1,000 nm, about 50 to 1,500 nm, about 50 to 2,000 nm, about 100 to 250 nm, about 100 to 500 nm, about 200 to 500 nm, about 300 to 500 nm, about 100 to 1,000 nm, or about The proteins are coupled on a solid support spaced apart by an average distance between two adjacent proteins ranging from 500 to 600 nm, about 500 to 700 nm, about 500 to 800 nm, about 500 to 900 nm, about 500 to 1000 nm, about 500 to 2,000 nm, about 500 to 5,000 nm, about 1000 to 5,000 nm, or about 3,000 to 5,000 nm.

[0239] In some embodiments, the appropriate spacing of polypeptides on the solid support is achieved by titrating the ratio of available attachment molecules on the substrate surface. In some examples, the substrate surface (e.g., bead surface) is functionalized with carboxyl groups (COOH) that are treated with an activating agent (e.g., the activating agent is EDC and sulfo-NHS). In some examples, the substrate surface (e.g., bead surface) contains NHS moieties. In some embodiments, mPEG n -NH2 and NH2-PEG n A mixture of mPEG-NH (where n is any number, such as 1-100) and NH-PEG-mTet is added to the activated beads. The ratio between mPEG-NH (unavailable for coupling) and NH-PEG-mTet (available for coupling) is titrated to produce an appropriate density of functional moieties available for attaching polypeptides onto the substrate surface. In certain embodiments, the average spacing between coupling moieties (e.g., NH-PEG-mTet) on the solid surface is at least 50 nm, at least 100 nm, at least 250 nm, or at least 500 nm. In some specific embodiments, the NH-PEG n The ratio of mTet to mPEG3-NH2 is about 1:1000 or more, about 1:10,000 or more, about 1:100,000 or more, or about 1:1,000,000 or more. In some further embodiments, the recording tag is n In some embodiments, spacing of polypeptides on a solid support is achieved by controlling the concentration and / or number of available COOH or other functional groups on the solid support.

[0240] A. Periodic transfer of coding tag information to recording tag In some embodiments, a polypeptide analysis assay involves performing an assay utilizing an extended recording tag (containing information transferred from a probe tag and / or a spatial tag) associated with a polymer, e.g., a polypeptide. A recording tag associated with a polypeptide is used in a polypeptide analysis assay that involves transferring identifying information from one or more coding tags to the recording tag, thereby further extending the extended recording tag. In some embodiments, the spatial tag comprises a spacer polymer. In certain embodiments, the recording tag contains a spacer at its end, e.g., the 3' end. As used herein, reference to a spacer sequence in the context of a recording tag includes a spacer sequence identical to or complementary to the spacer sequence associated with its cognate binder. The end, e.g., the 3' spacer, on the recording tag allows the identity of the cognate binder to be transferred from its coding tag to the recording tag during the first binding cycle (e.g., by annealing a complementary spacer sequence for primer extension or sticky end ligation). In one embodiment, the spacer sequence is about 1 to 20 bases in length, about 2 to 12 bases in length, or about 5 to 10 bases in length. The length of the spacer can vary depending on factors such as the temperature and reaction conditions of the primer extension reaction for transferring the coding tag information to the recording tag.

[0241] In some embodiments, recording tags associated with a library of polypeptides share a common spacer sequence, while in other embodiments, recording tags associated with a library of polypeptides have binding cycle-specific spacer sequences that are complementary to the binding cycle-specific spacer sequences of their cognate binders.

[0242] In some embodiments, the spacer sequence in the recording tag is designed to have minimal complementarity to other regions in the recording tag, and similarly, the spacer sequence in the coding tag must have minimal complementarity to other regions in the coding tag. In other words, the spacer sequences of the recording tag and coding tag must have minimal sequence complementarity to components present in the recording tag or coding tag, such as unique molecular identifiers, barcodes (e.g., compartments, partitions, samples, spatial locations), universal primer sequences, encoder sequences, cycle-specific sequences, etc.

[0243] In some embodiments, the recording tag comprises, in a 5' to 3' direction, a universal forward (or 5') priming sequence, information transferred from the probe tag, and a spacer sequence. In some embodiments, the recording tag comprises, in a 5' to 3' direction, a universal forward (or 5') priming sequence, information transferred from the probe tag, optionally another barcode (e.g., a sample barcode, a partition barcode, a compartment barcode, or any combination thereof), and a spacer sequence. In some other embodiments, the recording tag comprises, in a 5' to 3' direction, a universal forward (or 5') priming sequence, information transferred from the probe tag, optionally another barcode (e.g., a sample barcode, a partition barcode, a compartment barcode, or any combination the...

Claims

1. 1. A method for analyzing macromolecules, wherein the macromolecules comprise polypeptides, nucleic acids, carbohydrates, or lipids, the method comprising: (a) providing a spatial sample comprising a macromolecule associated with a nucleic acid recording tag at a spatial location within the spatial sample; (b1) providing a plurality of spatial probes at spatial locations within the spatial sample, each spatial probe comprising a nucleic acid spatial tag; (b2) evaluating nucleic acid spatial tags in situ within the spatial sample using fluorescence imaging, combinatorial hybridization-based approaches, and / or in situ sequencing to obtain a spatial location of the nucleic acid spatial tag within the spatial sample for each of the plurality of spatial probes; (b3) extending the nucleic acid recording tag by transferring information from the nucleic acid spatial tag in a spatial probe of the plurality of spatial probes to the nucleic acid recording tag, so that the nucleic acid recording tag comes into proximity with the spatial probe, thereby recording information of the spatial position of the spatial probe in the nucleic acid recording tag; (c1) binding a molecular probe comprising a nucleic acid probe tag to the macromolecule or a portion proximate to the macromolecule within the spatial sample, wherein the molecular probe comprises a targeting moiety capable of specifically and / or selectively binding to the macromolecule; (c2) extending the nucleic acid recording tag by transferring information from the nucleic acid probe tag in the molecular probe to the nucleic acid recording tag, wherein transferring information from the nucleic acid probe tag and the nucleic acid spatial tag to the nucleic acid recording tag produces an extended nucleic acid recording tag; and (d) determining the sequence of the extended nucleic acid recording tag, wherein at least the sequence of the nucleic acid probe tag and the sequence of the nucleic acid spatial tag are determined; (e) associating information from the sequences of the nucleic acid spatial tags and nucleic acid probe tags determined in step (d) with information about the spatial position of the nucleic acid spatial tags evaluated in step (b2).

2. The method described in claim 1, wherein step (b2) is performed after step (b3).

3. The method described in claim 1, wherein in (b1), the multiple spatial probes are randomly distributed within the spatial sample.

4. 2. The method of claim 1, wherein the molecular probe further comprises a detectable label, and the method further comprises evaluating or observing the detectable label in order to assess in situ the spatial location of the macromolecule within the spatial sample in step (b).

5. 10. The method of claim 1 or 4, further comprising repeating steps (c1) and (c2) sequentially two or more times.

6. The method of claim 1 , wherein the spatial probe comprises a bead or a microparticle.

7. 10. The method of claim 1, wherein the nucleic acid spatial tag comprises a sequence complementary to the nucleic acid recording tag or a portion thereof.

8. The method of claim 1 , wherein performing step (b2) comprises obtaining an image of the spatial sample or a portion thereof.

9. 10. The method of claim 1, wherein the nucleic acid spatial tag is evaluated in step (b2) using a decoder, the decoder comprising a detectable label and a sequence complementary to the nucleic acid spatial tag or a portion thereof, and the detectable label comprises a radioisotope, a fluorescent label, a colorimetric label, or an enzyme substrate label.

10. 2. The method of claim 1, wherein extending the nucleic acid recording tag by transferring information from the nucleic acid spatial tag to the nucleic acid recording tag comprises contacting the spatial sample with a polymerase and a nucleotide mixture, thereby adding one or more nucleotides to the nucleic acid recording tag.

11. 10. The method of claim 1, further comprising performing a macromolecule analysis assay on the macromolecule associated with the nucleic acid recording tag, wherein the macromolecule is coupled directly or indirectly to a solid support prior to performing the macromolecule analysis assay.

12. the macromolecular analysis assay comprising: contacting the macromolecule with a binding agent capable of binding to the macromolecule, the binding agent comprising a nucleic acid coding tag having identifying information regarding the binding agent; and extending the nucleic acid coding tag associated with the polymer by transferring information from the nucleic acid coding tag to the nucleic acid coding tag.

13. contacting the macromolecule with an additional binding agent capable of binding to the macromolecule, wherein the additional binding agent comprises a nucleic acid coding tag having identifying information for the additional binding agent; and extending the nucleic acid coding tag associated with the polymer by transferring the identifying information of the nucleic acid coding tag for the additional binding agent to the nucleic acid coding tag one or more times.

14. 1. A method for analyzing macromolecules, wherein the macromolecules comprise polypeptides, nucleic acids, carbohydrates, or lipids, the method comprising: (a) providing a spatial sample comprising a macromolecule associated with a nucleic acid recording tag at a spatial location within the spatial sample; (b1) binding a molecular probe comprising a nucleic acid probe tag to the macromolecule or a portion proximate to the macromolecule within the spatial sample, wherein the molecular probe comprises a targeting moiety capable of specifically and / or selectively binding to the macromolecule, and the molecular probe further comprises a detectable label; (b2) evaluating or observing the detectable label within the spatial sample using an imaging method to evaluate in situ the spatial location of the macromolecule within the spatial sample; (b3) extending the nucleic acid recording tag by transferring information from the nucleic acid probe tag in the molecular probe to the nucleic acid recording tag, wherein transferring information from the nucleic acid probe tag to the nucleic acid recording tag produces an extended nucleic acid recording tag; and (c) repeating steps (b1) through (b3) by binding a second molecular probe having a second detectable label to transfer information from the nucleic acid probe tag of the second molecular probe to the extended nucleic acid recording tag associated with the polymer, and evaluating or observing the second detectable label; (d) determining the sequence of the extended nucleic acid recording tag after transferring information from the nucleic acid probe tag of the molecular probe and the nucleic acid probe tag of the second molecular probe, wherein the sequence of at least the nucleic acid probe tag is determined; (e) correlating information from the sequence of the nucleic acid probe tag determined in step (d) with information about the spatial location of the macromolecule evaluated in step (b2).

15. The method of claim 1, wherein step (e) further comprises associating at least a portion of the sequence of the polymer, or the identity of the polymer, with the spatial position evaluated in step (b2).

Citation Information

Patent Citations

  • Spatial molecular barcoding of in situ nucleic acids

    US20150148239A1

  • Methods and systems for determining spatial patterns of biological targets in a sample

    US9879313B2

  • Macromolecule analysis employing nucleic acid encoding

    WO2017192633A1

  • Kits for analysis using nucleic acid encoding and / or label

    WO2019089836A1